,Term,fdr,es,nes
0,negative regulation of microtubule depolymerization (GO:0007026),0.0,0.8163379092402893,1.9796286356292772
1,cristae formation (GO:0042407),0.0,0.6954937049558041,2.2685651059443592
2,regulation of microtubule depolymerization (GO:0031114),0.0,0.7398556241301996,2.09240505982175
3,response to muscle stretch (GO:0035994),0.0,0.8431777281916681,2.6104985602395816
4,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.013053933356234972,0.8113938567426316,1.9438263748529703
5,regulation of extracellular matrix disassembly (GO:0010715),0.03768411128184274,-0.9419550285225899,-1.4164342724265002
6,endothelial cell development (GO:0001885),0.05181565301253378,-0.9097057298843438,-1.4069965702864893
7,positive regulation of dephosphorylation (GO:0035306),0.056526166922764125,-0.8952939671636075,-1.4189031863187567
8,endothelial cell proliferation (GO:0001935),0.062283461701934544,-0.883125177125446,-1.3692656769035312
9,ethanol metabolic process (GO:0006067),0.06509073766863747,-0.9002387789758157,-1.3785190127279616
10,regulation of interleukin-12 production (GO:0032655),0.06594719474322482,-0.8525318052872939,-1.3699839495261872
11,eye morphogenesis (GO:0048592),0.06594719474322482,-0.9175227299441708,-1.3694859320210107
12,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.06688929752527088,-0.8908726179720589,-1.379585705761768
13,protein trimerization (GO:0070206),0.06908753735004504,-0.9393453253431997,-1.3702658172121198
14,protein homotrimerization (GO:0070207),0.06908753735004504,-0.9393453253431997,-1.3702658172121198
15,negative regulation of B cell activation (GO:0050869),0.07065770865345515,-0.8960116560511802,-1.3858168032662899
16,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.07348401699959335,-0.8967965781539615,-1.3990854105174992
17,necroptotic process (GO:0070266),0.07432144169474542,-0.8967743044738035,-1.3799738283135359
18,positive regulation of leukocyte activation (GO:0002696),0.07487237899418758,-0.8932971509606747,-1.363101696115971
19,regulation of T cell receptor signaling pathway (GO:0050856),0.07615330821539056,-0.8682214682459214,-1.3734506146891317
20,programmed necrotic cell death (GO:0097300),0.0767813767367546,-0.8910632070797571,-1.3616596457894168
21,regulation of DNA replication (GO:0006275),0.07897038025974398,-0.8450474697248977,-1.3460779965562193
22,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.07971638925005198,-0.8902551938407673,-1.370347169908156
23,positive regulation of nervous system process (GO:0031646),0.07985442628771439,-0.8903951456989566,-1.3603722993687557
24,regulation of myelination (GO:0031641),0.0805069650112095,-0.8498840688159569,-1.3463906563857915
25,positive regulation of macrophage activation (GO:0043032),0.08075166703252018,-0.8928991900562786,-1.386171928275097
26,negative regulation of osteoclast differentiation (GO:0045671),0.08227697629869,-0.8707193359375368,-1.3482049678275099
27,positive regulation of extracellular matrix organization (GO:1903055),0.08272840054842041,-0.9000675437799583,-1.3468210304601114
28,regulation of neuroinflammatory response (GO:0150077),0.08478925038414618,-0.869987625127665,-1.347073481137151
29,negative regulation of protein dephosphorylation (GO:0035308),0.0847892503841462,-0.9253743704214232,-1.4230424087179026
30,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.08511411341243794,-0.8613075152803924,-1.3482803363940234
31,camera-type eye development (GO:0043010),0.08546218094275053,-0.8731808230967552,-1.349293307932218
32,establishment of endothelial barrier (GO:0061028),0.0863594216875563,-0.8920816269234384,-1.390840859692299
33,granulocyte differentiation (GO:0030851),0.08682123677679458,-0.8524731961108074,-1.3312001172950785
34,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.0872317390783397,-0.8450824332125406,-1.3497550458147913
35,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.08742713817387518,-0.8487985371393002,-1.3317979215500995
36,prostanoid biosynthetic process (GO:0046457),0.08909600595921394,-0.881518420394847,-1.341768635232074
37,regulation of protein import into nucleus (GO:0042306),0.08913741707051266,-0.8589500563739464,-1.3502672425609799
38,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.0892113654835461,-0.9005358576030887,-1.3318346643665584
39,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.0894108866734288,-0.8476692849995799,-1.329080435419278
40,regulation of T cell migration (GO:2000404),0.09035622136896387,-0.8566287061532674,-1.334452362019283
41,positive regulation of neuron death (GO:1901216),0.09040563235403622,-0.8443847652990963,-1.3296527009909742
42,prostaglandin metabolic process (GO:0006693),0.09048112135900785,-0.8522823162086501,-1.332085272768201
43,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.0905465451633166,-0.8727309049212955,-1.3281434318351615
44,female gonad development (GO:0008585),0.09069158106684445,-0.8455169267386833,-1.3123659935627043
45,aorta morphogenesis (GO:0035909),0.0907285940100888,-0.8648458166928394,-1.333168314364004
46,prostaglandin biosynthetic process (GO:0001516),0.09078444990625754,-0.8799032339398666,-1.3551983387911473
47,leukocyte cell-cell adhesion (GO:0007159),0.09081870818924104,-0.8727185794922696,-1.350689180067952
48,dicarboxylic acid transport (GO:0006835),0.09122312304202176,-0.8240557513216905,-1.3126322845329146
49,negative regulation of T cell receptor signaling pathway (GO:0050860),0.0914040145985122,-0.8736527853875155,-1.3321544628783741
50,macrophage activation (GO:0042116),0.09148313857236826,-0.8427231325157741,-1.3388954167709533
51,negative regulation of cell-cell adhesion (GO:0022408),0.09159332603225669,-0.8366333321325357,-1.3408304737825198
52,negative regulation of interleukin-2 production (GO:0032703),0.09174286615639096,-0.8726582053789644,-1.3353460423447865
53,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.09179463004551439,-0.8430072179346827,-1.3377836734558113
54,regulation of cellular carbohydrate metabolic process (GO:0010675),0.09190736029293871,-0.8792943370459433,-1.3334767101229728
55,maintenance of blood-brain barrier (GO:0035633),0.09200040748128893,-0.8500362078723358,-1.3128665523680592
56,T cell activation involved in immune response (GO:0002286),0.09210558050003587,-0.8675401915373057,-1.3067425205555612
57,regulation of T cell activation (GO:0050863),0.09222139455362073,-0.8286390335780881,-1.3084976470565468
58,stem cell differentiation (GO:0048863),0.09223843517241744,-0.8391958951267825,-1.3346571742558617
59,embryonic digit morphogenesis (GO:0042733),0.0924973640554322,-0.8768178243078009,-1.3267356976364464
60,apoptotic cell clearance (GO:0043277),0.09255383375265774,-0.8044638439718275,-1.3077636043133125
61,regulation of leukocyte activation (GO:0002694),0.09256159833602626,-0.8858930956450461,-1.3368385032112824
62,negative regulation of T cell activation (GO:0050868),0.09258945621398998,-0.8237351925365923,-1.3068273719551076
63,regulation of nitric oxide biosynthetic process (GO:0045428),0.09262246452700114,-0.813285507156383,-1.308763816088454
64,amyloid-beta metabolic process (GO:0050435),0.09279712403153777,-0.8346469417249098,-1.3129346826276107
65,positive regulation of gene silencing by miRNA (GO:2000637),0.09281853545840246,-0.8376651600516457,-1.3091034091878495
66,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.09301606341046398,-0.8485535262742795,-1.3164757172998935
67,negative regulation of protein localization to nucleus (GO:1900181),0.09305076708824249,-0.8648480271441678,-1.3198178354202175
68,regulation of interleukin-10 production (GO:0032653),0.09306137237284337,-0.8371205429777876,-1.3357619950232487
69,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.09330689197524764,-0.8155151170166259,-1.315752035969752
70,interleukin-7-mediated signaling pathway (GO:0038111),0.09332705684643869,-0.8810474286848331,-1.3203277164625302
71,cellular response to interleukin-7 (GO:0098761),0.09332705684643869,-0.8810474286848331,-1.3203277164625302
72,positive regulation of organelle organization (GO:0010638),0.09349346087044139,-0.8219306510842221,-1.306925316998216
73,negative regulation of interleukin-10 production (GO:0032693),0.09361526592120935,-0.8477983908521556,-1.3057872550717111
74,integrated stress response signaling (GO:0140467),0.09364782878248981,-0.8456064540555218,-1.3182852970296293
75,regulation of interferon-alpha production (GO:0032647),0.09367193375772341,-0.8522494853914173,-1.3167060252792822
76,positive regulation of interleukin-6 production (GO:0032755),0.09388541517631513,-0.8165176723250405,-1.3091149550839114
77,acyl-CoA biosynthetic process (GO:0071616),0.09395565583108091,-0.8743093429100073,-1.3389057375684508
78,regulation of osteoclast differentiation (GO:0045670),0.09397177117117748,-0.8265975297696541,-1.3130107920029932
79,pulmonary valve development (GO:0003177),0.09421027820460687,-0.8541668560581968,-1.3045583247044452
80,regulation of interferon-gamma production (GO:0032649),0.09434882273137835,-0.8089805779617996,-1.317906339523328
81,positive regulation of nitric oxide metabolic process (GO:1904407),0.0946028210304594,-0.8260360549409325,-1.31578443345779
82,T cell proliferation (GO:0042098),0.0946028210304594,-0.840782354487761,-1.3510762582820266
83,hematopoietic progenitor cell differentiation (GO:0002244),0.0946198881098443,-0.8553864463437801,-1.3529854865813427
84,response to axon injury (GO:0048678),0.09476445631169281,-0.8500757620723959,-1.3096904773925448
85,positive regulation of interleukin-12 production (GO:0032735),0.09478124958766511,-0.8425374795752203,-1.3183723878565778
86,protein homotetramerization (GO:0051289),0.09488320876321123,-0.8195669051605183,-1.3038948110639526
87,cellular response to amyloid-beta (GO:1904646),0.09489722814984879,-0.8181025932398568,-1.3048465853799156
88,response to amyloid-beta (GO:1904645),0.09493497265233462,-0.8194397116436172,-1.313129226499988
89,negative regulation of cell junction assembly (GO:1901889),0.09496396043024373,-0.8518226690832105,-1.3028372020734966
90,negative regulation of phosphate metabolic process (GO:0045936),0.09497710605045834,-0.8443958085965986,-1.3091255943491185
91,negative regulation of tumor necrosis factor production (GO:0032720),0.09502949801508172,-0.8273819467582297,-1.3167118876827577
92,negative regulation of chemokine production (GO:0032682),0.0950514414028623,-0.8427623553804945,-1.325035795169079
93,protein localization to cell surface (GO:0034394),0.09525705907354695,-0.8360513334033857,-1.3031812586970317
94,regulation of triglyceride biosynthetic process (GO:0010866),0.0953560788854737,-0.8791286673289328,-1.3145344087983257
95,negative regulation of lymphocyte activation (GO:0051250),0.09557384802072619,-0.8334504260706711,-1.313504716424824
96,positive regulation of response to biotic stimulus (GO:0002833),0.09566829441491626,-0.8195255504462653,-1.3097672997946384
97,positive regulation of lipid storage (GO:0010884),0.09572979882081022,-0.8712599169969723,-1.3206745154488433
98,positive regulation of phosphatase activity (GO:0010922),0.09580706258095614,-0.8464065482006743,-1.322726856490741
99,positive regulation of T cell cytokine production (GO:0002726),0.09596887006442621,-0.8484322124751825,-1.3139433770953843
100,regulation of B cell activation (GO:0050864),0.09604554336443688,-0.846925492909403,-1.3131682675109775
101,regulation of establishment or maintenance of cell polarity (GO:0032878),0.0961936524825986,-0.8791167708139219,-1.3237709585194464
102,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.09668136746899,-0.8263503488060022,-1.3208502812090837
103,regulation of interleukin-2 production (GO:0032663),0.09697161394508673,-0.8428217129805301,-1.322927763792872
104,positive regulation of chromatin organization (GO:1905269),0.09813570646313216,-0.8466596709499055,-1.3208730445288013
105,prostanoid metabolic process (GO:0006692),0.0983666140077513,-0.8416052272289876,-1.3010452230969822
106,regulation of macrophage activation (GO:0043030),0.09846785808500737,-0.8325347668798346,-1.3001272048424908
107,regulation of lymphocyte activation (GO:0051249),0.0986006601015206,-0.8117545090204694,-1.3004081850127966
108,negative regulation of interferon-gamma production (GO:0032689),0.09860675785415518,-0.83260725322577,-1.2997456731815573
109,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.09878087586007792,-0.8310910328973808,-1.3014665846581193
110,defense response to Gram-positive bacterium (GO:0050830),0.10061657712252015,-0.8121563853103674,-1.2915835810317726
111,negative regulation of focal adhesion assembly (GO:0051895),0.10087393202883517,-0.861984101856786,-1.2920598059340003
112,negative regulation of cell-substrate junction organization (GO:0150118),0.10087393202883517,-0.861984101856786,-1.2920598059340003
113,T cell receptor signaling pathway (GO:0050852),0.10089616891590157,-0.7873956773939131,-1.291877160178677
114,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.1011015855917957,-0.8474607146533824,-1.297753057921126
115,purinergic nucleotide receptor signaling pathway (GO:0035590),0.10121122548403179,-0.8525807779296886,-1.297355135086539
116,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.10158712074326948,-0.8289018160365756,-1.2984233194798476
117,regulation of interleukin-17 production (GO:0032660),0.10177930910309667,-0.8191163586600103,-1.2939955412967852
118,maintenance of gastrointestinal epithelium (GO:0030277),0.10191159459752315,-0.8524388225509917,-1.2909326510129655
119,embryo development ending in birth or egg hatching (GO:0009792),0.10191839187589287,-0.8723764657593566,-1.2967155345917802
120,regulation of B cell differentiation (GO:0045577),0.10195841323451847,-0.8492115085514873,-1.2978378673554898
121,positive regulation of cell development (GO:0010720),0.10207411134399968,-0.8141647958766228,-1.292151537543952
122,negative regulation of cytokine production (GO:0001818),0.10208820664068176,-0.7823010077964311,-1.2943660022183072
123,positive regulation of immune effector process (GO:0002699),0.10218844590842044,-0.8222652169081344,-1.296328584851906
124,positive regulation of neuron apoptotic process (GO:0043525),0.10281208621459273,-0.833163736611354,-1.2944539135912072
125,modulation by symbiont of entry into host (GO:0052372),0.10292472893853301,-0.8450411817283132,-1.2921591844585483
126,positive regulation of interferon-gamma production (GO:0032729),0.10318621809654187,-0.8018094289623847,-1.2902697112341452
127,lymphocyte proliferation (GO:0046651),0.10323210993098025,-0.8338996247251398,-1.2928665889254893
128,regulation of interleukin-8 production (GO:0032677),0.10330074364540227,-0.8014356699543865,-1.2946350774451343
129,positive regulation of endothelial cell apoptotic process (GO:2000353),0.10346307338541648,-0.8665388737226449,-1.2953866354495762
130,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.10363130602506757,-0.8286052438462967,-1.2923006603479739
131,regulation of cytokine production involved in immune response (GO:0002718),0.10413153759075576,-0.8412473311975245,-1.294666312800309
132,negative regulation of T cell proliferation (GO:0042130),0.1057657576406407,-0.8117392878502634,-1.2889389389341293
133,positive regulation of interferon-alpha production (GO:0032727),0.10888955411090609,-0.837030335564562,-1.287159265611576
134,regulation of cellular biosynthetic process (GO:0031326),0.1096265055471789,-0.8281989445440664,-1.2860917413031745
135,calcium ion transport into cytosol (GO:0060402),0.10971873938598062,-0.8266635796447059,-1.2865282830864773
136,Rac protein signal transduction (GO:0016601),0.10988855584611981,-0.8386695407636536,-1.2851812468381931
137,negative regulation of Rho protein signal transduction (GO:0035024),0.10993560283725554,-0.8393351336204581,-1.2855875699465793
138,protein tetramerization (GO:0051262),0.11010376788645278,-0.8020199384360795,-1.2862000183592919
139,positive regulation of inflammatory response (GO:0050729),0.11151705523774948,-0.7929760299569442,-1.2843515673216246
140,positive regulation of T cell migration (GO:2000406),0.11305233384552825,-0.8296115001785898,-1.282625117041275
141,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.1138775333626489,-0.8187956554698748,-1.282626904236411
142,inflammatory response (GO:0006954),0.11412902273929519,-0.7814391235894815,-1.2814833893984896
143,plasma membrane invagination (GO:0099024),0.1141367687025597,-0.8136371218180382,-1.2817340761295875
144,antigen receptor-mediated signaling pathway (GO:0050851),0.11418739743835483,-0.7767415320052302,-1.2737830121265998
145,myeloid cell activation involved in immune response (GO:0002275),0.11422996232308583,-0.8455674997586556,-1.283007810641182
146,epithelial cell morphogenesis (GO:0003382),0.11459395657978545,-0.8445785935224188,-1.2738609255683486
147,protein homooligomerization (GO:0051260),0.11500547375952619,-0.7883224068469298,-1.2739667602203382
148,regulation of T cell proliferation (GO:0042129),0.1151458955834084,-0.7966386967663234,-1.2798312559967011
149,defense response to bacterium (GO:0042742),0.11529229850214127,-0.7842262307335546,-1.2800269558892403
150,regulation of necroptotic process (GO:0060544),0.11530644479643604,-0.8201910540141986,-1.2741829327197491
151,defense response to Gram-negative bacterium (GO:0050829),0.1153181506631074,-0.8021454217066919,-1.2755976083426177
152,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.11552451845089737,-0.8257552989194402,-1.280766746256961
153,"phagocytosis, engulfment (GO:0006911)",0.11557260880386805,-0.8127255569866711,-1.2758810659383364
154,dorsal/ventral pattern formation (GO:0009953),0.11570614449917914,-0.8181908367891398,-1.2801833606542508
155,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.11572744051059733,-0.7849591253269388,-1.274304967258783
156,negative regulation of chondrocyte differentiation (GO:0032331),0.11574405607994559,-0.8391074573334689,-1.2747653105933412
157,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.11581658751739995,-0.7899600058077332,-1.2729746868948626
158,response to peptide (GO:1901652),0.11613228524837116,-0.8130889911931334,-1.2759599788472646
159,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.11617304931105585,-0.8014235387226156,-1.274916559916421
160,regulation of chondrocyte differentiation (GO:0032330),0.116585219278201,-0.8169434706068635,-1.2726744000306467
161,gluconeogenesis (GO:0006094),0.11662370386897086,-0.8060626404415336,-1.276790328781733
162,positive regulation of interleukin-4 production (GO:0032753),0.11663840249976813,-0.8020901775630407,-1.2762037701173443
163,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.11679493393858797,-0.8037010327454049,-1.2788132225046682
164,regulation of phagocytosis (GO:0050764),0.11689765132326731,-0.7941907993518218,-1.2784649920632607
165,regulation of protein kinase A signaling (GO:0010738),0.11690369741993041,-0.8339313707486964,-1.274941929823296
166,positive regulation of interleukin-8 production (GO:0032757),0.11695069018502921,-0.7993951595283738,-1.2790432174070094
167,negative regulation of phagocytosis (GO:0050765),0.11699898063518069,-0.8411220782802111,-1.2781036399271264
168,negative regulation of lymphocyte proliferation (GO:0050672),0.11726039293866736,-0.8176644794902701,-1.2774599620640532
169,peptidyl-tyrosine modification (GO:0018212),0.11732898463244791,-0.7916000736002903,-1.2767983324014414
170,positive regulation of cartilage development (GO:0061036),0.11735730682308976,-0.841405557720371,-1.2770424532524731
171,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.1173957947237926,-0.8313309566141497,-1.2762215763462563
172,regulation of tumor necrosis factor production (GO:0032680),0.11748575870221564,-0.7839784982046379,-1.2716863497603716
173,B cell proliferation (GO:0042100),0.1177312335684416,-0.8399674129992475,-1.2775691097891895
174,regulation of T cell cytokine production (GO:0002724),0.11812519497962247,-0.8303257606735298,-1.2717151528881165
175,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.11883717548967078,-0.8257119945338259,-1.2710483004991262
176,ATP synthesis coupled proton transport (GO:0015986),0.11966105576548722,0.812070821347002,1.7224439619311545
177,cellular response to peptide (GO:1901653),0.12055629205136031,-0.7757832587924127,-1.270397461807105
178,negative regulation of cell-matrix adhesion (GO:0001953),0.12096599721471522,-0.8183266778772348,-1.269379864748135
179,regulation of DNA recombination (GO:0000018),0.12097220888141003,-0.8024534385610815,-1.2675494780866134
180,regulation of interleukin-4 production (GO:0032673),0.12135561260254443,-0.8083178745823264,-1.2687209103838313
181,positive regulation of interleukin-2 production (GO:0032743),0.12140279032275476,-0.8220656821196145,-1.268896372642268
182,regulation of leukocyte migration (GO:0002685),0.12155291641916231,-0.8452470201055242,-1.2694360363089063
183,positive regulation of positive chemotaxis (GO:0050927),0.12158851374915007,-0.8220554915447001,-1.2675507234970458
184,regulation of interleukin-6 production (GO:0032675),0.12171096635103837,-0.7842153332301915,-1.2696102522229236
185,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.1218452931446249,-0.8164822210394174,-1.2677557159641297
186,sensory perception of pain (GO:0019233),0.12194409044012038,-0.8430367970384831,-1.268231543202863
187,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.12198011413612188,-0.7964307691943586,-1.2652029019930255
188,"wound healing, spreading of cells (GO:0044319)",0.12217585552429018,-0.8278512438015376,-1.265361022512848
189,glucose metabolic process (GO:0006006),0.12222802239983109,-0.7966288272075507,-1.2649873334476176
190,positive regulation of endopeptidase activity (GO:0010950),0.12226283590463785,-0.8388209093137453,-1.2679168308912756
191,receptor internalization (GO:0031623),0.12252401235319571,-0.779533309533405,-1.2662275606589197
192,dendritic cell chemotaxis (GO:0002407),0.12252456290414362,-0.819030601354306,-1.266602036776004
193,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.12262780474501289,-0.800964625556098,-1.266714349903571
194,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.12267274849816799,-0.837213667145982,-1.2654278066029214
195,positive regulation of tumor necrosis factor production (GO:0032760),0.12272526080557346,-0.7877195187334785,-1.2658684047857751
196,positive regulation of histone modification (GO:0031058),0.12282414461675077,-0.7928703570213289,-1.2656154390501215
197,cellular defense response (GO:0006968),0.12293168193833567,-0.7929714010252743,-1.2662976497226182
198,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.12296149782248948,-0.8282910596294488,-1.2645551077172925
199,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.12334299500326223,-0.8152738217492075,-1.2639868620861139
200,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.12383309764007602,-0.8210750872889273,-1.2640236259886766
201,regulation of defense response to virus (GO:0050688),0.12451934245528092,-0.8345038215375509,-1.2628256882236968
202,regulation of intracellular protein transport (GO:0033157),0.12452972814456666,-0.8035542471438701,-1.2630369226529936
203,regulation of platelet activation (GO:0010543),0.12497281802651934,-0.8143130585307709,-1.2630643786317812
204,regulation of protein dephosphorylation (GO:0035304),0.12678146986529507,-0.7868085531161694,-1.2619184248069577
205,positive regulation of lymphocyte activation (GO:0051251),0.12797673435318876,-0.8119921833397816,-1.2608829128482877
206,regulation of focal adhesion assembly (GO:0051893),0.1280978558871595,-0.7960979416010435,-1.2610102455303527
207,regulation of bone mineralization (GO:0030500),0.1282989247626989,-0.790260387181657,-1.2596244710006874
208,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.12831439891467458,-0.8183563294602512,-1.261084690354714
209,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.12883026878756193,-0.8175125212298913,-1.2596576738391791
210,positive regulation of phagocytosis (GO:0050766),0.12897062223182387,-0.7827132651889894,-1.260219200054267
211,positive regulation of production of molecular mediator of immune response (GO:0002702),0.12899914679040558,-0.7918807997612893,-1.2598192774179242
212,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.1296314955491821,-0.8157241266660166,-1.2598227258963821
213,negative regulation of ATP metabolic process (GO:1903579),0.13039970718801117,-0.8290063061762468,-1.2586814281820642
214,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.1305393335623497,0.4290814639868578,1.676790979669702
215,response to molecule of bacterial origin (GO:0002237),0.13099285572372613,-0.7803388933482804,-1.2582299445381537
216,positive regulation of interleukin-10 production (GO:0032733),0.13271173893206037,-0.806631370274766,-1.2553468566384627
217,sterol transport (GO:0015918),0.13281888287070043,-0.8055122067734102,-1.2564079247826248
218,regulation of phosphate metabolic process (GO:0019220),0.13317907509833063,-0.82732979352539,-1.25497087412497
219,receptor metabolic process (GO:0043112),0.13322129481327508,-0.783046561407011,-1.2565268135737517
220,pyroptosis (GO:0070269),0.13327729265275576,-0.8063289700051994,-1.2553724712212082
221,response to organonitrogen compound (GO:0010243),0.13332436692348384,-0.7982069255172485,-1.2539918614626733
222,cellular response to molecule of bacterial origin (GO:0071219),0.13333077937835844,-0.7766682242477543,-1.2542634575458722
223,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.13346456078985974,-0.7838359142002982,-1.254392280684929
224,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.13353862547398285,-0.7961975230839577,-1.2566678351391496
225,positive regulation of response to external stimulus (GO:0032103),0.13354415472689896,-0.7754316757208132,-1.2555508376862972
226,negative regulation of DNA biosynthetic process (GO:2000279),0.13356923887675376,-0.8015985955365177,-1.2536483768055802
227,cellular response to interferon-gamma (GO:0071346),0.13372625600709476,-0.7718564386623328,-1.2556900421633714
228,regulation of programmed necrotic cell death (GO:0062098),0.13385532740383058,-0.8298348267712298,-1.2544871532920898
229,hexose biosynthetic process (GO:0019319),0.13412686053395217,-0.7939916605193765,-1.2567293397597457
230,response to cadmium ion (GO:0046686),0.13412914492293102,-0.8093871284901176,-1.2557929374519732
231,positive regulation of erythrocyte differentiation (GO:0045648),0.13449638764638638,-0.819287463715503,-1.2567841351227034
232,positive regulation of immune response (GO:0050778),0.1350625227358081,-0.7738006385806631,-1.2530226126811699
233,negative regulation of viral entry into host cell (GO:0046597),0.13565453655514226,-0.8082835475076339,-1.2524015367931343
234,cellular response to lipopolysaccharide (GO:0071222),0.1357541057300745,-0.7756445945567582,-1.2525534800865037
235,positive regulation of defense response (GO:0031349),0.13609065515320504,-0.7750072150383035,-1.252076496401425
236,positive regulation of mitochondrial fission (GO:0090141),0.13656394240615624,-0.8180137080406501,-1.2516217609997746
237,lymphocyte migration (GO:0072676),0.1367476462424445,-0.777346949878756,-1.2513324678445592
238,positive regulation of epithelial cell apoptotic process (GO:1904037),0.13705159006058112,-0.8240073569063641,-1.2510264393421315
239,regulation of actin cytoskeleton reorganization (GO:2000249),0.13884896796335622,-0.7963643846545678,-1.250129923530466
240,positive regulation of RNA metabolic process (GO:0051254),0.13902055155577245,-0.7846767987028995,-1.2498796102672318
241,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.13986357167394614,0.5684346935609981,1.690330372097769
242,liver development (GO:0001889),0.1399299720391955,-0.7932705130672646,-1.2486776681134062
243,production of small RNA involved in gene silencing by RNA (GO:0070918),0.14015774863405708,-0.7932174872246858,-1.2490237553521535
244,regulation of glucose transmembrane transport (GO:0010827),0.14023300134455952,-0.8176968406399856,-1.2491714490262131
245,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.14032163800095454,-0.8230952344715443,-1.2487601559220143
246,epiboly involved in wound healing (GO:0090505),0.14347762041324555,-0.8325032743390015,-1.246372965896976
247,cellular response to lectin (GO:1990858),0.14359216569685496,-0.7701012730729472,-1.2470966923382534
248,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.14359216569685496,-0.7701012730729472,-1.2470966923382534
249,cellular response to interleukin-12 (GO:0071349),0.1436132289704373,-0.7698715121741281,-1.2459466783096629
250,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.14366090141158933,-0.7719056919719404,-1.2468463377996593
251,regulation of SMAD protein signal transduction (GO:0060390),0.14373796731788593,-0.8030845911742537,-1.2461799284648356
252,pattern recognition receptor signaling pathway (GO:0002221),0.1438742149865416,-0.7880684140912512,-1.2464096556169826
253,interleukin-12-mediated signaling pathway (GO:0035722),0.14442980666904606,-0.7721716782439433,-1.2464411340367172
254,regulation of inflammatory response (GO:0050727),0.14528216586289375,-0.7626095317173236,-1.2453279359267928
255,negative regulation of interleukin-8 production (GO:0032717),0.14585567167821667,-0.8214749926250675,-1.2447305340035706
256,neutrophil activation (GO:0042119),0.14610190724795083,-0.8049365880458645,-1.2448668074643114
257,DNA conformation change (GO:0071103),0.14630743603249305,-0.8011318246052339,-1.2442408812531902
258,positive regulation of protein dephosphorylation (GO:0035307),0.14647814055252278,-0.7830817080662373,-1.2444247617234163
259,peptide catabolic process (GO:0043171),0.14654142141863757,-0.8020079791901982,-1.2412461180565195
260,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.14666147674471142,-0.7974413632436125,-1.2438623334165324
261,neutrophil migration (GO:1990266),0.14702513113749255,-0.7694695073531373,-1.241286299818553
262,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.14754834065580827,-0.785766400049447,-1.2412978150988165
263,positive regulation of cytokine production (GO:0001819),0.1479763783830954,-0.7561458959225286,-1.242584689789231
264,regulation of acute inflammatory response (GO:0002673),0.14805480424963688,-0.8112802758298495,-1.240449062348728
265,phosphatidylglycerol metabolic process (GO:0046471),0.14807554413991264,-0.8175447406858727,-1.2413011759733048
266,granulocyte chemotaxis (GO:0071621),0.14809709102981,-0.7683732053259686,-1.2423323415160694
267,positive regulation of lymphocyte proliferation (GO:0050671),0.14813754090103703,-0.7665119675588442,-1.2414979180184236
268,sterol biosynthetic process (GO:0016126),0.1481509750864175,-0.7824704784638883,-1.2405659575673609
269,regulation of myoblast differentiation (GO:0045661),0.14827248400509666,-0.8078755202537109,-1.2416638480477555
270,defense response to fungus (GO:0050832),0.148335006663332,-0.8334978448813165,-1.2427602441315913
271,regulation of cytokine production involved in inflammatory response (GO:1900015),0.14841634126113815,-0.7780032164272026,-1.2401395397313515
272,regulation of extracellular matrix organization (GO:1903053),0.14853003340733748,-0.8269622439719492,-1.2399173658408882
273,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.14855396764000559,-0.7666262411429611,-1.2417845082067807
274,regulation of cytokine production (GO:0001817),0.14884482143113678,-0.7630279282508952,-1.2427995983256113
275,positive regulation of purine nucleotide metabolic process (GO:1900544),0.14892872023193204,-0.7971078475439418,-1.2394561329153653
276,positive regulation of glycolytic process (GO:0045821),0.14892872023193204,-0.7971078475439418,-1.2394561329153653
277,positive regulation of BMP signaling pathway (GO:0030513),0.14905672698883923,-0.788512517003218,-1.2417878273906608
278,mesoderm development (GO:0007498),0.14932142909109627,-0.8188342203296308,-1.242877703783887
279,regulation of calcium-mediated signaling (GO:0050848),0.14973199730827777,-0.7702238525571293,-1.2390339135803519
280,positive regulation of myeloid cell differentiation (GO:0045639),0.15001175067964326,-0.7945219519754508,-1.2387894650624358
281,regulation of glucose metabolic process (GO:0010906),0.15035960401455256,-0.7815741763336858,-1.2383395762721774
282,positive regulation of defense response to virus by host (GO:0002230),0.15080521175379774,-0.7936715250385211,-1.238358287390107
283,lymphocyte chemotaxis (GO:0048247),0.1512466090887678,-0.7601080455030285,-1.2376668230105687
284,regulation of heterotypic cell-cell adhesion (GO:0034114),0.1514532624615365,-0.8034364900172123,-1.2377622865840847
285,response to estradiol (GO:0032355),0.15171921421655574,-0.7906895778302214,-1.2373956307390854
286,positive regulation of interleukin-1 production (GO:0032732),0.15353640094813728,-0.7719516593091011,-1.2354497171387928
287,regulation of vascular endothelial growth factor production (GO:0010574),0.15367845030639204,-0.7966228207994777,-1.2355758536360608
288,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.1538099719340461,-0.8096606312491386,-1.2361190524783028
289,chemokine-mediated signaling pathway (GO:0070098),0.15388784527858143,-0.7793221827072748,-1.2356488132606465
290,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.15403214037198446,-0.7735359751125743,-1.2357700951896209
291,chondroitin sulfate biosynthetic process (GO:0030206),0.15404562335821384,-0.8199035545636524,-1.2365758828499236
292,regulation of cell killing (GO:0031341),0.15425675801402,-0.8252523138997474,-1.2361367042892306
293,positive regulation of focal adhesion assembly (GO:0051894),0.15447120972762507,-0.8010476439333559,-1.2362314007443784
294,negative regulation of smooth muscle cell proliferation (GO:0048662),0.15454424731264432,-0.7803759618751993,-1.2349653047218263
295,peptide metabolic process (GO:0006518),0.15562260531899977,-0.7493364882372214,-1.2333470968993043
296,neutrophil chemotaxis (GO:0030593),0.15577407805914512,-0.7644090923544702,-1.2344728468213706
297,B cell receptor signaling pathway (GO:0050853),0.1560237566592622,-0.8000542251558983,-1.2333881036788117
298,interferon-gamma-mediated signaling pathway (GO:0060333),0.1560599711218094,-0.7716463336537709,-1.2336854288926817
299,leukocyte tethering or rolling (GO:0050901),0.15649195359106544,-0.8071143250402792,-1.2334469618485968
300,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.15653151035026608,-0.7801340871649882,-1.233709714684546
301,regulation of T cell mediated cytotoxicity (GO:0001914),0.15663681203222699,-0.7870616046466278,-1.233970178084171
302,peptidyl-tyrosine phosphorylation (GO:0018108),0.15664895224228081,-0.7602337835415374,-1.2338831178264678
303,regulation of defense response to virus by host (GO:0050691),0.1576198223564618,-0.778275051560032,-1.2324895618950877
304,regulation of monocyte chemotaxis (GO:0090025),0.157786408899058,-0.7865723942385074,-1.2323198083782765
305,endocardial cushion development (GO:0003197),0.1579295271794795,-0.8075305898019205,-1.2325435963236326
306,regulation of immune effector process (GO:0002697),0.15927523622885878,-0.7761778449069132,-1.2318768097851873
307,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.15974922840894507,-0.8081164497083013,-1.2315273087064114
308,positive regulation of fibroblast proliferation (GO:0048146),0.15978436293514017,-0.7807414299739103,-1.23092371225675
309,negative regulation of DNA metabolic process (GO:0051053),0.15996967837333745,-0.7915180590568979,-1.231223818227189
310,monovalent inorganic cation homeostasis (GO:0055067),0.16009549250164445,-0.7914704057913026,-1.23064095126421
311,regulation of chemokine production (GO:0032642),0.16012627749147254,-0.7796527462334369,-1.2310133745747749
312,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.1602806236382952,-0.7728416627482221,-1.2303118800198531
313,regulation of lipid storage (GO:0010883),0.16052813633748916,-0.8086202077601662,-1.2303546715557545
314,regulation of complement activation (GO:0030449),0.16082606201896116,-0.7703797318101682,-1.2294053090261992
315,positive regulation of monocyte chemotaxis (GO:0090026),0.16119409089571407,-0.7885042606745523,-1.2294474491125649
316,regulation of fatty acid oxidation (GO:0046320),0.16131980754905736,-0.8090049147396882,-1.2296147426597337
317,regulation of interferon-beta production (GO:0032648),0.16153840536451158,-0.7740182131058759,-1.2297280634843988
318,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.16396723027961674,-0.7913961808727014,-1.2270382626581045
319,cellular response to cadmium ion (GO:0071276),0.16406808826953234,-0.7889761421128882,-1.2271947451069625
320,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.16455593388609094,-0.8086418829592497,-1.2272116249143918
321,regulation of activated T cell proliferation (GO:0046006),0.16461049895943208,-0.7847320987457518,-1.228188446740758
322,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.1646868132461301,-0.8064584391833114,-1.228016411171414
323,regulation of brown fat cell differentiation (GO:0090335),0.16483817347888335,-0.8192191583799979,-1.2272777881983816
324,response to glucagon (GO:0033762),0.1651539285970217,-0.8268832442892122,-1.2277143161289168
325,positive regulation of synapse assembly (GO:0051965),0.16536146926770523,-0.8019333963992236,-1.227295733257323
326,positive regulation of cell-substrate junction organization (GO:0150117),0.1655156825207187,-0.7923152952247053,-1.2265416798224358
327,regulation of protein localization to nucleus (GO:1900180),0.16552805887096056,-0.7618597771956515,-1.2273894790324549
328,regulation of transforming growth factor beta production (GO:0071634),0.1655870372680349,-0.7823189755993757,-1.226359985082729
329,natural killer cell activation (GO:0030101),0.16559943311741457,-0.7697628803889789,-1.2262598736382981
330,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.1661060977649806,-0.8013827746475672,-1.224918402602491
331,response to glucocorticoid (GO:0051384),0.1662668667465547,-0.8003464374652031,-1.2250453000709627
332,negative regulation of metabolic process (GO:0009892),0.16642843573854083,-0.7619438690737258,-1.225907966907452
333,embryonic organ morphogenesis (GO:0048562),0.1664672354078316,-0.7761646769071435,-1.2256821457012208
334,regulation of humoral immune response (GO:0002920),0.166505177668325,-0.7660631633444321,-1.225198300491395
335,regulation of DNA biosynthetic process (GO:2000278),0.1666863311334397,-0.7914790586630794,-1.225059939825258
336,positive regulation of nervous system development (GO:0051962),0.16689090694221004,-0.7697695930750307,-1.2253544550152233
337,cellular response to chemokine (GO:1990869),0.16695674684883696,-0.7694956015597206,-1.2252099321123882
338,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.16697863255671122,-0.8048270413482306,-1.2236499755318477
339,dendritic cell differentiation (GO:0097028),0.16708555186810892,-0.7925202961053313,-1.225416206575436
340,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.16708885978270516,-0.7596919227607826,-1.2242128366646459
341,positive regulation of B cell proliferation (GO:0030890),0.16710372331097734,-0.7888235020118737,-1.223945109045852
342,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.16710973745389454,-0.7947521282671839,-1.2243878440910105
343,mesenchyme development (GO:0060485),0.16723734714823776,-0.8175205316255815,-1.2240789767369749
344,negative regulation of epithelial cell apoptotic process (GO:1904036),0.1673073601330027,-0.7725085602794881,-1.2237166278399843
345,negative regulation of ossification (GO:0030279),0.16759952746872814,-0.7938076421062279,-1.223370232023517
346,negative regulation of viral life cycle (GO:1903901),0.1681543919117111,-0.7910257013750617,-1.2223374696870744
347,regulation of immune response (GO:0050776),0.16817770654425887,-0.7527504497383302,-1.222447298619432
348,regulation of fatty acid metabolic process (GO:0019217),0.16822474603749304,-0.8015586337934144,-1.2227411732794113
349,positive regulation of chemokine production (GO:0032722),0.16844907930443598,-0.7695992779715165,-1.2225145733432539
350,GTP metabolic process (GO:0046039),0.16846687506676308,-0.8009449853546042,-1.2229371333704309
351,monocyte chemotaxis (GO:0002548),0.16852556236482913,-0.7794361910812733,-1.222817699304439
352,negative regulation of biomineral tissue development (GO:0070168),0.16914158353603911,-0.7980853769201885,-1.2218772569459344
353,artery development (GO:0060840),0.16974093228243825,-0.7841286135227263,-1.2212486889881025
354,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.16981801842474475,-0.8111488304321963,-1.220226210601635
355,positive regulation of DNA replication (GO:0045740),0.16984844425884998,-0.7984103969222637,-1.2210804674302747
356,glutathione metabolic process (GO:0006749),0.17013895851398553,-0.7531591821756083,-1.2203314459576324
357,pyrimidine nucleoside metabolic process (GO:0006213),0.17023009923426083,-0.8125566610058271,-1.2212548869270115
358,filopodium assembly (GO:0046847),0.1702743721413946,-0.7863204521455341,-1.220463742874554
359,regulation of lymphocyte proliferation (GO:0050670),0.17027834854924087,-0.8010139385715203,-1.2207866405087648
360,response to interleukin-1 (GO:0070555),0.1705042665078752,-0.7588773764201554,-1.2213540607198474
361,positive regulation of T cell activation (GO:0050870),0.17070580324253554,-0.7583580371076996,-1.2204967488688003
362,cellular response to glucagon stimulus (GO:0071377),0.1714206011801143,-0.828385019661374,-1.219161773084371
363,regulation of cellular response to heat (GO:1900034),0.17151578254545755,-0.7577230779166642,-1.2195746488723946
364,toll-like receptor 4 signaling pathway (GO:0034142),0.17168965546195303,-0.8093192163975219,-1.2192316878343976
365,positive regulation of muscle hypertrophy (GO:0014742),0.17185436703952725,-0.8097346520874953,-1.2193363135250297
366,regulation of viral entry into host cell (GO:0046596),0.1747482569817485,-0.7576905613831806,-1.2180877605468208
367,negative regulation of protein localization to membrane (GO:1905476),0.17498058597282248,-0.7881183274389258,-1.2176858565154816
368,positive regulation of T cell proliferation (GO:0042102),0.1753619650691863,-0.7580346504098784,-1.2177480809245917
369,regulation of interleukin-1 beta production (GO:0032651),0.17559026161505042,-0.7554223381045966,-1.217331427463802
370,cellular zinc ion homeostasis (GO:0006882),0.17607310577803773,-0.7769576376135737,-1.2164532446893608
371,positive regulation of interleukin-1 beta production (GO:0032731),0.17619657816283085,-0.7625507750274438,-1.2169794460021184
372,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.1762281003091721,0.6469043379069821,1.5736336560581785
373,release of sequestered calcium ion into cytosol (GO:0051209),0.1765026988111993,-0.7792723391236455,-1.216475962179506
374,dendritic cell migration (GO:0036336),0.17690883474366453,-0.786427901365714,-1.2164900720808343
375,regulation of fibroblast proliferation (GO:0048145),0.17733548834872603,-0.7526236943364883,-1.2158256784035737
376,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.17734308413680394,-0.7615597909729083,-1.216501199183305
377,phosphatidylethanolamine metabolic process (GO:0046337),0.1778250915162837,-0.7690471047387988,-1.2155051570610536
378,regulation of cardiac muscle cell action potential (GO:0098901),0.1780081821304769,0.6262067110829934,1.5558508075474267
379,positive regulation of vascular endothelial growth factor production (GO:0010575),0.1788725605588277,-0.7881737762976362,-1.2149785533569084
380,negative regulation of dephosphorylation (GO:0035305),0.17912683977551605,-0.7916666335043888,-1.2150572433943903
381,cellular response to gamma radiation (GO:0071480),0.1795566861480276,-0.7866051796628715,-1.214703032361235
382,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.18074229244830212,-0.7596369949515901,-1.2142484685418835
383,regulation of lymphocyte differentiation (GO:0045619),0.18076282256584464,-0.7846258195647169,-1.21412377357852
384,negative regulation of Notch signaling pathway (GO:0045746),0.18084965291525182,-0.7585331149803738,-1.2124118317442785
385,response to lipopolysaccharide (GO:0032496),0.18100967077152488,-0.7452592470938444,-1.2120921248165486
386,regulation of neutrophil chemotaxis (GO:0090022),0.18113398020432617,-0.7851758747784121,-1.2127157555990449
387,cellular response to virus (GO:0098586),0.1811717344851805,-0.771032995511525,-1.2124828193615094
388,negative regulation of cold-induced thermogenesis (GO:0120163),0.18119214631678868,-0.7657875758846653,-1.211809688963193
389,regulation of toll-like receptor signaling pathway (GO:0034121),0.18120184678054907,-0.7663991936741622,-1.2125958578528109
390,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.18135478554386822,-0.7784515447927501,-1.2121252088239665
391,cellular response to mechanical stimulus (GO:0071260),0.1813668637846637,-0.7587086203575145,-1.2118849711726856
392,cellular response to cytokine stimulus (GO:0071345),0.18136724722087944,-0.7315665130119713,-1.2133168443205011
393,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.1814235065690838,-0.7819092544458025,-1.2134772810710954
394,regulation of endothelial cell apoptotic process (GO:2000351),0.18153312092689264,-0.7619698029044709,-1.2127336490802008
395,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.1815350030945235,-0.79141434782115,-1.2131739023331531
396,regulation of NIK/NF-kappaB signaling (GO:1901222),0.18158907812055508,-0.754457341167377,-1.2128053295340002
397,positive regulation of interferon-beta production (GO:0032728),0.18164318435469867,-0.7655065797526094,-1.2115263311921796
398,regulation of protein modification process (GO:0031399),0.18174423748132823,-0.7607391336419369,-1.2128568528006918
399,regulation of fatty acid biosynthetic process (GO:0042304),0.18185590404495655,-0.7917568666551019,-1.2135017100067156
400,macrophage migration (GO:1905517),0.18194979782726572,-0.7845585402672832,-1.2129243225037605
401,positive regulation of lamellipodium assembly (GO:0010592),0.18196401200959134,-0.7775650098184379,-1.213647705612158
402,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.18302683819139273,-0.7835500390191511,-1.2110559239507837
403,ruffle organization (GO:0031529),0.1839127734773984,-0.7831768216136781,-1.210570252853006
404,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.18394915488021335,-0.7921228692003847,-1.2106931008352995
405,negative regulation of protein localization to plasma membrane (GO:1903077),0.1841124482099076,-0.7927349949592617,-1.2100800378351997
406,cellular response to hydrogen peroxide (GO:0070301),0.18412979126326137,-0.7708679616560792,-1.2093320257982725
407,icosanoid metabolic process (GO:0006690),0.18426214762063134,-0.7654287240408142,-1.2096135648458783
408,regulation of dephosphorylation (GO:0035303),0.18435936145904022,-0.7694292233198057,-1.2098827924245354
409,positive regulation of neutrophil migration (GO:1902624),0.18441661958551797,-0.7766525470783127,-1.2096909442724517
410,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.18444783383432067,-0.742974413971234,-1.2079056840207765
411,cellular response to interferon-beta (GO:0035458),0.18451655728758362,-0.7901992492154533,-1.2093729984170232
412,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.1845287464279655,-0.8023194706045769,-1.210091569282603
413,vasculature development (GO:0001944),0.1846885550503839,-0.816437383573554,-1.2079356055668857
414,neutrophil activation involved in immune response (GO:0002283),0.18478113734898688,-0.7346068106031372,-1.2085476393498547
415,positive regulation of type I interferon production (GO:0032481),0.1848115059506293,-0.7450873520466476,-1.2094385324968462
416,regulation of B cell proliferation (GO:0030888),0.18482819479080578,-0.7681577401937015,-1.2101698827817502
417,hexose metabolic process (GO:0019318),0.18509683613192227,-0.7822145076414275,-1.2082275517758438
418,positive regulation of protein targeting to membrane (GO:0090314),0.18511293162963313,-0.7843714662645918,-1.207948365947163
419,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.18520362008027594,-0.7833398653311331,-1.2083317557186426
420,neutrophil mediated immunity (GO:0002446),0.18521094153900777,-0.7347808080985763,-1.2085528982343812
421,positive regulation of interleukin-17 production (GO:0032740),0.1852192362760475,-0.792259532451992,-1.2080879867839245
422,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.1856428577889305,-0.7862203192995836,-1.208562727584083
423,external encapsulating structure organization (GO:0045229),0.18589126568894226,-0.7409677882178201,-1.2086131564359377
424,sensory perception of smell (GO:0007608),0.18635025646842115,-0.759479373463256,-1.2086170125608888
425,negative regulation of interleukin-1 beta production (GO:0032691),0.18785438887192646,-0.791391334729497,-1.2068663091347085
426,response to interferon-gamma (GO:0034341),0.1878557465878432,-0.7463581664727181,-1.2067361517450106
427,negative regulation of JNK cascade (GO:0046329),0.18855681514561623,0.5531158211825629,1.579488693698969
428,extracellular structure organization (GO:0043062),0.18982701316914036,-0.7394400211677636,-1.205473745026913
429,negative regulation of cytokine production involved in immune response (GO:0002719),0.18983035392153924,-0.7931893646763482,-1.2055976699454596
430,negative regulation of immune response (GO:0050777),0.18986301042957138,-0.7367503501957385,-1.2060627281956287
431,regulation of smooth muscle cell proliferation (GO:0048660),0.18990100363814327,-0.7522648169676243,-1.20569724282636
432,microglial cell activation (GO:0001774),0.18990453692508583,-0.7919698282617211,-1.2058417357353064
433,neutrophil degranulation (GO:0043312),0.1911600042151633,-0.7325330026780646,-1.2049906672810113
434,T cell activation (GO:0042110),0.19166458957380633,-0.7549867648290582,-1.2047571628767373
435,regulation of T cell differentiation (GO:0045580),0.19267097361193325,-0.762581185529962,-1.2037151363225265
436,organophosphate biosynthetic process (GO:0090407),0.19269881139591707,-0.7657273082682924,-1.2043057880056132
437,negative regulation of blood vessel morphogenesis (GO:2000181),0.19272668745476076,-0.7513725107262423,-1.2035970265630198
438,positive regulation of mitotic cell cycle (GO:0045931),0.19274676265777027,-0.7643563625550553,-1.2037878224230432
439,positive regulation of T cell mediated immunity (GO:0002711),0.19277722889895732,-0.7592246176093614,-1.2041155570077984
440,blood circulation (GO:0008015),0.19304302333046783,-0.7623663195171313,-1.2038239561225703
441,positive regulation of cellular biosynthetic process (GO:0031328),0.1931421019679458,-0.7317792213646429,-1.2039171383694127
442,regulation of cholesterol storage (GO:0010885),0.19417785118838415,-0.7661107365188529,-1.203080584972315
443,eye development (GO:0001654),0.1945997062960748,-0.7648141839585966,-1.2027827657803716
444,positive regulation of B cell activation (GO:0050871),0.19582279255386145,-0.7629193002319394,-1.2022776609569856
445,positive regulation of viral transcription (GO:0050434),0.1980798171170884,-0.776031708928959,-1.2014207022700105
446,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.19900840877624523,-0.7886649473257905,-1.2010171192489278
447,T cell differentiation (GO:0030217),0.19904885552932158,-0.7659127147106173,-1.2008819058161297
448,receptor clustering (GO:0043113),0.1992827003574618,-0.7657116360411707,-1.2007129485843826
449,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.19930087783284375,-0.7334598850353037,-1.2005995605709436
450,negative regulation of angiogenesis (GO:0016525),0.20034672117284238,-0.7445076880001462,-1.2001465165507703
451,regulation of cholesterol biosynthetic process (GO:0045540),0.2012481392419558,0.4868364615361285,1.53660542262995
452,regulation of immunoglobulin production (GO:0002637),0.20231763817152226,-0.7670476263196475,-1.1993382136321378
453,endothelial cell migration (GO:0043542),0.202370513703456,-0.759973231122284,-1.199472652352062
454,water transport (GO:0006833),0.20284134022211192,-0.7798770813383535,-1.1975427004804573
455,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.20314220647591164,-0.7696299975266581,-1.197594044881578
456,phosphatidylserine acyl-chain remodeling (GO:0036150),0.20316919603207467,-0.7991334362299922,-1.1972106154756272
457,stress-activated protein kinase signaling cascade (GO:0031098),0.20318085382595305,-0.7761985871975451,-1.1973406252691476
458,positive regulation of protein secretion (GO:0050714),0.20354815394471118,-0.7505750912260479,-1.197601540305571
459,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2035493691028815,-0.7295387898955493,-1.1987449189458341
460,O-glycan processing (GO:0016266),0.20357340425318485,-0.7399159575069443,-1.1978108555800482
461,positive regulation of leukocyte chemotaxis (GO:0002690),0.2037479239670052,-0.7512412669190217,-1.197670170181279
462,cellular response to copper ion (GO:0071280),0.20380823518263286,-0.7839447569602451,-1.198027389195154
463,negative regulation of endothelial cell apoptotic process (GO:2000352),0.2038599834919552,-0.7675868199501048,-1.1988155912588119
464,retinoic acid metabolic process (GO:0042573),0.20391898833706987,-0.7907721687911217,-1.198188924562627
465,positive regulation of leukocyte migration (GO:0002687),0.20393754340761958,-0.778576150222518,-1.1969375583869148
466,negative regulation of calcium ion transport (GO:0051926),0.20394122973649154,-0.7784677504931563,-1.197832749644587
467,activation of phospholipase C activity (GO:0007202),0.2041572398509632,-0.7737125496556857,-1.1980493211007488
468,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.20419283894009735,-0.7386447372902939,-1.1984205149241833
469,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.20435410681697277,-0.7602377037045969,-1.1981917571896799
470,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.2045182256850444,-0.7631896058633895,-1.1966913209153343
471,endodermal cell differentiation (GO:0035987),0.20468555959700463,-0.7668222284629264,-1.1982281020787282
472,positive regulation of smooth muscle cell proliferation (GO:0048661),0.20507595266447506,-0.7417792014104614,-1.1964546519562596
473,negative regulation of protein localization to cell periphery (GO:1904376),0.20718104470969823,-0.7746863035280231,-1.1957517883957616
474,positive regulation of lymphocyte differentiation (GO:0045621),0.20807652374088767,-0.7853159755308784,-1.1954107267680918
475,chondrocyte differentiation (GO:0002062),0.20897736015450163,-0.7759631759761716,-1.1947421971411751
476,positive regulation of viral life cycle (GO:1903902),0.20900875082720324,-0.7732929874709762,-1.195077362425683
477,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2090139569654772,-0.7372922885194173,-1.1945429195942718
478,renal system development (GO:0072001),0.20914681761422727,-0.744432234569456,-1.1942165436694505
479,eosinophil chemotaxis (GO:0048245),0.20928429183993355,-0.7682387638874058,-1.1947863474889477
480,eosinophil migration (GO:0072677),0.20928429183993355,-0.7682387638874058,-1.1947863474889477
481,monocarboxylic acid catabolic process (GO:0072329),0.2094521473005194,-0.7733336827650648,-1.1942681904057515
482,regulation of mitochondrial fission (GO:0090140),0.21074299175450914,-0.7656938834020857,-1.1937472112817407
483,microtubule depolymerization (GO:0007019),0.21087123113918027,0.6548427875387857,1.5122817668520339
484,toll-like receptor signaling pathway (GO:0002224),0.21109052440665915,-0.7482526009525661,-1.1932645537020328
485,positive regulation of mitotic nuclear division (GO:0045840),0.2111946935768952,-0.7700637874544307,-1.193574084281858
486,positive regulation of immune system process (GO:0002684),0.21143648513514937,-0.7960887315254278,-1.1932825576788424
487,positive regulation of mononuclear cell migration (GO:0071677),0.2116644030613863,-0.7555118241263656,-1.1933528098049018
488,positive regulation of cardiac muscle tissue growth (GO:0055023),0.21250751199219833,-0.7852482925316409,-1.192841934756887
489,response to exogenous dsRNA (GO:0043330),0.21293102920835782,-0.7577541288057368,-1.192571600387084
490,sensory perception of chemical stimulus (GO:0007606),0.212986033961939,-0.7537109030148481,-1.1922910113632559
491,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.2131951002801742,-0.7378660244746635,-1.192360079817542
492,bone development (GO:0060348),0.21389658580704285,-0.7587949135864238,-1.191911092935971
493,regulation of erythrocyte differentiation (GO:0045646),0.21415700247176125,-0.7733882650746625,-1.1917710039313412
494,unsaturated fatty acid metabolic process (GO:0033559),0.21422088156068286,-0.7450750110536118,-1.1916031336648154
495,negative regulation of Ras protein signal transduction (GO:0046580),0.2142844961399195,-0.7492820398472197,-1.1914726665036275
496,regulation of calcium ion transport (GO:0051924),0.21847441375382387,-0.7317615280610422,-1.1903007138413946
497,regulation of cellular senescence (GO:2000772),0.22074342299322733,-0.7657306697694279,-1.1896094264774504
498,negative regulation of stress fiber assembly (GO:0051497),0.22170303993887402,-0.7858805937377581,-1.1890681840097017
499,positive regulation of cell junction assembly (GO:1901890),0.22171204122262084,-0.7470224292436721,-1.1889725613598692
500,erythrocyte differentiation (GO:0030218),0.22177138179417108,-0.7564957664823827,-1.1891693008107178
501,positive regulation of phospholipase C activity (GO:0010863),0.2220144683698277,-0.7600779752067759,-1.189203117154783
502,regulation of establishment of endothelial barrier (GO:1903140),0.2228746010097557,-0.7746020232477048,-1.1886095026771806
503,proteolysis involved in cellular protein catabolic process (GO:0051603),0.22357707486117678,-0.7312866748198704,-1.1882670741935608
504,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.22362042100411958,-0.7571505378233605,-1.1881325165885779
505,visual system development (GO:0150063),0.22399405046040338,-0.7663284196992401,-1.1882808205615747
506,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.22459806607604355,-0.7350968773973445,-1.1877904389529632
507,epithelial cell development (GO:0002064),0.2251984365580262,-0.7754435595885308,-1.1870544791630495
508,defense response to symbiont (GO:0140546),0.2254575667902572,-0.7319186780543365,-1.1874523158072054
509,positive regulation of immunoglobulin production (GO:0002639),0.22565064225392586,-0.7562356591287998,-1.187055126998385
510,defense response to virus (GO:0051607),0.22600988873914038,-0.7293941953536094,-1.1870817337914614
511,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.22610466769105653,-0.7288078256643263,-1.1871829513042063
512,amide transport (GO:0042886),0.22860828728901358,-0.767154768771175,-1.1853386706039128
513,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.22878301158434852,-0.7299989422001071,-1.1858157441130401
514,calcium-mediated signaling (GO:0019722),0.22899055565977466,-0.7297992187553958,-1.18548320518375
515,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.22904060929979966,-0.7596285142185452,-1.1853537433890036
516,sulfur compound catabolic process (GO:0044273),0.22908954779258858,-0.7616131140976117,-1.1855647891284153
517,negative regulation of type I interferon production (GO:0032480),0.22913218361739218,-0.7578315002816601,-1.1859870796811531
518,antibacterial humoral response (GO:0019731),0.22914491969686254,-0.7519553907127301,-1.1858353494725664
519,positive regulation of macrophage migration (GO:1905523),0.22931890071215486,-0.7638635664941542,-1.1849730793326116
520,peptide cross-linking (GO:0018149),0.22935716539097747,-0.77512723990712,-1.185599214481304
521,cellular divalent inorganic cation homeostasis (GO:0072503),0.22940202742821775,-0.7337699453620308,-1.1860394932666776
522,positive regulation of carbohydrate metabolic process (GO:0045913),0.22951030446701873,-0.7620260370355828,-1.185034571241533
523,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.23076909046713587,-0.7201948691138801,-1.1844763335105324
524,integrin-mediated signaling pathway (GO:0007229),0.2322935300214566,-0.7198854727939074,-1.1839066135692893
525,negative regulation of defense response (GO:0031348),0.23261140869546026,-0.7345345932046919,-1.183731889774245
526,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.2326184252075469,-0.7607712525427777,-1.1839469013898194
527,negative regulation of interleukin-6 production (GO:0032715),0.23281829334175375,-0.7576326611179244,-1.1835616419651465
528,leukotriene metabolic process (GO:0006691),0.233079149527134,-0.7861193915527742,-1.18340600757334
529,negative regulation of growth (GO:0045926),0.23457812598218653,-0.7352657684432453,-1.1829964151258887
530,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.23554381287271037,-0.7407775891521537,-1.182470239593153
531,regulation of mast cell degranulation (GO:0043304),0.23597950224660683,-0.7753052662073178,-1.1824735764797198
532,receptor-mediated endocytosis (GO:0006898),0.2361585860560779,-0.7131703620276085,-1.1822807554883317
533,response to hydrogen peroxide (GO:0042542),0.2362168133825162,-0.7493599760285626,-1.1825180963997632
534,regulation of neuron death (GO:1901214),0.23794412027768913,-0.7262071762093953,-1.1817751057769819
535,alpha-amino acid catabolic process (GO:1901606),0.23806559020116336,-0.752515189499261,-1.1816311090373537
536,regulation of regulatory T cell differentiation (GO:0045589),0.2396909696712275,-0.7420008854497308,-1.180909499050421
537,regulation of fibroblast migration (GO:0010762),0.23974272701210436,-0.7642717880756382,-1.181122005588462
538,T cell migration (GO:0072678),0.23975627026862975,-0.758869696847575,-1.1805817763745978
539,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.2398421740376218,-0.7447393165338287,-1.1809771774288442
540,innate immune response (GO:0045087),0.23990674058492611,-0.7185406521419317,-1.1806492066831817
541,myoblast fusion (GO:0007520),0.23995072373021842,-0.7582638787661309,-1.1807511993999487
542,cortical actin cytoskeleton organization (GO:0030866),0.24011035599666503,-0.756868440005845,-1.1811688890625074
543,regulation of peptidase activity (GO:0052547),0.24028056454331276,-0.7717748162161757,-1.1803597996500945
544,endocardial cushion morphogenesis (GO:0003203),0.24124560525965402,-0.7895831550025585,-1.180078525423947
545,negative regulation of protein tyrosine kinase activity (GO:0061099),0.24330290421883935,-0.7437120394745741,-1.1795040703776523
546,extracellular matrix organization (GO:0030198),0.24443509448030493,-0.7219932337796959,-1.1791462345254111
547,regulation of oxidative phosphorylation (GO:0002082),0.24491150453638738,-0.7590173713253979,-1.1788761887994912
548,sarcomere organization (GO:0045214),0.24802473376846446,0.739697004030986,1.4648691663895077
549,acute inflammatory response (GO:0002526),0.2481512736872647,-0.7588216208593487,-1.1777373167273018
550,negative regulation of immune system process (GO:0002683),0.24819776447224817,-0.7627304032754358,-1.1776117850688201
551,glycoprotein catabolic process (GO:0006516),0.24835022314048694,-0.791807215161098,-1.1778396152458102
552,response to tumor necrosis factor (GO:0034612),0.24839172604244483,-0.7316415884548879,-1.1779214427913347
553,regulation of angiogenesis (GO:0045765),0.2487325808079778,-0.7256381656773715,-1.1773719385397396
554,negative regulation of inflammatory response (GO:0050728),0.24909336356971287,-0.7240872746289275,-1.176981247855726
555,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.24945697509815037,-0.7217340419806186,-1.1771521408282404
556,negative regulation of sequestering of calcium ion (GO:0051283),0.2494834175407237,-0.7561582038901457,-1.1770104879884964
557,regulation of glycolytic process (GO:0006110),0.24970013809749264,-0.736335445469414,-1.1762332556517927
558,platelet degranulation (GO:0002576),0.24998628049329047,-0.7279321154037159,-1.176670804189952
559,positive regulation of MAPK cascade (GO:0043410),0.25012141197058857,-0.7090755483384404,-1.1762474715500684
560,mesenchyme morphogenesis (GO:0072132),0.25030310295202046,-0.7867771794426431,-1.1762995693624259
561,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.2503400456805719,-0.7747417748497448,-1.1765074451629025
562,organic hydroxy compound biosynthetic process (GO:1901617),0.2506234965058452,-0.7276671809353485,-1.1763352388413186
563,water-soluble vitamin metabolic process (GO:0006767),0.2509419228540892,-0.7294956763232144,-1.1757931383144515
564,protein O-linked mannosylation (GO:0035269),0.251754429013103,0.5528465963392827,1.4853886121268571
565,branching involved in ureteric bud morphogenesis (GO:0001658),0.2521450041167582,-0.7533094701416595,-1.1753751955804697
566,negative regulation of interleukin-1 production (GO:0032692),0.2529170494047227,-0.7625540192912525,-1.175091926646004
567,positive regulation of myoblast differentiation (GO:0045663),0.25307766445990704,-0.7778988875525938,-1.1748040076453292
568,positive regulation of ATP metabolic process (GO:1903580),0.2532092884186387,-0.7294379161886922,-1.174960002891514
569,positive regulation of mitochondrion organization (GO:0010822),0.25333041776426507,-0.733963711100217,-1.1748593508739382
570,response to interferon-beta (GO:0035456),0.25485913569703095,-0.752444987719355,-1.1743346317910286
571,maintenance of protein location in nucleus (GO:0051457),0.2549766506165976,-0.766525243200543,-1.1742273704943398
572,sprouting angiogenesis (GO:0002040),0.25603922383026223,-0.7318438691283733,-1.1738747705294055
573,regulation of oligodendrocyte differentiation (GO:0048713),0.25690806401116995,-0.778422693457444,-1.1734862479154335
574,extrinsic apoptotic signaling pathway (GO:0097191),0.25716540878785266,-0.7320419204177838,-1.1735272790452047
575,cellular response to tumor necrosis factor (GO:0071356),0.25793835422318256,-0.7181474711852258,-1.1730990849831757
576,regulation of defense response (GO:0031347),0.25819661807412314,-0.7212462046511157,-1.1731347268532912
577,positive regulation of cell-cell adhesion (GO:0022409),0.261195067938847,-0.74045228300134,-1.1723056516722143
578,regulation of blood coagulation (GO:0030193),0.26285666314613987,-0.7526876448943508,-1.1715768138012574
579,positive regulation of glucose transmembrane transport (GO:0010828),0.26294287682704803,-0.7643239487945573,-1.171336665733333
580,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.26297461607483474,-0.7887465160816653,-1.1714240804251193
581,cell chemotaxis (GO:0060326),0.2630050828533211,-0.7303680284693838,-1.1716511833123364
582,carboxylic acid metabolic process (GO:0019752),0.2631540288715207,-0.7381146607022958,-1.1717226847120448
583,aspartate family amino acid catabolic process (GO:0009068),0.2649581722862781,-0.7714983767173966,-1.1705267002820403
584,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.2652623668042191,-0.7226856377155085,-1.1707838764836855
585,proteoglycan metabolic process (GO:0006029),0.26540853463325914,-0.7661386865852757,-1.1706462135477644
586,zinc ion homeostasis (GO:0055069),0.2654221971063942,-0.7469812044137565,-1.1705314826129651
587,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.26722352869910887,-0.7643977682565186,-1.1696745457907634
588,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.26722352869910887,-0.7643977682565186,-1.1696745457907634
589,cell projection assembly (GO:0030031),0.26741603881318116,-0.7719246822012683,-1.169853567218615
590,positive regulation of innate immune response (GO:0045089),0.26753763087377463,-0.749421405409102,-1.1694540451146886
591,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.267849850302138,-0.7350624805955438,-1.1698650999769178
592,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2679033353173639,-0.7516404781444757,-1.1694718336752623
593,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.2689630222318051,-0.7599838000086356,-1.1691118412196766
594,metanephros development (GO:0001656),0.2689703442741526,-0.7371366462941611,-1.1689947272699617
595,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.27030728703456053,-0.7476129820100018,-1.1685841074819123
596,vesicle organization (GO:0016050),0.2735152667397571,-0.7308165698481728,-1.1674418804629365
597,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.2737116141171302,-0.7179829274764197,-1.16780371423213
598,cellular response to interleukin-1 (GO:0071347),0.2737430725190464,-0.7181416221954612,-1.1677021451530984
599,positive regulation of chromosome organization (GO:2001252),0.27388618827790584,-0.7508121123465936,-1.1674603771858307
600,aggrephagy (GO:0035973),0.2740809292288135,-0.7531643707698904,-1.1675162623121471
601,renal water homeostasis (GO:0003091),0.27614685635237923,-0.7603197900177637,-1.1668646654829073
602,glycosaminoglycan catabolic process (GO:0006027),0.2762860607755512,-0.7383519490183528,-1.1667603738802619
603,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.27828020716532265,-0.7527023252028281,-1.166172796227398
604,neurogenesis (GO:0022008),0.27875064857929194,-0.7310853468331864,-1.1659730500517673
605,regulation of gluconeogenesis (GO:0006111),0.2789325631174638,-0.7450746739312779,-1.1658595405973065
606,response to cholesterol (GO:0070723),0.279829988505035,-0.7655240180246338,-1.1655966321303604
607,regulation of cartilage development (GO:0061035),0.2825037381170859,-0.7613465834308759,-1.164910102848348
608,regulation of interleukin-1 production (GO:0032652),0.2844170361972301,-0.7640250810242992,-1.1641972835807741
609,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2846733767799373,-0.7143637931903074,-1.1642518744121586
610,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.284787837616485,-0.7510032695647488,-1.1643124852964188
611,arachidonic acid metabolic process (GO:0019369),0.28478916372987934,-0.7354329768298288,-1.163940302137799
612,endoderm formation (GO:0001706),0.2850768301115951,-0.7381792622562012,-1.1639842047469742
613,regulation of chromosome organization (GO:0033044),0.28574496401023336,-0.7666904909377491,-1.1636803257391721
614,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.2858496857858113,-0.7598124914062273,-1.1635449071408865
615,regulation of cAMP-mediated signaling (GO:0043949),0.2875529689493026,-0.7701479140854743,-1.163095320661675
616,ureteric bud morphogenesis (GO:0060675),0.2900085600427576,-0.7378940025080735,-1.1623293717474434
617,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.2901895662372135,-0.7348968660503521,-1.1624950097903264
618,positive regulation of biosynthetic process (GO:0009891),0.29027077259757733,-0.7385104189142573,-1.1623786730663486
619,cellular response to estradiol stimulus (GO:0071392),0.2915535601363396,-0.7622861099966964,-1.1619413631950437
620,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2921762324385118,-0.7061724625198941,-1.1616950770836587
621,response to copper ion (GO:0046688),0.29299706423863675,-0.7587634719912085,-1.1613437654751835
622,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.293206400157377,-0.7707792965365672,-1.1608785825238732
623,neuron maturation (GO:0042551),0.2933203752114205,-0.7643571851205859,-1.161170140559918
624,positive regulation of protein kinase B signaling (GO:0051897),0.29333373999018003,-0.7067790803525027,-1.161076001375164
625,monocarboxylic acid metabolic process (GO:0032787),0.29337111674192407,-0.7182614238823611,-1.1613668763240002
626,motor neuron axon guidance (GO:0008045),0.293377899083315,-0.7705706280677982,-1.1609502020232298
627,homotypic cell-cell adhesion (GO:0034109),0.29592750477343016,-0.7271635159030021,-1.1600509944899278
628,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.29612457429793887,-0.7508057805573374,-1.1601861784219512
629,regulation of leukocyte chemotaxis (GO:0002688),0.29624069076487697,-0.7649279028289548,-1.1600775926772449
630,cell-matrix adhesion (GO:0007160),0.2973588375214564,-0.7121656331747873,-1.1596670394003938
631,B cell activation (GO:0042113),0.297899923463838,-0.7280695777090431,-1.1594217122666033
632,positive regulation of lymphocyte chemotaxis (GO:0140131),0.29790201680666417,-0.7619756947274189,-1.1591007972005045
633,positive regulation of vasculature development (GO:1904018),0.29815498384947475,-0.7202967567609981,-1.1591858649690758
634,positive regulation of protein transport (GO:0051222),0.2981648594504702,-0.7159680225391144,-1.1592671656722529
635,positive regulation of fatty acid metabolic process (GO:0045923),0.299546206626403,-0.7764096307462824,-1.1586563448269787
636,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.29977649939317996,-0.7432436061819505,-1.158487178110749
637,organonitrogen compound catabolic process (GO:1901565),0.30147289025474205,-0.7243717930684447,-1.1576968221675397
638,positive regulation of viral genome replication (GO:0045070),0.3014880122897668,-0.7428026771211618,-1.1580256583494113
639,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3017446506726399,-0.7142207996755807,-1.157862626669068
640,regulation of macrophage chemotaxis (GO:0010758),0.3018648050120732,-0.7545502259829027,-1.157712328059286
641,leukotriene biosynthetic process (GO:0019370),0.30647640263785747,-0.7797590686391834,-1.1566850239166266
642,regulation of adaptive immune response (GO:0002819),0.30694848763446836,-0.7674546339091961,-1.1564737285996882
643,negative regulation of intracellular protein transport (GO:0090317),0.3070596046856352,-0.7477485746912645,-1.1563592261188844
644,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.30872558627525537,-0.7365682110651864,-1.1559806660708734
645,regulation of tissue remodeling (GO:0034103),0.3098040051894758,-0.746408507731366,-1.1556956327314485
646,positive regulation of biomineral tissue development (GO:0070169),0.3099995166998425,-0.7418277242349489,-1.1555457167529295
647,myeloid leukocyte differentiation (GO:0002573),0.3117869064942037,-0.7121147121241552,-1.1551412704027524
648,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.31698638086130504,-0.7245999620887613,-1.1541492485839806
649,regulation of protein targeting to membrane (GO:0090313),0.3194423546218687,-0.7414796681031943,-1.1533714127487995
650,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3195731326814539,-0.7585740242926902,-1.1535435642221328
651,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.31988537072774925,-0.7598828967735316,-1.1533896793762783
652,negative regulation of protein metabolic process (GO:0051248),0.31993281372197857,-0.708772570417431,-1.1528892011021228
653,negative regulation of response to DNA damage stimulus (GO:2001021),0.32005080492873456,-0.7405132157373107,-1.1527715872605284
654,positive regulation of Rho protein signal transduction (GO:0035025),0.3201530219799992,-0.7409795223664637,-1.1529456275808136
655,gliogenesis (GO:0042063),0.32025587989051946,-0.7656137895166246,-1.153101819467432
656,regulation of lamellipodium assembly (GO:0010591),0.3203295975719005,-0.7291089426040744,-1.1526421178337305
657,negative regulation of proteolysis (GO:0045861),0.3203591760732243,-0.7303427523034294,-1.153004698785976
658,protein targeting to lysosome (GO:0006622),0.3212643518000509,-0.7513361916146752,-1.1522601843994376
659,positive regulation of collagen metabolic process (GO:0010714),0.3214998888358145,-0.7595452925784951,-1.1523166163716494
660,second-messenger-mediated signaling (GO:0019932),0.3241066908388828,-0.7119667284203215,-1.1516198104040816
661,regulation of synapse assembly (GO:0051963),0.3245667853447739,-0.7450313460325289,-1.1514631143251313
662,regulation of chromatin silencing (GO:0031935),0.32551977299400425,-0.7563810743483923,-1.1511746881662153
663,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.32584562632647307,-0.7462709675200254,-1.1510340961264076
664,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.32630619861097937,-0.7102464744605916,-1.150755035133265
665,positive regulation of response to stimulus (GO:0048584),0.3267792203693949,-0.732510507620141,-1.1507603703257205
666,regulation of cell adhesion mediated by integrin (GO:0033628),0.32831992965722046,-0.737603404879128,-1.1502840839629445
667,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.32914535882218077,-0.7377914631139192,-1.1499520154339642
668,positive regulation of nuclear division (GO:0051785),0.3292469432643749,-0.7520476005239805,-1.1498346654527658
669,negative regulation of signaling receptor activity (GO:2000272),0.3293031546738364,-0.7324625967531065,-1.1499961083593304
670,central nervous system neuron development (GO:0021954),0.3310859380684461,-0.7681036760283594,-1.149401637554863
671,regulation of lipid biosynthetic process (GO:0046890),0.33273292168336344,-0.7310498371746773,-1.149009405516073
672,body fluid secretion (GO:0007589),0.33278563773703307,-0.7674820281177402,-1.1488957684383294
673,cellular response to organic substance (GO:0071310),0.33422490047731473,-0.7024902706979809,-1.1486046621659434
674,cellular component disassembly (GO:0022411),0.3353572818567313,-0.7349146052163705,-1.1481481004838436
675,regulation of vasculature development (GO:1901342),0.3354028646929769,-0.741274174722618,-1.1483275350778708
676,regulation of mononuclear cell migration (GO:0071675),0.3358503775511886,-0.7399371275594664,-1.1481518155427672
677,exogenous drug catabolic process (GO:0042738),0.3361587558802994,-0.7446723269083978,-1.1479246490972113
678,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3378091135201032,-0.7109891697383671,-1.1475672953052296
679,positive regulation of morphogenesis of an epithelium (GO:1905332),0.33873199276272936,-0.7550601589690928,-1.1472734690673254
680,negative regulation of response to biotic stimulus (GO:0002832),0.3388882334756407,-0.7282484263210136,-1.1471569915476567
681,positive regulation of natural killer cell mediated immunity (GO:0002717),0.3401583383258852,-0.7431349826373291,-1.146724858930712
682,negative regulation of multicellular organismal process (GO:0051241),0.34021633749840563,-0.6999045560136207,-1.1468115956768012
683,fatty acid derivative biosynthetic process (GO:1901570),0.3408046252361272,-0.7241359035214907,-1.146511398516963
684,positive regulation of histone acetylation (GO:0035066),0.34101308462957103,-0.7390084500632478,-1.1463920324124603
685,regulation of protein tyrosine kinase activity (GO:0061097),0.3415963748115254,-0.7069687053534969,-1.1461355181948447
686,regulation of cell size (GO:0008361),0.3417544533201693,-0.7397926482999108,-1.146192817032239
687,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.34320258406275583,-0.7103241030943913,-1.145757288351056
688,positive regulation of cell death (GO:0010942),0.34395138216331766,-0.7189172716691642,-1.1455335475316606
689,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.34475378991585104,-0.721533686002405,-1.1453495603196637
690,positive regulation of cell cycle (GO:0045787),0.3449963664134679,-0.7168734176766632,-1.1452429902437888
691,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.34519647875088305,-0.7230394969642621,-1.145141347403169
692,regulation of innate immune response (GO:0045088),0.3468828001622133,-0.6971734422913154,-1.1447326118448182
693,primary neural tube formation (GO:0014020),0.34695980762624523,0.3605496763202992,1.3992306794432312
694,phosphatidylserine metabolic process (GO:0006658),0.34712116938480925,-0.7613853470528702,-1.144607111346078
695,activation of protein kinase A activity (GO:0034199),0.3471669503002363,-0.7834435419724496,-1.1444050474336607
696,positive regulation of neutrophil chemotaxis (GO:0090023),0.3472795299213807,-0.7534933016430477,-1.1443158524865344
697,drug catabolic process (GO:0042737),0.34734498306877926,-0.741241289021998,-1.1444617740954706
698,protein kinase B signaling (GO:0043491),0.3474745414717792,-0.7350068625038009,-1.1441575359920584
699,negative regulation of ion transport (GO:0043271),0.34771156986406876,-0.7291441861448579,-1.1439343317466135
700,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.34775162340788224,-0.7184019904213027,-1.1440096263183075
701,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3486464961289965,-0.7195718554442049,-1.1435293421520063
702,positive regulation of transport (GO:0051050),0.3487153621241076,-0.6951048156179149,-1.1437120615827068
703,positive regulation of viral process (GO:0048524),0.34874258879495745,-0.7084644409010418,-1.143602870856359
704,peptide hormone secretion (GO:0030072),0.34907037120641976,-0.7395080555269651,-1.1417136786554223
705,negative regulation of fibroblast proliferation (GO:0048147),0.34910898323710027,-0.7370505009525445,-1.1431141502488549
706,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.34926802012699465,-0.7377637563095284,-1.1414978536064257
707,regulation of stress fiber assembly (GO:0051492),0.34928427330964007,-0.7203819468693249,-1.1417589076399917
708,positive regulation of macromolecule biosynthetic process (GO:0010557),0.34943206020762546,-0.7029374103233595,-1.1418216301120239
709,collagen fibril organization (GO:0030199),0.34946376701537935,-0.7141255797166262,-1.1422003525333433
710,positive regulation of MAP kinase activity (GO:0043406),0.34950817314749993,-0.7095732145481835,-1.1415293959420738
711,sulfur amino acid metabolic process (GO:0000096),0.3495596704613481,-0.7553283730889743,-1.1431191664794993
712,organic substance transport (GO:0071702),0.349611215669246,-0.70271411163547,-1.1429179629023996
713,chondroitin sulfate metabolic process (GO:0030204),0.3498816523222162,-0.7443021048950287,-1.1422185238713454
714,regulation of granulocyte chemotaxis (GO:0071622),0.3499028613942977,-0.7288572552732073,-1.1419022539121717
715,epidermal growth factor receptor signaling pathway (GO:0007173),0.3499277085199767,-0.7089313789646734,-1.1418242729934842
716,regulation of macrophage differentiation (GO:0045649),0.3499583506451073,-0.7236940977843653,-1.1420059740644157
717,extracellular matrix disassembly (GO:0022617),0.3500389713523922,-0.7338595872960055,-1.1431302216017365
718,positive regulation of JUN kinase activity (GO:0043507),0.3502334385312121,-0.7481139487893422,-1.142239384050864
719,regulation of protein localization to cell periphery (GO:1904375),0.3503829287362919,-0.7381532792622909,-1.143169355973423
720,epidermal cell differentiation (GO:0009913),0.35053231982051725,-0.7231063737106239,-1.1422721226538979
721,carbohydrate derivative catabolic process (GO:1901136),0.35089954337584084,-0.7440022605797546,-1.142296230580577
722,regulation of collagen biosynthetic process (GO:0032965),0.3509129238600991,-0.7566357089452856,-1.142633391091705
723,tRNA metabolic process (GO:0006399),0.3509738941906971,-0.7595611067184134,-1.1424479735321886
724,lymphocyte differentiation (GO:0030098),0.3513624364316723,-0.7131373626945797,-1.1423016510956299
725,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.351424670856753,-0.7545801909652298,-1.1424576158260051
726,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3532885432672757,-0.7120696280939275,-1.1403977388089657
727,proteolysis (GO:0006508),0.3535462011108929,-0.6954672398755044,-1.1406236944404413
728,negative regulation of epithelial cell migration (GO:0010633),0.353558656652338,-0.7415416020989877,-1.1404285065229174
729,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.35386911080803246,-0.7462698741947955,-1.1404637104082416
730,linoleic acid metabolic process (GO:0043651),0.35401629120284506,-0.7467116998362624,-1.1406256238571355
731,hyaluronan catabolic process (GO:0030214),0.3540239399536831,-0.7505329871034492,-1.1407074061860416
732,cellular transition metal ion homeostasis (GO:0046916),0.35481060347225274,-0.7059576044539986,-1.1400015865644713
733,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3552003417998797,-0.7318719363972311,-1.1400154205115216
734,phosphatidic acid metabolic process (GO:0046473),0.3559402433522879,-0.7089831851001679,-1.1393008859925824
735,negative regulation of insulin secretion (GO:0046676),0.3559589173598339,-0.7439231997986248,-1.1391126017605089
736,positive regulation of alpha-beta T cell activation (GO:0046635),0.35598400400479646,-0.7493244185875356,-1.139574719926536
737,Fc-epsilon receptor signaling pathway (GO:0038095),0.35600814936461866,-0.7044735384714221,-1.1392070923738042
738,negative regulation of cell development (GO:0010721),0.35604177992948804,-0.7402186843674704,-1.1393779859872777
739,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.35617774581861317,-0.7333472838391998,-1.1396304612651385
740,positive regulation of bone mineralization (GO:0030501),0.3562219978382791,-0.733469337685865,-1.1394359459089007
741,monocarboxylic acid biosynthetic process (GO:0072330),0.35641590925175376,-0.697621895247079,-1.1389538105735468
742,regulation of kinase activity (GO:0043549),0.35653471585190494,-0.7030537535642416,-1.1388427966652506
743,regulation of histone acetylation (GO:0035065),0.35655561652649165,-0.7260982789990755,-1.1384861746757342
744,keratinocyte differentiation (GO:0030216),0.35687319258907196,-0.7281696711587465,-1.1386762009179743
745,regulation of mitochondrion organization (GO:0010821),0.3569910459703786,-0.7019024052685041,-1.1385789660129422
746,positive regulation of protein-containing complex assembly (GO:0031334),0.3569924268076487,-0.7018129184864688,-1.1384996803267566
747,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3572139715258011,-0.6915651121261798,-1.1383002937536801
748,positive regulation of fat cell differentiation (GO:0045600),0.35972131874359303,-0.712704892950214,-1.1377761877269172
749,positive regulation of collagen biosynthetic process (GO:0032967),0.36063027066959663,-0.7552836300496648,-1.1375361176761178
750,positive regulation of cytokine production involved in immune response (GO:0002720),0.36102404025999413,-0.7334623390514043,-1.1373568871391762
751,detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),0.36159106371420824,-0.7364993833571999,-1.137057961987529
752,sensory perception of bitter taste (GO:0050913),0.36159106371420824,-0.7364993833571999,-1.137057961987529
753,cell projection organization (GO:0030030),0.36262045325700243,-0.7419054764247637,-1.1366181601626908
754,negative regulation of macromolecule metabolic process (GO:0010605),0.3626840398470306,-0.6987408758499261,-1.1367584332168932
755,negative regulation of peptidase activity (GO:0010466),0.36295816383807344,-0.7102759447173527,-1.136648056103262
756,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3634787643173423,-0.7256683624383929,-1.1364187524641796
757,regulation of macrophage derived foam cell differentiation (GO:0010743),0.36356025688823623,-0.7306181294047337,-1.136334843574177
758,acyl-CoA metabolic process (GO:0006637),0.36452033315537874,-0.7082444523901067,-1.1359697631179848
759,epithelial tube morphogenesis (GO:0060562),0.36477002468238634,-0.7226972106832452,-1.1360286203612031
760,regulation of activin receptor signaling pathway (GO:0032925),0.36623535249437,0.40906283573740276,1.3999319268036583
761,cellular response to lipid (GO:0071396),0.3682673452180619,-0.69961444194851,-1.1351931929495418
762,protein O-linked glycosylation (GO:0006493),0.36843038288756047,-0.7011474734501559,-1.135088406298358
763,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.3689420400931281,-0.7564184597046998,-1.1347565840817155
764,positive regulation of calcium ion transport (GO:0051928),0.36900917402792405,-0.7141679443746682,-1.134918896960347
765,nucleobase-containing compound biosynthetic process (GO:0034654),0.3694226831576637,-0.7381175897211708,-1.1347591190054138
766,positive regulation of translational initiation (GO:0045948),0.3695122547400106,-0.7393383369296973,-1.1343839062347423
767,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3696906656044959,-0.7132195379022213,-1.1344345869074148
768,positive regulation of protein export from nucleus (GO:0046827),0.36980674537915015,-0.7385169773735103,-1.1345073736791655
769,myeloid cell differentiation (GO:0030099),0.37005647341987297,-0.7060480130864758,-1.1341137924546427
770,positive regulation of angiogenesis (GO:0045766),0.3704853596540264,-0.7042982130053386,-1.1341282148360532
771,JNK cascade (GO:0007254),0.37155036341991715,-0.7139473141080646,-1.1338007342598704
772,ear morphogenesis (GO:0042471),0.37160720847372714,-0.7341324914956336,-1.133714925299269
773,ventricular cardiac muscle tissue development (GO:0003229),0.3724210398690565,0.7853127840657353,1.4025697881545534
774,ERK1 and ERK2 cascade (GO:0070371),0.37262218490411286,-0.7358385473233441,-1.1333570695218642
775,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3738497192680572,-0.7488933255402693,-1.1330345321867197
776,mesonephric tubule development (GO:0072164),0.37413163516030035,-0.7184570134587227,-1.1330737572326115
777,myoblast differentiation (GO:0045445),0.3744370422476623,-0.7346252475681085,-1.1319127300178693
778,phosphatidic acid biosynthetic process (GO:0006654),0.37484937801332363,-0.7089912156212859,-1.131927009157674
779,hyaluronan metabolic process (GO:0030212),0.3749000349079126,-0.7360703407703773,-1.1326143047147232
780,cellular amide metabolic process (GO:0043603),0.3749839650365874,-0.69872221135984,-1.1322901119483861
781,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.37508836345648133,-0.7122106624937543,-1.1316245224693382
782,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.37510372846712176,-0.7127061206261993,-1.131973574578988
783,cellular response to zinc ion (GO:0071294),0.37526887821501287,-0.7379030608612126,-1.1326366272958814
784,platelet aggregation (GO:0070527),0.3752852343617324,-0.7167657012835267,-1.1320214118495857
785,endoplasmic reticulum tubular network organization (GO:0071786),0.3753005839917554,0.5942778183737243,1.4091850845687492
786,cardiac muscle cell development (GO:0055013),0.3753005839917554,0.7430822919444526,1.3716287968707812
787,phosphatidylinositol 3-kinase signaling (GO:0014065),0.37530172918763327,-0.7294860972899445,-1.132321604536233
788,cellular response to corticosteroid stimulus (GO:0071384),0.375307742404941,-0.7522956736941662,-1.1320908321978238
789,regulated exocytosis (GO:0045055),0.3753176607129196,-0.6939704462974392,-1.1316789667771652
790,carbohydrate derivative transport (GO:1901264),0.3754031664668835,-0.7323585364038555,-1.1326909848880062
791,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3757313058762266,-0.7472046258727496,-1.1323469510590056
792,regulation of viral life cycle (GO:1903900),0.37576021262520654,-0.7257060196326259,-1.132100528631834
793,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3757915880939987,-0.7156323383318822,-1.1324126538569268
794,skeletal system development (GO:0001501),0.379184229273774,-0.6917688566749542,-1.13075996718752
795,B cell differentiation (GO:0030183),0.37957624992759353,-0.7175302860094108,-1.1307786323709137
796,odontogenesis (GO:0042476),0.3802967021734227,-0.7149225052857251,-1.1305115927041753
797,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3828198420121814,-0.7101158805648603,-1.1298753550976073
798,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3828725006676341,-0.7301321572525246,-1.1297912318327328
799,Fc-gamma receptor signaling pathway (GO:0038094),0.38319032925712054,-0.7054591103516621,-1.129902823722208
800,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3832541496361868,-0.7099217650219152,-1.1295672250807642
801,regulation of protein kinase B signaling (GO:0051896),0.38345025223329154,-0.6822797880709153,-1.1294289980978665
802,phosphatidylinositol metabolic process (GO:0046488),0.38351534480376664,-0.69482809023486,-1.1296180525667086
803,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.38362231536271796,-0.7502464867227492,-1.129907605163455
804,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.38382587484582636,-0.7378987653203484,-1.1292532256546737
805,positive regulation of blood coagulation (GO:0030194),0.3847878576593504,-0.7472045083840444,-1.1289992660532473
806,glycolytic process (GO:0006096),0.3851368844570288,-0.7151412835637274,-1.1288828685505015
807,kidney development (GO:0001822),0.38590392665331935,-0.7018849271165771,-1.1285932994581933
808,regulation of response to external stimulus (GO:0032101),0.3861186732101502,-0.6894284328350528,-1.1286312764650899
809,dendrite self-avoidance (GO:0070593),0.3866318265407037,-0.7214048182415685,-1.1284094969461105
810,positive regulation of T cell differentiation (GO:0045582),0.38668982916541605,-0.7192002896892149,-1.1281852338783942
811,retina homeostasis (GO:0001895),0.38686956468293815,-0.7196853653070551,-1.1282880537848967
812,cardiac ventricle development (GO:0003231),0.3869401691562699,-0.7218635422396329,-1.1282100762725438
813,epidermis development (GO:0008544),0.39007089369980485,-0.7157447826394292,-1.127503263465197
814,response to peptide hormone (GO:0043434),0.3905401167938395,-0.7051797276619209,-1.127352759507236
815,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.39110284463206463,-0.7318998693750911,-1.1271987529449317
816,regulation of mitochondrial membrane potential (GO:0051881),0.3925625268726467,-0.7056592301544838,-1.12684425953236
817,regulation of establishment of cell polarity (GO:2000114),0.3925900490496237,-0.7576404564018775,-1.1267623933280622
818,blood vessel diameter maintenance (GO:0097746),0.3930891432772446,-0.7260033481273463,-1.1266114469621304
819,positive regulation of actin filament bundle assembly (GO:0032233),0.3946468553990982,-0.7111310561803371,-1.126295985317886
820,activation of protein kinase B activity (GO:0032148),0.3946834339215971,-0.7264483113908927,-1.1262169812249083
821,protein K48-linked deubiquitination (GO:0071108),0.3966934033627898,-0.7355692645265544,-1.1258386336051516
822,myotube differentiation (GO:0014902),0.39670387757563785,-0.733820591159393,-1.1257666243028035
823,regulation of multicellular organismal development (GO:2000026),0.39720457667880216,-0.7250463679289074,-1.1255181657625228
824,positive regulation of insulin secretion (GO:0032024),0.3974173875108764,-0.7216371378709884,-1.1255592523863467
825,positive regulation of protein modification process (GO:0031401),0.399955902266398,-0.6868893930947552,-1.1249349668600506
826,negative regulation of peptide hormone secretion (GO:0090278),0.39996862981649295,-0.7330538636492532,-1.1247974224165862
827,regulation of cytosolic calcium ion concentration (GO:0051480),0.3999739336053013,-0.6915442836682987,-1.1248639099522981
828,zymogen activation (GO:0031638),0.3999749700220032,-0.7129014110343302,-1.1247162215042932
829,mononuclear cell differentiation (GO:1903131),0.4001131554865878,-0.7202110208879877,-1.1249936959982556
830,positive regulation of phosphate metabolic process (GO:0045937),0.4006782880189026,-0.7100019587385261,-1.1245051256522158
831,positive regulation of protein localization to nucleus (GO:1900182),0.4029024800610057,-0.6959400628021588,-1.1239795717273346
832,positive regulation of protein phosphorylation (GO:0001934),0.4031898248630903,-0.6813916674538619,-1.1240106258869322
833,positive regulation of stress fiber assembly (GO:0051496),0.40334498715363015,-0.7128829890056286,-1.1238058990760091
834,negative regulation of lipid metabolic process (GO:0045833),0.40371062125991264,-0.7142005708361526,-1.1234383011253188
835,negative regulation of cell growth (GO:0030308),0.4038442060559688,-0.6964956941224335,-1.1236595327907561
836,fluid transport (GO:0042044),0.4038588217331636,-0.7309009129000672,-1.1234884438802761
837,ureteric bud development (GO:0001657),0.404103427756757,-0.7063586612270993,-1.123309510826906
838,negative regulation of gene expression (GO:0010629),0.404203656855795,-0.6802383513239273,-1.1235175354077491
839,response to zinc ion (GO:0010043),0.4055407804958797,-0.7114699328283087,-1.1229794565501514
840,regulation of monocyte differentiation (GO:0045655),0.40572384975399334,-0.7338550193027634,-1.1228934447529462
841,negative regulation of immune effector process (GO:0002698),0.40680982586091363,-0.7459974440893297,-1.122573884061735
842,regulation of peptide hormone secretion (GO:0090276),0.4068692063580954,-0.6944070585222694,-1.1226258465667995
843,regulation of endothelial cell proliferation (GO:0001936),0.4076652523863426,-0.6940425939716339,-1.1223251212925274
844,positive regulation of signaling receptor activity (GO:2000273),0.4078897405632631,-0.7183863553145947,-1.1216782316236693
845,positive regulation of chemotaxis (GO:0050921),0.40790442957903195,-0.706346595113982,-1.121750546037585
846,positive regulation of Ras protein signal transduction (GO:0046579),0.40793621433977834,-0.7039118351063385,-1.1222221281329916
847,triglyceride catabolic process (GO:0019433),0.4079665659764567,-0.7303861163796528,-1.1213720151712365
848,macrophage differentiation (GO:0030225),0.4080169778281645,-0.7210258515687916,-1.1219673992324024
849,regulation of endothelial cell migration (GO:0010594),0.4080525035473638,-0.6986816956737016,-1.1215286113605551
850,substantia nigra development (GO:0021762),0.40807806289301524,-0.7071698043738562,-1.12180323740281
851,positive regulation of wound healing (GO:0090303),0.408138471826327,-0.7055584669976913,-1.1218701829346645
852,protein destabilization (GO:0031648),0.4082294953292319,-0.7127547159012861,-1.1214104387239543
853,secondary alcohol biosynthetic process (GO:1902653),0.4082939034016101,-0.7147824228208024,-1.1219955617469264
854,glycerophospholipid metabolic process (GO:0006650),0.4084518844369,-0.6970993357571459,-1.1215447214901912
855,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4085829050997134,-0.7135173923895486,-1.1220530718220734
856,negative regulation of nervous system development (GO:0051961),0.4121952924887584,-0.7229228522749136,-1.1206169567527806
857,regulation of DNA binding (GO:0051101),0.4137382647357926,-0.7168006108228347,-1.1202489142791567
858,dopamine metabolic process (GO:0042417),0.4146824283785616,-0.7362689383526855,-1.1200309764548952
859,regulation of cell-matrix adhesion (GO:0001952),0.4163175718425695,-0.7067282895241025,-1.11960847636152
860,Fc receptor signaling pathway (GO:0038093),0.41681318799952494,-0.6920617492925184,-1.1196086660479814
861,positive regulation of peptidase activity (GO:0010952),0.41694201983568535,-0.724079974167914,-1.1194445529010688
862,positive regulation of cellular catabolic process (GO:0031331),0.42156584987356827,-0.6862428081975875,-1.118597456930924
863,regulation of cell adhesion (GO:0030155),0.42162448203132835,-0.6834001036555971,-1.1185051575188323
864,regulation of MAPK cascade (GO:0043408),0.42479258538923564,-0.684948586067158,-1.1178211850596949
865,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.4252507019266409,-0.6990899281368852,-1.1178362491933773
866,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4253810955911435,-0.7324384067124599,-1.1176524352459103
867,positive regulation of lipid kinase activity (GO:0090218),0.4262459603627538,-0.7114513321575517,-1.117417571533595
868,cellular response to ketone (GO:1901655),0.42718646408041827,-0.7131223425862251,-1.1171938582881362
869,regulation of calcium ion import (GO:0090279),0.43072939195146265,-0.7107515964541878,-1.1165480616093832
870,negative regulation of anoikis (GO:2000811),0.43230450809517024,-0.7228974020490229,-1.1162536660938596
871,positive regulation of kinase activity (GO:0033674),0.4327266940277254,-0.683938217282379,-1.1160429963276608
872,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.43277017234412024,-0.7020657342790745,-1.1161161011168719
873,positive regulation of epithelial cell proliferation (GO:0050679),0.43652233121268075,-0.6878829027115314,-1.1154164867684773
874,negative regulation of endothelial cell migration (GO:0010596),0.43744421575706344,-0.7183643969712111,-1.1151860228068977
875,positive regulation of actin filament polymerization (GO:0030838),0.4377145998218948,-0.6983924975714955,-1.115066765076771
876,respiratory system development (GO:0060541),0.4386487650344802,-0.7004474840150238,-1.11481073943454
877,carbohydrate derivative biosynthetic process (GO:1901137),0.43874287204481505,-0.7062781965960561,-1.1148728571931288
878,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.4445191475565742,-0.6978649713028441,-1.1137899379028466
879,anterior/posterior pattern specification (GO:0009952),0.4445321299405269,-0.702120090306529,-1.1138657055764922
880,response to alcohol (GO:0097305),0.44507517726487683,-0.7300454921082118,-1.1136297883428041
881,response to organic cyclic compound (GO:0014070),0.44669005574251597,-0.7027602789340183,-1.1132920342884662
882,positive regulation of cytoskeleton organization (GO:0051495),0.4470021160653578,-0.6844313550798283,-1.1131983270771135
883,positive chemotaxis (GO:0050918),0.44720441435249325,-0.7290292509017294,-1.1130935721070918
884,import into cell (GO:0098657),0.44923942707381537,-0.6959604821238587,-1.112622990174628
885,osteoclast differentiation (GO:0030316),0.44924688501544785,-0.7070777308592259,-1.1126930025297272
886,hydrogen peroxide metabolic process (GO:0042743),0.4498404956302555,-0.7072414322183607,-1.1124516512185925
887,stress-activated MAPK cascade (GO:0051403),0.45250238578666657,-0.702620167545658,-1.111939559204798
888,xenobiotic transport (GO:0042908),0.45784029453916997,-0.7223842452083924,-1.1110964987849778
889,regulation of receptor recycling (GO:0001919),0.458009392785964,-0.7290065177143956,-1.111146741330036
890,activation of protein kinase activity (GO:0032147),0.45904525912784344,-0.6922204801042959,-1.1108289112513219
891,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.459620832039035,-0.7096490919898224,-1.1106693268451537
892,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.46010875389823813,-0.7013434246367364,-1.1105544675466752
893,establishment of protein localization to membrane (GO:0090150),0.4611996876450669,-0.697069080622175,-1.1102263427777836
894,regulation of Rho protein signal transduction (GO:0035023),0.4616734800347039,-0.6961273887609781,-1.1102341054362677
895,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.46259827701974426,-0.7080404660826936,-1.1099468415789653
896,heterochromatin assembly (GO:0031507),0.46352101416768327,-0.7110397233399327,-1.1097314523665502
897,regulation of epithelial cell proliferation (GO:0050678),0.4653966283107533,-0.6912656409238978,-1.109373155741446
898,embryonic limb morphogenesis (GO:0030326),0.46567100880930146,-0.7021363745932172,-1.1092475831453055
899,cellular senescence (GO:0090398),0.4670260427724739,-0.7191215611688714,-1.1089710977083633
900,bile acid and bile salt transport (GO:0015721),0.4680037259505811,-0.7126717403056084,-1.1087923318682213
901,positive regulation of cell-matrix adhesion (GO:0001954),0.46806058854034843,-0.7037347511754402,-1.108722207401565
902,anterior/posterior axis specification (GO:0009948),0.4685419524613767,-0.7339243212863041,-1.1083056245796203
903,glutathione derivative biosynthetic process (GO:1901687),0.46892953791031805,-0.6898718822094209,-1.1081079710775463
904,glutathione derivative metabolic process (GO:1901685),0.46892953791031805,-0.6898718822094209,-1.1081079710775463
905,regulation of peptidyl-serine phosphorylation (GO:0033135),0.46893059403630166,-0.687681969918744,-1.1084015714684288
906,positive regulation of glial cell differentiation (GO:0045687),0.46903944270883435,-0.7252982952541829,-1.108307660444456
907,positive regulation of secretion by cell (GO:1903532),0.4691735870633503,-0.6917387282286216,-1.1084557900466376
908,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.47151767361482316,-0.7233989149499604,-1.1076258335004816
909,skeletal muscle contraction (GO:0003009),0.4720358355031499,-0.7096398921941651,-1.1074832017071927
910,regulation of actin filament polymerization (GO:0030833),0.47410714527680897,-0.6940892426556328,-1.1071240773374977
911,regulation of ruffle assembly (GO:1900027),0.47565628802944787,-0.7278481420619611,-1.106836245692622
912,response to fatty acid (GO:0070542),0.4772161575498459,-0.741621311188445,-1.1064323349158276
913,cognition (GO:0050890),0.477634505647858,-0.7060968921127906,-1.1064494641723315
914,positive regulation of cell-substrate adhesion (GO:0010811),0.4784829503987274,-0.6898602275377541,-1.1061564913842998
915,positive regulation of phosphorylation (GO:0042327),0.4796943428851088,-0.6729985437778371,-1.1059114756177697
916,cartilage development (GO:0051216),0.47991576948509557,-0.7002630907637792,-1.105785291276459
917,protein localization to lysosome (GO:0061462),0.4845534654160554,-0.7143783970790558,-1.1050413066268099
918,positive regulation of calcium ion transport into cytosol (GO:0010524),0.48487378890422195,-0.6988758902818911,-1.104875006210429
919,response to progesterone (GO:0032570),0.4859366149793623,-0.7002997938835189,-1.104648896198252
920,regulation of chemotaxis (GO:0050920),0.4863174294446466,-0.695644555401817,-1.104511975656798
921,response to growth factor (GO:0070848),0.4885460934612513,-0.6952059625575239,-1.1041479689325415
922,regulation of vasoconstriction (GO:0019229),0.4917609593769817,-0.7139570414284366,-1.1036108152494848
923,regulation of mitotic nuclear division (GO:0007088),0.49318663780473626,-0.7049255392246386,-1.1033394465273958
924,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.49707632975358884,-0.7100789070968477,-1.1027115436091397
925,proteoglycan biosynthetic process (GO:0030166),0.4974136496871239,-0.7064095152752629,-1.102535243918593
926,pyrimidine-containing compound catabolic process (GO:0072529),0.49745928858797805,-0.7311924221213237,-1.102390306638787
927,cellular metal ion homeostasis (GO:0006875),0.4977547016664593,-0.6861845638501739,-1.1025599905541348
928,positive regulation of ossification (GO:0045778),0.4978100151959068,-0.7044221135096547,-1.1024125832405887
929,negative regulation of response to external stimulus (GO:0032102),0.49828146704796245,-0.6822626638105214,-1.1020459670656002
930,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4985802341164113,-0.6917939234457267,-1.1020825566344217
931,organic hydroxy compound transport (GO:0015850),0.4985897800366887,-0.7044197260226714,-1.1021495099805585
932,cholesterol biosynthetic process (GO:0006695),0.5020695833870046,-0.7024434519279804,-1.1014888984118676
933,heart trabecula morphogenesis (GO:0061384),0.5027999472362734,-0.7188517293889902,-1.1009346687809685
934,carbohydrate catabolic process (GO:0016052),0.5029316587018168,-0.69394006614468,-1.10070089576316
935,ERBB2 signaling pathway (GO:0038128),0.5029969609288962,-0.6991183478511682,-1.1007645809019437
936,activation of adenylate cyclase activity (GO:0007190),0.5031731961189406,-0.7227299844360956,-1.1009616454503548
937,regulation of chromosome segregation (GO:0051983),0.5033798527938979,-0.7149337000860526,-1.1007929332243023
938,negative regulation of endopeptidase activity (GO:0010951),0.5034137003299604,-0.6850999921863345,-1.1009953378122987
939,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5035313100809109,-0.7045632258320158,-1.1010580461544597
940,zinc ion transmembrane transport (GO:0071577),0.5035468152763296,-0.7139429159181021,-1.1003049210387688
941,positive regulation of glucose import (GO:0046326),0.5036125001495347,-0.7232953523855433,-1.1003692408800152
942,response to cytokine (GO:0034097),0.5038924414664369,-0.6736929698726787,-1.1004183717822056
943,positive regulation of granulocyte chemotaxis (GO:0071624),0.5039487664867143,-0.71474942060907,-1.1001748169701246
944,response to interferon-alpha (GO:0035455),0.5039992478814761,-0.7036852233151939,-1.1010675454458747
945,cardiac epithelial to mesenchymal transition (GO:0060317),0.5040505058047781,-0.7222423691391007,-1.1004720233737622
946,positive regulation of signal transduction (GO:0009967),0.5042381797569633,-0.6728471853620178,-1.100057800356112
947,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5042633028766499,-0.6933021521171524,-1.0999794929505742
948,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5043857498538548,-0.6994873266806311,-1.1010879203957302
949,apoptotic process (GO:0006915),0.5076651604517487,-0.6737073982015024,-1.0991728616328988
950,base conversion or substitution editing (GO:0016553),0.5076729803702388,-0.7310981098910393,-1.0993347434724048
951,regulation of phosphorylation (GO:0042325),0.507787347470698,-0.6779883751006958,-1.099066232869894
952,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5078237899351552,-0.6893940168048509,-1.0993954418793364
953,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5079066135910597,-0.6944012573588797,-1.0992168997822063
954,L-alpha-amino acid transmembrane transport (GO:1902475),0.5083626915782921,-0.71118690212342,-1.09891016409784
955,positive regulation of cell migration (GO:0030335),0.5087757631075287,-0.6656029185163593,-1.0987854048774872
956,regulation of DNA metabolic process (GO:0051052),0.5090773539013506,-0.7070984537803356,-1.0986513318562485
957,basement membrane organization (GO:0071711),0.5096465687572277,-0.7260447906812844,-1.0983000515915933
958,monocarboxylic acid transport (GO:0015718),0.5097800512316659,-0.687219840560832,-1.0984719961291292
959,purine ribonucleotide metabolic process (GO:0009150),0.5098893023041882,-0.6855097662261108,-1.0984075587736637
960,regulation of osteoblast proliferation (GO:0033688),0.5100985446278374,-0.7294106920503125,-1.098307590787764
961,positive regulation of gene expression (GO:0010628),0.5114557990853074,-0.6657965171863531,-1.0980000903586866
962,cellular response to interleukin-6 (GO:0071354),0.5130522272215539,-0.6988242768730012,-1.097505304909517
963,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5130813634945912,-0.6995855603344423,-1.0976803874412646
964,negative regulation of macrophage activation (GO:0043031),0.5133961167033465,-0.7222610489091676,-1.0975436098162341
965,keratan sulfate biosynthetic process (GO:0018146),0.514400044348825,-0.7176633978602753,-1.0970797826896002
966,positive regulation of protein localization to membrane (GO:1905477),0.5146360407819025,-0.6732744821198856,-1.0969018949361633
967,interleukin-6-mediated signaling pathway (GO:0070102),0.5147117496683307,-0.7057068962958186,-1.0969831822732712
968,positive regulation of macromolecule metabolic process (GO:0010604),0.5148338022562419,-0.6671295043694048,-1.0970937558312615
969,regulation of filopodium assembly (GO:0051489),0.5153083124121753,-0.6769330881438396,-1.097110065760532
970,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5156303870189051,-0.6789599521507387,-1.0967035246466053
971,hydrogen peroxide catabolic process (GO:0042744),0.5245191658245425,-0.7180502526735191,-1.0949581048859054
972,regulation of anoikis (GO:2000209),0.5247729752403364,-0.706872904288466,-1.095229352951395
973,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5248066674103689,-0.6869042203273154,-1.095366050836338
974,retinol metabolic process (GO:0042572),0.5248309887066047,-0.7242162424010861,-1.0949758307029513
975,regulation of protein secretion (GO:0050708),0.5250468306404072,-0.6693616698166129,-1.0952689445138193
976,organic anion transport (GO:0015711),0.5252518648855174,-0.6784449758882853,-1.0950034755193203
977,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5252888894072154,-0.6953736217032064,-1.095083810540018
978,cell-substrate junction assembly (GO:0007044),0.5287735677211327,-0.6942873593232184,-1.0941733576688621
979,cellular response to glucocorticoid stimulus (GO:0071385),0.5291640511962294,-0.7265049976850513,-1.0940330277296806
980,microvillus assembly (GO:0030033),0.5292164242437327,-0.7370739017219984,-1.0941859347715386
981,negative regulation of small molecule metabolic process (GO:0062014),0.5295030234857466,-0.6984067824328593,-1.0942229676612278
982,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5324201423394933,-0.6927786362706496,-1.0935248428516013
983,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.5339396835797403,-0.6748195808288621,-1.0932893775656145
984,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5349484139089569,-0.7059490100055625,-1.0930827252103057
985,retinoid metabolic process (GO:0001523),0.5381189768721051,-0.6792503948267875,-1.0925074094248148
986,regulation of cellular component size (GO:0032535),0.5383805960457069,-0.6884556674023734,-1.0923890292880531
987,positive regulation of protein kinase activity (GO:0045860),0.5384322204345903,-0.672591767194626,-1.0925351290517686
988,cellular biogenic amine biosynthetic process (GO:0042401),0.5387875115856242,-0.711130503335674,-1.0922713966585063
989,epithelial structure maintenance (GO:0010669),0.539125601325724,-0.7114216557966312,-1.0921405311543824
990,ERBB signaling pathway (GO:0038127),0.5391525179764984,-0.6757369786186791,-1.0920548901666198
991,negative regulation of secretion by cell (GO:1903531),0.5422906446036785,-0.6980109106215081,-1.0915612074993366
992,negative regulation of cation channel activity (GO:2001258),0.5448832613575372,-0.7046161019970894,-1.0909490387616942
993,hepaticobiliary system development (GO:0061008),0.5453072745730104,-0.7073270165919022,-1.0909718077844006
994,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.545693429530672,-0.6909542542132513,-1.0909990406330228
995,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.5469403254621599,-0.695702386075406,-1.0905155098821746
996,cortical cytoskeleton organization (GO:0030865),0.5469987751330596,-0.6905613056010539,-1.0905703038776942
997,cellular response to steroid hormone stimulus (GO:0071383),0.5479208192455471,-0.7078471949675746,-1.0902107014089366
998,regulation of early endosome to late endosome transport (GO:2000641),0.5482306087096714,-0.7125945921072832,-1.0902597842946633
999,negative regulation of innate immune response (GO:0045824),0.5497938796734358,-0.6801410822284872,-1.089888606000244
1000,cellular response to hexose stimulus (GO:0071331),0.5503914114662217,-0.6912862551035177,-1.089678546141169
1001,acylglycerol catabolic process (GO:0046464),0.5505683230856383,-0.6905413824691242,-1.0897212471950841
1002,positive regulation of cell motility (GO:2000147),0.5507228094070524,-0.6618144155633743,-1.0895545007826353
1003,ribonucleoside bisphosphate metabolic process (GO:0033875),0.551416771345443,-0.6863030706204353,-1.0892664910564025
1004,purine nucleoside bisphosphate metabolic process (GO:0034032),0.551416771345443,-0.6863030706204353,-1.0892664910564025
1005,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5517524514891554,-0.6751377379727387,-1.0893506962489696
1006,regulation of protein phosphorylation (GO:0001932),0.5520989565990544,-0.6577422496340493,-1.0891004101011355
1007,vitamin transport (GO:0051180),0.554930763468786,-0.6904444019665373,-1.0881975138368574
1008,regulation of cellular respiration (GO:0043457),0.5549447478707004,-0.7112180122693306,-1.0878411251291518
1009,regulation of MAP kinase activity (GO:0043405),0.5551987276879509,-0.6663590791314623,-1.0878981760185513
1010,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5553567819722928,-0.70151975872844,-1.0882157925153535
1011,negative regulation of cellular catabolic process (GO:0031330),0.5555394696886444,-0.6819230866633414,-1.0876377266489752
1012,primary alcohol metabolic process (GO:0034308),0.555575527056454,-0.7042152986161927,-1.088047316741767
1013,response to nutrient levels (GO:0031667),0.5556705526401111,-0.7093647244870652,-1.0879082990779496
1014,negative regulation of signal transduction (GO:0009968),0.5557266773609654,-0.6574163710577808,-1.088248027913121
1015,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.555727135047898,-0.7038051006208564,-1.0879633145666696
1016,negative regulation of actin filament bundle assembly (GO:0032232),0.5558594834628215,-0.7156147411400081,-1.087663257831808
1017,cellular protein catabolic process (GO:0044257),0.5559346636409177,-0.6829152644246821,-1.0875226674828755
1018,negative regulation of catabolic process (GO:0009895),0.5560497863234773,-0.6802194347413746,-1.0882882047959448
1019,positive regulation of organelle assembly (GO:1902117),0.5562022566164507,-0.6861487985782477,-1.0883302731754427
1020,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5563462073252523,0.6013212613390463,1.3153818003214275
1021,regulation of response to biotic stimulus (GO:0002831),0.5563478552679033,-0.683963167201359,-1.0874009217039375
1022,cellular response to oxygen-containing compound (GO:1901701),0.55650744822966,-0.6665585035907557,-1.088355211166688
1023,regulation of cell death (GO:0010941),0.5568704703592148,-0.666429449920378,-1.088389676191306
1024,positive regulation of ATPase activity (GO:0032781),0.5577589706754942,0.8816108327908588,1.3112527924910211
1025,regulation of cytokine-mediated signaling pathway (GO:0001959),0.5584961701653383,-0.6705557421165586,-1.087004887042725
1026,regulation of endopeptidase activity (GO:0052548),0.5594309435516944,-0.6767674868468786,-1.0868003502489163
1027,negative regulation of cell-substrate adhesion (GO:0010812),0.5594447214257117,-0.6866461920535301,-1.0865218786725406
1028,protein processing (GO:0016485),0.5596389902603157,-0.6718882095342442,-1.0866470096767369
1029,phosphatidylcholine metabolic process (GO:0046470),0.5597473771501891,-0.6819528993245022,-1.086552288602106
1030,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5598206978919676,-0.6940500193771855,-1.0866970101265698
1031,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5618578230457176,-0.6732460853876925,-1.0858828914287897
1032,positive regulation of protein import into nucleus (GO:0042307),0.5618890527593698,-0.7088356003952837,-1.0857872566520308
1033,blood vessel endothelial cell migration (GO:0043534),0.5621989042543887,-0.7115088264897049,-1.0859130784786601
1034,positive regulation of hydrolase activity (GO:0051345),0.5622331489094912,-0.674248827920585,-1.085997825946445
1035,T cell mediated immunity (GO:0002456),0.56278981539356,-0.7191563209349006,-1.0859991065191656
1036,regulation of postsynapse organization (GO:0099175),0.563758017496691,-0.6956264755096293,-1.0854446483725468
1037,myeloid cell development (GO:0061515),0.5647145819821617,-0.7017825259451882,-1.0852701442277857
1038,positive regulation of endothelial cell proliferation (GO:0001938),0.5651134524674374,-0.6773341483491625,-1.0851530863995102
1039,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5659372439141772,-0.6875865959342281,-1.084971207824491
1040,sensory perception (GO:0007600),0.5661307336193225,-0.7048357604683572,-1.0848652198125277
1041,regulation of monooxygenase activity (GO:0032768),0.5667394775132036,-0.6974987111059103,-1.084716613239444
1042,nucleosome assembly (GO:0006334),0.5673285744497599,-0.6724877393322988,-1.0845646891771732
1043,substrate adhesion-dependent cell spreading (GO:0034446),0.5681285377718323,-0.673245005850979,-1.0844014971231024
1044,positive regulation of protein import (GO:1904591),0.568684151990543,-0.7077169497882647,-1.0841946690875643
1045,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5689637740016639,-0.7006436421443986,-1.0842271703976858
1046,protein maturation (GO:0051604),0.5693977302219899,-0.6679683884791185,-1.0840201976106185
1047,anion transport (GO:0006820),0.5696508030465304,-0.6818424538841653,-1.0839003453820326
1048,hemopoiesis (GO:0030097),0.5716859304164963,-0.6742376034854941,-1.0834864238915045
1049,negative regulation of cellular protein localization (GO:1903828),0.5721233331124559,-0.6828304965768976,-1.0834999559983678
1050,embryonic skeletal system development (GO:0048706),0.5725219948463247,-0.6877099490346202,-1.0833024230262724
1051,positive regulation of protein polymerization (GO:0032273),0.5726247055339236,-0.6718645672985306,-1.0832296972251267
1052,negative regulation of leukocyte activation (GO:0002695),0.5726366244036968,-0.7085134481349072,-1.0827628260819269
1053,cellular polysaccharide catabolic process (GO:0044247),0.572654114917993,-0.7280055079704186,-1.0831629925057868
1054,positive regulation of phospholipase activity (GO:0010518),0.5728929743088245,-0.7219756890766439,-1.082652962223258
1055,nitrogen compound transport (GO:0071705),0.5728986183497345,-0.6588614630504848,-1.0828061046503528
1056,regulation of ERBB signaling pathway (GO:1901184),0.5731884527903113,-0.7006238695469222,-1.0828501977144174
1057,negative regulation of cell population proliferation (GO:0008285),0.5732508467404424,-0.6571217996256864,-1.0829197745874424
1058,cellular response to cAMP (GO:0071320),0.5737789356583485,-0.7026587203216327,-1.0829237152316284
1059,glycerolipid catabolic process (GO:0046503),0.5769089918068275,-0.7204034923976497,-1.0818494704672648
1060,cellular response to reactive oxygen species (GO:0034614),0.5770606443399716,-0.6802688567268991,-1.0820411139725634
1061,branching morphogenesis of an epithelial tube (GO:0048754),0.5771285408091831,-0.6686838800361018,-1.0818975675022247
1062,snRNA processing (GO:0016180),0.5773575798267698,-0.7095230062657922,-1.081931046491816
1063,positive regulation of intracellular protein transport (GO:0090316),0.5780008517602988,-0.6619503289937075,-1.0816242215165206
1064,negative regulation of cell adhesion (GO:0007162),0.5811590891356094,-0.6663764946038553,-1.0811118171642216
1065,NIK/NF-kappaB signaling (GO:0038061),0.5827977506487091,-0.6705556665708328,-1.0806774005377593
1066,natural killer cell mediated cytotoxicity (GO:0042267),0.5831742556487279,-0.7144472597030153,-1.0807681303974204
1067,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.5831841604305846,-0.6755654264775244,-1.0807030576591141
1068,regulation of small molecule metabolic process (GO:0062012),0.5926159429374793,-0.7057562345740858,-1.079371006367155
1069,regulation of GTPase activity (GO:0043087),0.592761371025783,-0.6636912472817085,-1.0792122385146612
1070,positive regulation of apoptotic signaling pathway (GO:2001235),0.5932730458388583,-0.6796798190985526,-1.079226742545285
1071,regulation of protein localization to plasma membrane (GO:1903076),0.5960077447977461,-0.6605930992369107,-1.0786283018051117
1072,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.596431812702194,-0.6670791809896609,-1.0786417912607753
1073,organic acid transport (GO:0015849),0.5969725623001235,-0.6658619653978174,-1.0784142378245667
1074,regulation of intracellular transport (GO:0032386),0.5998680658178995,-0.684709105047121,-1.077999353748452
1075,cellular response to BMP stimulus (GO:0071773),0.6001391365477907,-0.6765419936763671,-1.0778907354307132
1076,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6001775164105808,-0.6892587162312684,-1.0778053722223906
1077,positive regulation of GTPase activity (GO:0043547),0.6009314453274366,-0.6620001788828453,-1.077588109017282
1078,regulation of Ras protein signal transduction (GO:0046578),0.6014023734896546,-0.6670055156411038,-1.0775974412727891
1079,regulation of insulin secretion (GO:0050796),0.6052431578040766,-0.6608300148048205,-1.0769378761966766
1080,regulation of smooth muscle cell migration (GO:0014910),0.6074294424750291,-0.7071364828554426,-1.0766020695561387
1081,regulation of cysteine-type endopeptidase activity (GO:2000116),0.6093712228141256,-0.7059012160765388,-1.0761097526602457
1082,negative regulation of response to stimulus (GO:0048585),0.6095813066956465,-0.6759852826491451,-1.0761507323183022
1083,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.6101292032302689,-0.673058097940868,-1.0761572280823903
1084,respiratory chain complex IV assembly (GO:0008535),0.6103137352860519,-0.7016026579499823,-1.0762062479973944
1085,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.6105605210410594,-0.6604825378038284,-1.0759004806602621
1086,positive regulation of ERBB signaling pathway (GO:1901186),0.61128759199746,-0.686138562749439,-1.0757170422760063
1087,negative regulation of signaling (GO:0023057),0.611307273804682,-0.6913966053737597,-1.0755738098805874
1088,skin development (GO:0043588),0.611334729439501,-0.6732830959412222,-1.0755270807847577
1089,positive regulation of osteoblast differentiation (GO:0045669),0.611536061036208,-0.68379342068975,-1.0756131471415908
1090,positive regulation of keratinocyte differentiation (GO:0045618),0.6182571518924571,-0.7280528486113882,-1.0744962804582208
1091,positive regulation of cell cycle process (GO:0090068),0.618491798353537,-0.6556392526974386,-1.0745426369145876
1092,protein insertion into membrane (GO:0051205),0.6203100278648429,-0.690084082405573,-1.0741919894261187
1093,positive regulation of catabolic process (GO:0009896),0.6217790478781847,-0.6609258911315836,-1.0739745722461813
1094,positive regulation of epidermal cell differentiation (GO:0045606),0.6232001131328021,-0.7177163098815866,-1.073664345873402
1095,positive regulation of protein ubiquitination (GO:0031398),0.6235701927650872,-0.6686650897996179,-1.073689049431492
1096,negative regulation of protein binding (GO:0032091),0.6257227584679745,-0.6483854091561797,-1.0733046535837631
1097,hexose transmembrane transport (GO:0008645),0.6279578228305959,-0.6968007495171844,-1.072792757900853
1098,positive regulation of smooth muscle cell migration (GO:0014911),0.62798702961892,-0.711548366468351,-1.0727102305859182
1099,regulation of actin cytoskeleton organization (GO:0032956),0.6282347233404514,-0.6653356805997717,-1.0728275836312526
1100,focal adhesion assembly (GO:0048041),0.6286347169641603,-0.677004960986993,-1.0728546057553343
1101,diterpenoid metabolic process (GO:0016101),0.6297286655147863,-0.669698216156522,-1.0722771642023348
1102,regulation of viral genome replication (GO:0045069),0.630041039985721,-0.6705028373293924,-1.0723073310068267
1103,positive regulation of intracellular transport (GO:0032388),0.6300518956420376,-0.6707948582440477,-1.0721426610061022
1104,lipid transport (GO:0006869),0.6301184672323867,-0.6694306515757745,-1.0723697313204188
1105,response to lipid (GO:0033993),0.6331643356125668,-0.6655257864727925,-1.0716980940559944
1106,regulation of multicellular organism growth (GO:0040014),0.6336227310068919,-0.7030693148264082,-1.0715882846993463
1107,visual perception (GO:0007601),0.6336985831094225,-0.6780926773854851,-1.0715033489401675
1108,cellular response to alcohol (GO:0097306),0.6358501056177106,-0.6786709154470617,-1.071111202327251
1109,positive regulation of DNA binding (GO:0043388),0.6364263973176162,-0.6797960391626686,-1.071111552528274
1110,mammary gland development (GO:0030879),0.6368493691489564,-0.703887601278132,-1.0709380458090474
1111,purine ribonucleotide catabolic process (GO:0009154),0.6388753333990758,-0.6833059042070976,-1.070620086012079
1112,calcium ion transport (GO:0006816),0.640328763048207,-0.6649454136126953,-1.0700865188350293
1113,positive regulation of autophagy (GO:0010508),0.6407160072193018,-0.657067717217878,-1.0701099307420385
1114,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.6407591831154867,-0.6675161082331409,-1.070181687479258
1115,iron ion homeostasis (GO:0055072),0.6411998164807404,-0.6600029726113439,-1.0702640032235538
1116,positive regulation of metabolic process (GO:0009893),0.6412510584608077,-0.6454436792209056,-1.070188484527908
1117,calcium ion homeostasis (GO:0055074),0.643010936231352,-0.6665114313632917,-1.0696699937770535
1118,regulation of actin filament bundle assembly (GO:0032231),0.6437332891910079,-0.6875647600744006,-1.068922240189702
1119,heparan sulfate proteoglycan metabolic process (GO:0030201),0.6438352459912675,-0.6939581585571148,-1.068513690829556
1120,cellular response to sterol (GO:0036315),0.6438752910676337,-0.701199705108191,-1.0688376996168936
1121,protein autophosphorylation (GO:0046777),0.6440603747476902,-0.6505309307543561,-1.0689488932997344
1122,regulation of sprouting angiogenesis (GO:1903670),0.6442282606671452,-0.685364481875327,-1.0694371739495736
1123,cellular response to fibroblast growth factor stimulus (GO:0044344),0.6443473784448058,-0.662941681368009,-1.0685248019652445
1124,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.6445121367993976,-0.6776186940200821,-1.0685651158562572
1125,odontogenesis of dentin-containing tooth (GO:0042475),0.6445759614677119,-0.7040739898349663,-1.0689572846243771
1126,androgen metabolic process (GO:0008209),0.6446516843536715,-0.6946245741707042,-1.0686043813452384
1127,DNA geometric change (GO:0032392),0.644921503375602,-0.6891867761458212,-1.0689957403113006
1128,TOR signaling (GO:0031929),0.6450057790303385,-0.6922617149917305,-1.069269129083422
1129,positive regulation of transferase activity (GO:0051347),0.645021265192734,-0.6573891887268241,-1.0686331121044956
1130,positive regulation of multicellular organismal process (GO:0051240),0.6453789813386744,-0.6447757582484858,-1.0691390199663706
1131,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6454559223914538,-0.6930258811073389,-1.0689990494410593
1132,sodium ion homeostasis (GO:0055078),0.6459056673707847,-0.690952922968255,-1.0690251623667573
1133,response to gamma radiation (GO:0010332),0.6476554561138625,-0.6782833062883165,-1.0679166217432319
1134,negative regulation of cell communication (GO:0010648),0.6479837156655712,-0.6951700590026284,-1.0679444441052461
1135,regulation of Rac protein signal transduction (GO:0035020),0.6490107163605158,-0.6795586915386937,-1.067690106735575
1136,pyruvate metabolic process (GO:0006090),0.6506413152675012,-0.6775960154355551,-1.0672707248753603
1137,positive regulation of cellular component biogenesis (GO:0044089),0.6508866559506993,-0.6657386039647164,-1.0673188735950512
1138,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6511493354114823,-0.6889408189767603,-1.06735593380262
1139,positive regulation of locomotion (GO:0040017),0.6515845753034903,-0.6767251254126614,-1.0670802255177616
1140,type I interferon signaling pathway (GO:0060337),0.6519754649917031,-0.6606808850450563,-1.0668006859946013
1141,cellular response to type I interferon (GO:0071357),0.6519754649917031,-0.6606808850450563,-1.0668006859946013
1142,natural killer cell mediated immunity (GO:0002228),0.6522314792234938,-0.7118665580994048,-1.0669154864075492
1143,mucosal immune response (GO:0002385),0.6542912217947934,-0.6921910685449608,-1.0664733057810436
1144,cellular iron ion homeostasis (GO:0006879),0.6548075739076032,-0.6626142589344087,-1.0663394393416954
1145,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.6548368687981603,-0.6962556485663668,-1.0662616789440083
1146,positive regulation of striated muscle cell differentiation (GO:0051155),0.657766632724729,-0.6899519310322041,-1.065700254108762
1147,"negative regulation of gene expression, epigenetic (GO:0045814)",0.6578236859041569,-0.673699710887087,-1.0657601466172406
1148,negative regulation of catalytic activity (GO:0043086),0.6578975890053622,-0.6938337305570548,-1.065819064337294
1149,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6590877565814137,-0.6883794928233268,-1.0654719586434906
1150,positive regulation of oxidoreductase activity (GO:0051353),0.6598467893879694,-0.7082019420051187,-1.065172935774544
1151,respiratory tube development (GO:0030323),0.6600477232689282,-0.6781691811533541,-1.0652777403203884
1152,cellular response to heat (GO:0034605),0.6602056203952574,-0.6793443153195986,-1.0651961694732597
1153,fatty-acyl-CoA metabolic process (GO:0035337),0.6611614073682494,-0.678060821648169,-1.0649524364159833
1154,negative regulation of cell death (GO:0060548),0.6613511639260028,-0.6550163951105297,-1.0648440283332512
1155,skeletal system morphogenesis (GO:0048705),0.6638379920433162,-0.6742706185526713,-1.0643916163815552
1156,regulation of receptor-mediated endocytosis (GO:0048259),0.6639996900796477,-0.6700132678516698,-1.0644444706618437
1157,positive regulation of signaling (GO:0023056),0.6645473603073554,-0.682082524944591,-1.0642636301470112
1158,carboxylic acid transport (GO:0046942),0.665562057764736,-0.6683227722387415,-1.0640726446874043
1159,membrane lipid metabolic process (GO:0006643),0.6683631459200995,-0.6945420197551953,-1.0636652611857844
1160,regulation of cell cycle G1/S phase transition (GO:1902806),0.6724795770720771,-0.6707887800966945,-1.0629830678916108
1161,glycerophospholipid catabolic process (GO:0046475),0.6728549351526216,-0.6995363863202987,-1.063005863834125
1162,3'-UTR-mediated mRNA stabilization (GO:0070935),0.6731369790210846,-0.6842577246509393,-1.0628335292700288
1163,regulation of nervous system development (GO:0051960),0.6760536163631815,-0.6649184083395034,-1.062398932494929
1164,sulfur compound biosynthetic process (GO:0044272),0.6789651502278645,-0.6556512373473562,-1.061980397327911
1165,positive regulation of cell cycle phase transition (GO:1901989),0.6797057458193738,-0.6644457995934812,-1.0617906160967523
1166,cardiac conduction system development (GO:0003161),0.6839125954027452,0.6361887378855074,1.2782627628701737
1167,adherens junction organization (GO:0034332),0.6850609400275606,-0.6665016298622635,-1.0610976850391016
1168,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6863551419016186,-0.7037927037460315,-1.0608060289077863
1169,inositol lipid-mediated signaling (GO:0048017),0.6867912868175389,-0.663092078913748,-1.0606957091703046
1170,cellular response to inorganic substance (GO:0071241),0.6869293932615139,-0.6641322854195252,-1.060812488390073
1171,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6878170241731816,-0.6810128046641244,-1.0605079980586904
1172,cellular response to nutrient levels (GO:0031669),0.6885378663078955,-0.6538387791980307,-1.0603457897299353
1173,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.6910008780703146,-0.692196466784206,-1.0600046234051024
1174,regulation of telomere maintenance (GO:0032204),0.6920611799535465,-0.6771769995130451,-1.0598087519690833
1175,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.693421965293492,-0.6526920949723389,-1.059573572524813
1176,energy derivation by oxidation of organic compounds (GO:0015980),0.6955151344576674,-0.6840384301464278,-1.0592357387092646
1177,morphogenesis of an epithelium (GO:0002009),0.6962996016395036,-0.6870815172939061,-1.0590693816522523
1178,positive regulation of nucleocytoplasmic transport (GO:0046824),0.6969115683727295,-0.6692182937083149,-1.0589331747864625
1179,chloride transport (GO:0006821),0.7005241981939447,-0.6611898294751051,-1.0583413721723889
1180,positive regulation of epithelial cell differentiation (GO:0030858),0.7007143898787765,-0.7040869212132038,-1.0583980707315184
1181,regulation of proteolysis (GO:0030162),0.7008870783599852,-0.662574653326729,-1.0582165339769767
1182,glucose catabolic process to pyruvate (GO:0061718),0.7017245674676821,-0.6704198090364263,-1.0579709821646854
1183,canonical glycolysis (GO:0061621),0.7017245674676821,-0.6704198090364263,-1.0579709821646854
1184,protein localization to cell-cell junction (GO:0150105),0.7035691680135612,-0.7104879394827152,-1.0576757037714393
1185,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7066013884119905,-0.6945445521136443,-1.057228586187584
1186,plasma membrane organization (GO:0007009),0.7073042670695785,-0.6678984266017157,-1.0569130746398951
1187,skeletal muscle organ development (GO:0060538),0.7078143545659082,-0.6640528259643295,-1.0569290084724963
1188,phosphatidylinositol-mediated signaling (GO:0048015),0.7080501338398126,-0.6567228205756503,-1.0569781836379812
1189,positive regulation of cell adhesion (GO:0045785),0.7141332836553324,-0.6546445781917422,-1.0560993151021478
1190,regulation of phosphatase activity (GO:0010921),0.7166514561816023,-0.6734852094496331,-1.055755698799351
1191,negative regulation of blood coagulation (GO:0030195),0.7172069716459183,-0.6830660380441285,-1.0556249061142267
1192,amino acid transport (GO:0006865),0.7204670634493334,-0.6637072972505577,-1.0551804456897187
1193,regulation of sodium ion transmembrane transport (GO:1902305),0.7216619944451953,-0.687369006480928,-1.054953836613135
1194,lipid biosynthetic process (GO:0008610),0.7223989657398321,-0.6488564131488478,-1.0545080189100702
1195,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.7225536128978817,-0.6896211811971665,-1.054427113764095
1196,insulin secretion (GO:0030073),0.7226780410775403,-0.684185737048987,-1.0547602026510474
1197,negative regulation of hydrolase activity (GO:0051346),0.7227044726074289,-0.6642817188527328,-1.0546826173930544
1198,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.7227331130929897,-0.6652260330704786,-1.054041186056475
1199,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.7227732364897265,-0.6818688105328021,-1.0545385823883069
1200,regulation of reactive oxygen species metabolic process (GO:2000377),0.7228833288950082,-0.6564318844409162,-1.0545967344976057
1201,negative regulation of MAPK cascade (GO:0043409),0.7230419480260256,-0.6472700436910973,-1.054073370070772
1202,positive regulation of amyloid-beta formation (GO:1902004),0.7234117754666991,-0.6746742244254984,-1.0542602282231186
1203,phospholipid metabolic process (GO:0006644),0.7234774036170574,-0.6561644467260795,-1.0541828899871086
1204,positive regulation of response to wounding (GO:1903036),0.7236467115177253,-0.6851033768722766,-1.0540764854528901
1205,negative regulation of wound healing (GO:0061045),0.7284373750951303,-0.6842400954090263,-1.053286619883546
1206,positive regulation of cold-induced thermogenesis (GO:0120162),0.7301694408315667,-0.6419133813590747,-1.0529981756909907
1207,negative regulation of cytoskeleton organization (GO:0051494),0.7307571950383309,-0.6651276963176266,-1.0527726483232493
1208,epithelial cell migration (GO:0010631),0.7309843062888252,-0.6607420895736363,-1.0528158486060628
1209,DNA packaging (GO:0006323),0.7323421701950539,-0.6741835433541129,-1.0524406662338452
1210,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.732601981415167,-0.6524953290912937,-1.0524873246263453
1211,positive regulation of activated T cell proliferation (GO:0042104),0.7327166750792949,-0.7050327042456818,-1.052318797512884
1212,keratan sulfate metabolic process (GO:0042339),0.7328451288104243,-0.6889815910855879,-1.0522214856116352
1213,regulation of cell-substrate adhesion (GO:0010810),0.7347295203403241,-0.662656185690927,-1.0518491250482884
1214,homologous chromosome pairing at meiosis (GO:0007129),0.7351723976772597,-0.6734952865743891,-1.0518704183308778
1215,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.7362418412916525,0.4167523184314761,1.2539747224051918
1216,cellular lipid catabolic process (GO:0044242),0.7364576831476878,-0.6689213109161459,-1.0515011701923633
1217,heterotypic cell-cell adhesion (GO:0034113),0.7364827297500458,-0.6751490732316586,-1.0515674618618598
1218,inorganic anion transport (GO:0015698),0.7365509340436658,-0.6495595660008249,-1.051414466939192
1219,regulation of protein localization (GO:0032880),0.7391725824551756,-0.6470570708468959,-1.051055547216508
1220,cytosolic calcium ion transport (GO:0060401),0.7397041592967228,-0.6757673161017367,-1.0509242320758454
1221,regulation of dendrite extension (GO:1903859),0.7397228901866484,0.6300644282509882,1.259616345019621
1222,BMP signaling pathway (GO:0030509),0.7401090252878441,-0.6610312928022631,-1.0508025609675915
1223,carboxylic acid transmembrane transport (GO:1905039),0.7410501975009207,-0.6627171346732545,-1.0505356358709914
1224,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.7410660362613253,-0.6330839184961744,-1.0503017419447598
1225,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.7414317543528449,-0.6750479093165553,-1.0503327356741112
1226,cellular response to growth factor stimulus (GO:0071363),0.7416368247621543,-0.6441695365668269,-1.0505411438295051
1227,regulation of cell migration (GO:0030334),0.7417823928278301,-0.6341961437906083,-1.0503594927261808
1228,cell morphogenesis involved in differentiation (GO:0000904),0.7435810074260374,-0.6488488901512388,-1.0498457326417587
1229,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.7441438262073354,-0.6592464665058274,-1.0498542347860091
1230,protein-DNA complex disassembly (GO:0032986),0.7452975888007791,-0.6810119995671181,-1.04932950887333
1231,positive regulation of JNK cascade (GO:0046330),0.7454778206144009,-0.6546355718875512,-1.0493780973913271
1232,regulation of cell growth (GO:0001558),0.7455813915988635,-0.6413243700353439,-1.0495226922599168
1233,ncRNA 3'-end processing (GO:0043628),0.746017396043075,-0.6972004681893657,-1.0493874674087433
1234,cellular amino acid catabolic process (GO:0009063),0.7482554021733334,-0.6542318461451102,-1.0488723053201623
1235,extracellular matrix assembly (GO:0085029),0.7486255220172848,-0.6788918663302401,-1.0487388636376718
1236,regulation of B cell receptor signaling pathway (GO:0050855),0.7488551148476585,-0.6764651969765505,-1.0486343267004434
1237,protein phosphorylation (GO:0006468),0.7523774171670797,-0.6335067970069881,-1.0481697066831457
1238,glycerophospholipid biosynthetic process (GO:0046474),0.7531002016776008,-0.636452382885562,-1.0480032811906475
1239,positive regulation of cell population proliferation (GO:0008284),0.7537597649604802,-0.6356507190124905,-1.0478419482623018
1240,chloride transmembrane transport (GO:1902476),0.7551387661222552,-0.6546216462019361,-1.0475735001017232
1241,positive regulation of cellular metabolic process (GO:0031325),0.7555323699664278,-0.6418881674703574,-1.0474622111682343
1242,steroid metabolic process (GO:0008202),0.7562965995312028,-0.6499658088067161,-1.04728025300134
1243,negative regulation of cellular component organization (GO:0051129),0.7579328944647905,-0.6488511060703219,-1.0469957174928546
1244,positive regulation of protein processing (GO:0010954),0.7582305743141101,-0.6823905788835163,-1.046892801642848
1245,carbohydrate homeostasis (GO:0033500),0.759106453775908,-0.6562061194602253,-1.0467233035632204
1246,actin filament bundle assembly (GO:0051017),0.759911514081153,-0.6691733560020473,-1.0465770973784432
1247,regulation of catabolic process (GO:0009894),0.7602838780016422,-0.7068959728909862,-1.0464662291578022
1248,negative regulation of programmed cell death (GO:0043069),0.7617562927803708,-0.6326758849262624,-1.0462260271288788
1249,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.7637877199683533,-0.635633952374809,-1.0459168528156018
1250,cellular response to nitrogen compound (GO:1901699),0.7648629723568962,-0.6795357170547014,-1.045704461632691
1251,pulmonary valve morphogenesis (GO:0003184),0.7648922505902963,-0.6848664093336477,-1.0456236608903005
1252,poly(A)+ mRNA export from nucleus (GO:0016973),0.7668120184678054,-0.691863324020399,-1.0450169013875727
1253,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.7668440684096223,-0.6793580604296963,-1.0452277703581114
1254,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.7670063600279371,-0.6852850261654256,-1.04505360498646
1255,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.7670063600279371,-0.6852850261654256,-1.04505360498646
1256,telomere organization (GO:0032200),0.7673994876425421,-0.6618067048211544,-1.045231499272083
1257,regulation of platelet aggregation (GO:0090330),0.7716921159354504,-0.6997762758429255,-1.0442998025504726
1258,positive regulation of hormone secretion (GO:0046887),0.7722644962446088,-0.6802570335928424,-1.044306216414901
1259,mitochondrial calcium ion transmembrane transport (GO:0006851),0.7744390002922992,-0.6824047102671285,-1.0439212424157749
1260,amino acid transmembrane transport (GO:0003333),0.7752920408634484,-0.6526474672361717,-1.0435499999811504
1261,metal ion transport (GO:0030001),0.7756899901415176,-0.6446515377197874,-1.0435768517322466
1262,copper ion homeostasis (GO:0055070),0.7757179792201494,-0.695955286838295,-1.043726406905701
1263,outer dynein arm assembly (GO:0036158),0.7758444338241807,-0.6714055916592016,-1.0434015580655032
1264,MAPK cascade (GO:0000165),0.7759667263665785,-0.6362826862004335,-1.0436268849932344
1265,regulation of protein export from nucleus (GO:0046825),0.7762820643326741,-0.666616474479282,-1.0432623714966613
1266,nucleotide catabolic process (GO:0009166),0.7777126734107838,-0.6806100677771889,-1.0430298416380526
1267,regulation of type I interferon production (GO:0032479),0.7839538146271366,-0.6391194692061156,-1.0421737111919198
1268,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.7871102134178144,-0.6509632478983322,-1.041764935031741
1269,spermatid development (GO:0007286),0.789898321338642,-0.6755860384729299,-1.0413666002691107
1270,steroid hormone mediated signaling pathway (GO:0043401),0.7900734029240759,-0.6858075677229909,-1.0412715351993598
1271,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.7914418864601609,-0.6611666383293603,-1.0410325955178155
1272,regulation of keratinocyte differentiation (GO:0045616),0.7957899926100359,-0.6737511231641599,-1.0404422599034764
1273,regulation of actin polymerization or depolymerization (GO:0008064),0.8021526217731885,-0.6666432412569722,-1.039606732819834
1274,positive regulation of cytokinesis (GO:0032467),0.8035533785072457,-0.6551700723422081,-1.039364168068314
1275,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.8045648056064678,-0.6529957259713273,-1.0390970986276202
1276,positive regulation of DNA metabolic process (GO:0051054),0.8048389338577898,-0.6587722347553884,-1.039142698523579
1277,cell migration involved in sprouting angiogenesis (GO:0002042),0.8051858493959577,-0.6786368164507082,-1.0389417295325774
1278,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.8066473341968612,-0.639878668319941,-1.0387175997336646
1279,long-chain fatty acid metabolic process (GO:0001676),0.8089172238065361,-0.6466429233766039,-1.0383775122144896
1280,glycolytic process through glucose-6-phosphate (GO:0061620),0.8116623936711301,-0.6576795643043958,-1.0379303095286598
1281,negative regulation of developmental growth (GO:0048640),0.8118885758651789,-0.6596385529107145,-1.0379807776949042
1282,fatty acid metabolic process (GO:0006631),0.817817108192042,-0.6404298762416686,-1.0372155139970014
1283,regulation of cellular metabolic process (GO:0031323),0.8186940522485806,-0.6636452485180966,-1.0370263103854906
1284,endosome transport via multivesicular body sorting pathway (GO:0032509),0.8192468520119879,0.6093114625319568,1.21826381096765
1285,myofibril assembly (GO:0030239),0.8194969273636399,0.46802233383743774,1.230668948397485
1286,positive regulation of lamellipodium organization (GO:1902745),0.8206454868222548,-0.6592192865335288,-1.0366393825495115
1287,positive regulation of isotype switching (GO:0045830),0.8212220227021101,-0.6909877828609754,-1.036648001808746
1288,regulation of metal ion transport (GO:0010959),0.8254223820192854,-0.6600978131937543,-1.0359973054732259
1289,regulation of biomineral tissue development (GO:0070167),0.8269245630629068,-0.6839909392439683,-1.0357384771001759
1290,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.8275261324041813,0.3884980457844778,1.222341652932087
1291,protein methylation (GO:0006479),0.8299075828519273,-0.6678801359543624,-1.0352983155414939
1292,glycosaminoglycan biosynthetic process (GO:0006024),0.8321783783859898,-0.6484733483785651,-1.0349529593667453
1293,phospholipid catabolic process (GO:0009395),0.835690525425222,-0.6793904435964192,-1.0344023890201581
1294,regulation of stress-activated MAPK cascade (GO:0032872),0.835985991588115,-0.6558984564280471,-1.0344533389268995
1295,zinc ion transport (GO:0006829),0.8364579913685211,-0.6745003146339112,-1.0342487064700734
1296,glucose homeostasis (GO:0042593),0.8365103036938825,-0.6435901523485393,-1.0338707026774858
1297,bile acid biosynthetic process (GO:0006699),0.8366420783231602,-0.6492348068970255,-1.0339369148386486
1298,regulation of potassium ion transport (GO:0043266),0.8369210864033033,-0.6701762376116388,-1.034058834883853
1299,regulation of ossification (GO:0030278),0.8370442716494558,-0.6647512195653436,-1.0337309271098152
1300,regulation of neural precursor cell proliferation (GO:2000177),0.8372336226409721,-0.6542148291110409,-1.0339450992844164
1301,striated muscle tissue development (GO:0014706),0.8373356074185343,-0.6439506152429051,-1.034081373793961
1302,receptor signaling pathway via JAK-STAT (GO:0007259),0.8383239266424505,-0.6617719745282273,-1.0333450675552645
1303,embryonic skeletal system morphogenesis (GO:0048704),0.8388554050544369,-0.6599326914121204,-1.0333623316085248
1304,NAD biosynthetic process (GO:0009435),0.8389739308380925,-0.6665776213504293,-1.0334136124753228
1305,regulation of ATP biosynthetic process (GO:2001169),0.8416557395034413,-0.6729165654958988,-1.0321271047330938
1306,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.842009855832263,-0.6625488090596469,-1.0321611989536739
1307,negative regulation of protein-containing complex assembly (GO:0031333),0.8421618082634177,-0.65414807547016,-1.032710738081219
1308,polyol biosynthetic process (GO:0046173),0.8421941826323726,-0.6645806074682182,-1.032789936359977
1309,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.8425289747629909,-0.6591667975782327,-1.032263382205158
1310,negative regulation of cellular response to insulin stimulus (GO:1900077),0.8426284587246597,-0.6540069481062861,-1.032164703979695
1311,regulation of hydrolase activity (GO:0051336),0.8426602325402388,-0.637779425432954,-1.0324068453031048
1312,regulation of cell development (GO:0060284),0.8427182987181931,-0.654979375839053,-1.0325465324558565
1313,cellular calcium ion homeostasis (GO:0006874),0.8431269176719538,-0.6402616072924093,-1.0322727691362434
1314,negative regulation of protein secretion (GO:0050709),0.8432003760120678,-0.6519827066443232,-1.0324179889612302
1315,regulation of cardiac muscle contraction (GO:0055117),0.8463300125959007,0.5106051153596549,1.2041725321357912
1316,aspartate family amino acid metabolic process (GO:0009066),0.8472785656436972,-0.6633976310742347,-1.0313387586323557
1317,negative regulation of myeloid cell differentiation (GO:0045638),0.8474243782354762,-0.6755169562085648,-1.0313851548347273
1318,cardiac muscle tissue development (GO:0048738),0.8485056681552731,0.4774985803689946,1.2307531828728988
1319,mRNA splice site selection (GO:0006376),0.8501856842566747,-0.6613949754837263,-1.030910541382506
1320,positive regulation of protein catabolic process (GO:0045732),0.8536429065699848,-0.6359039362085672,-1.030431583928923
1321,regulation of receptor internalization (GO:0002090),0.85419258885499,-0.6544943997465372,-1.0300595532534327
1322,positive regulation of proteasomal protein catabolic process (GO:1901800),0.8543772020318796,-0.6353995271869035,-1.0301866651934113
1323,regulation of JNK cascade (GO:0046328),0.8545978876302133,-0.6344118545594185,-1.0300896237036627
1324,negative regulation of cell cycle (GO:0045786),0.854790562911242,-0.6504234189976602,-1.0302226979533546
1325,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.8550745836922452,-0.6694476285810746,-1.029883186476593
1326,modified amino acid transport (GO:0072337),0.8557663620969587,-0.6626114176740469,-1.0297205055102534
1327,positive regulation of cell division (GO:0051781),0.856406267811724,-0.6446348083646447,-1.029564864023794
1328,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.8579517537159645,-0.6381908858444292,-1.0292985635432785
1329,negative regulation of autophagy (GO:0010507),0.8581976588881504,-0.6504921942662055,-1.0292017328227734
1330,myelination (GO:0042552),0.861325252962872,-0.6580142385285029,-1.0287777029211664
1331,cellular response to glucose stimulus (GO:0071333),0.8641441386223795,-0.6509145989230128,-1.028387775937866
1332,positive regulation of protein localization to cell periphery (GO:1904377),0.8663730465192037,-0.6350122366443317,-1.0280382427583055
1333,response to hexose (GO:0009746),0.8712537651648418,-0.6711270726222993,-1.0273053854465342
1334,positive regulation of reproductive process (GO:2000243),0.871690713688546,-0.6688202261888954,-1.0273265897562966
1335,positive regulation of receptor-mediated endocytosis (GO:0048260),0.8722127393932863,-0.6504922665303416,-1.0270050003263396
1336,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.872757957820886,-0.663994784866188,-1.0270252582382038
1337,regulation of protein polymerization (GO:0032271),0.8758968863100625,-0.6506986370513015,-1.0262477610269956
1338,regulation of myeloid cell differentiation (GO:0045637),0.8763713360315567,-0.6359581819369611,-1.0262786299184403
1339,regulation of blood vessel endothelial cell migration (GO:0043535),0.8765589340596832,-0.6315287182656878,-1.0264112987410658
1340,negative regulation of protein catabolic process (GO:0042177),0.8767529481195729,-0.6521965496693028,-1.0263097014088094
1341,membrane fusion (GO:0061025),0.8795664014908917,-0.6447588094758381,-1.0257545165114166
1342,calcium ion transmembrane import into cytosol (GO:0097553),0.881594383257078,-0.6528054922691914,-1.025410126174661
1343,negative regulation of viral process (GO:0048525),0.8837841821285441,-0.6342183231968637,-1.0250726198992124
1344,negative regulation of binding (GO:0051100),0.8860637861436784,-0.627589330844111,-1.0247178691168524
1345,apoptotic DNA fragmentation (GO:0006309),0.8897653270374093,-0.6727965622191036,-1.0240204891033478
1346,negative regulation of DNA recombination (GO:0045910),0.8901834047333098,-0.633863103629955,-1.0240627125508235
1347,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.8903549832900128,-0.6574171453352322,-1.0238617291763723
1348,protein exit from endoplasmic reticulum (GO:0032527),0.8908168828775426,-0.6737171192436576,-1.024069543054011
1349,digestive tract development (GO:0048565),0.8911422904090686,-0.6646991292503094,-1.0235214564574304
1350,Ras protein signal transduction (GO:0007265),0.8916365506298897,-0.6368825741640801,-1.0233849238211974
1351,modulation by host of symbiont process (GO:0051851),0.8916457253997709,-0.6663442328575644,-1.0235371894201721
1352,negative regulation of insulin receptor signaling pathway (GO:0046627),0.8918644374792334,-0.6513304586023285,-1.023599630192923
1353,oxoacid metabolic process (GO:0043436),0.8937533562504969,-0.6531659074233341,-1.0230023413590688
1354,clathrin-dependent endocytosis (GO:0072583),0.8944283965497798,-0.6645958266707883,-1.0230023874673382
1355,negative regulation of lipid storage (GO:0010888),0.8961743853201358,-0.6678426095964256,-1.0223695130575077
1356,regulation of protein kinase activity (GO:0045859),0.8965619157824745,-0.6255868754955525,-1.0221572369812324
1357,glucose transmembrane transport (GO:1904659),0.896565449531357,-0.6623770044381649,-1.0224142567345955
1358,actin cytoskeleton reorganization (GO:0031532),0.897063595540415,-0.6394675570321812,-1.0224329408639103
1359,sensory organ development (GO:0007423),0.8971433068968416,-0.6481112561505071,-1.0225044326829489
1360,apoptotic nuclear changes (GO:0030262),0.8971722711699919,-0.65205576303722,-1.0221642141638911
1361,autophagosome assembly (GO:0000045),0.8997717170117049,-0.6326892373808193,-1.0215475931309286
1362,negative regulation of stress-activated MAPK cascade (GO:0032873),0.8999910706023578,-0.6415026425706768,-1.0216761635586646
1363,folic acid-containing compound metabolic process (GO:0006760),0.9002276208786049,-0.6599303977639894,-1.0215756384649037
1364,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.9074037604781249,-0.6310564027166131,-1.0205692061389398
1365,proton transmembrane transport (GO:1902600),0.9108497915518459,-0.653382394744481,-1.0200972872368417
1366,ncRNA metabolic process (GO:0034660),0.9135158067463152,-0.6518523989645663,-1.0196224802283835
1367,regulation of cell motility (GO:2000145),0.913635353179456,-0.6279554572323821,-1.0196902925164093
1368,endoderm development (GO:0007492),0.9137060170846204,-0.6946788287154445,-1.019512183302303
1369,regulation of androgen receptor signaling pathway (GO:0060765),0.9146904033356388,-0.6442771544577524,-1.0193015759879176
1370,bile acid metabolic process (GO:0008206),0.9184904968077626,-0.6370766848396328,-1.0187806395349002
1371,regulation of megakaryocyte differentiation (GO:0045652),0.9219198796736214,-0.6256872801907832,-1.018275795531599
1372,negative regulation of receptor-mediated endocytosis (GO:0048261),0.9232817398501001,-0.6584627608802649,-1.017860697858361
1373,regulation of fat cell differentiation (GO:0045598),0.9236596852355828,-0.6251371080959786,-1.0177471691413718
1374,neutral amino acid transport (GO:0015804),0.9238565503372449,-0.6499465046080309,-1.0178784752363221
1375,positive regulation of endothelial cell migration (GO:0010595),0.9242287843643607,-0.6296917060395609,-1.0179084932442297
1376,cellular response to chemical stress (GO:0062197),0.9275760747089516,-0.624621250186988,-1.0172366479661017
1377,action potential (GO:0001508),0.9288099074804038,-0.6475999351157055,-1.0170083749839065
1378,regulation of intracellular signal transduction (GO:1902531),0.9293365560595588,-0.6178999443108392,-1.0168680313207648
1379,bicarbonate transport (GO:0015701),0.9303299865400559,-0.6496559570000102,-1.016664077936082
1380,receptor signaling pathway via STAT (GO:0097696),0.9306734226102916,-0.6501280928087104,-1.0165193868098044
1381,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.9324937514531376,-0.6702554921695842,-1.0161163263646265
1382,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.932772341031574,-0.6254586043773497,-1.0161763462935032
1383,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.9369355392781552,0.5635285807282868,1.1797083024764323
1384,cellular response to drug (GO:0035690),0.9380493066074499,-0.660028401621067,-1.0152738159149015
1385,folic acid metabolic process (GO:0046655),0.9387281893629643,-0.6621096186003161,-1.01527651364596
1386,iron ion transport (GO:0006826),0.9392681365071691,-0.6440612375164592,-1.0150232919211482
1387,negative regulation of cellular biosynthetic process (GO:0031327),0.9399089391637802,-0.6454940774689546,-1.0148645880498859
1388,neuron apoptotic process (GO:0051402),0.9413743520599507,-0.6548472597682957,-1.0146089323821679
1389,cellular response to oxidative stress (GO:0034599),0.9438705245730867,-0.622684188107861,-1.0142116917952813
1390,embryonic axis specification (GO:0000578),0.947086720349325,-0.6794255324605877,-1.0136593140109948
1391,regulation of viral transcription (GO:0046782),0.9472421533167018,-0.6373607361041722,-1.0135695524134825
1392,ventricular cardiac muscle cell action potential (GO:0086005),0.9476722720222823,-0.6639153751384547,-1.0136793221936882
1393,positive regulation of programmed cell death (GO:0043068),0.948510186880674,-0.6142531077358476,-1.013341215278403
1394,sensory perception of light stimulus (GO:0050953),0.9521583154005574,-0.643121492169395,-1.0126008939081717
1395,fat cell differentiation (GO:0045444),0.9526289157692227,-0.6395649131795709,-1.0127230212607323
1396,estrogen metabolic process (GO:0008210),0.9527799469092576,-0.652219511609966,-1.0126074670040075
1397,positive regulation of muscle cell differentiation (GO:0051149),0.9555141354759273,-0.6595609451753136,-1.0121143967177637
1398,regulation of transferase activity (GO:0051338),0.9603250332251176,-0.6559351349961219,-1.0114406886996377
1399,CENP-A containing chromatin organization (GO:0061641),0.9611484801808491,0.3874891042053744,1.0
1400,regulation of delayed rectifier potassium channel activity (GO:1902259),0.9611484801808491,0.6150971848273993,1.0
1401,ncRNA export from nucleus (GO:0097064),0.9611484801808491,0.3252868424973925,1.0
1402,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.9611484801808491,0.5722287392564227,1.0
1403,branched-chain amino acid catabolic process (GO:0009083),0.9611484801808491,0.31360859903332244,1.0
1404,vesicle transport along microtubule (GO:0047496),0.9611484801808491,0.39426894158169656,1.0
1405,peripheral nervous system development (GO:0007422),0.9611484801808491,0.4610605101941333,1.0
1406,negative regulation of osteoblast differentiation (GO:0045668),0.9611484801808491,0.3838199173570017,1.0
1407,NADH dehydrogenase complex assembly (GO:0010257),0.9611484801808491,0.7399546591647955,1.0
1408,inner mitochondrial membrane organization (GO:0007007),0.9611484801808491,0.5560886539127886,1.0
1409,regulation of purine nucleotide metabolic process (GO:1900542),0.9611484801808491,0.2710607697753269,1.0
1410,branched-chain amino acid metabolic process (GO:0009081),0.9611484801808491,0.31360859903332244,1.0
1411,cellular modified amino acid biosynthetic process (GO:0042398),0.9611484801808491,0.3033281215099396,1.0
1412,positive regulation of potassium ion transmembrane transport (GO:1901381),0.9611484801808491,0.51323892031488,1.0
1413,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.9611484801808491,0.32051377513030527,1.0
1414,striated muscle contraction (GO:0006941),0.9611484801808491,0.5560934080949979,1.0
1415,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.9611484801808491,0.5504034428236461,1.0
1416,membrane depolarization during action potential (GO:0086010),0.9611484801808491,0.3474704797184775,1.0
1417,aerobic electron transport chain (GO:0019646),0.9611484801808491,0.5463316769773193,1.0
1418,mitochondrial respiratory chain complex assembly (GO:0033108),0.9611484801808491,0.4183867734625326,1.0
1419,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.9611484801808491,0.5915646658415183,1.0
1420,negative regulation of protein depolymerization (GO:1901880),0.9611484801808491,0.4497218470097948,1.0
1421,CENP-A containing nucleosome assembly (GO:0034080),0.9611484801808491,0.3874891042053744,1.0
1422,aortic valve morphogenesis (GO:0003180),0.9611484801808491,0.44792260437218573,1.0
1423,in utero embryonic development (GO:0001701),0.9611484801808491,0.6083580018097882,1.0
1424,positive regulation of heart rate (GO:0010460),0.9611484801808491,0.6122348082214213,1.0
1425,glutamine family amino acid metabolic process (GO:0009064),0.9611484801808491,0.25843121051754125,1.0
1426,heart contraction (GO:0060047),0.9611484801808491,0.712751263109367,1.0
1427,microtubule polymerization or depolymerization (GO:0031109),0.9611484801808491,0.47163357886421703,1.0
1428,fatty-acyl-CoA biosynthetic process (GO:0046949),0.9611484801808491,0.4169428642585744,1.0
1429,mitotic recombination (GO:0006312),0.9611484801808491,0.25998436743960984,1.0
1430,regulation of microtubule cytoskeleton organization (GO:0070507),0.9611484801808491,0.3575701391257847,1.0
1431,cardiac atrium morphogenesis (GO:0003209),0.9611484801808491,0.5973730113132764,1.0
1432,actin-myosin filament sliding (GO:0033275),0.9611484801808491,0.559638109340279,1.0
1433,regulation of dendritic spine development (GO:0060998),0.9611484801808491,0.5286000653411764,1.0
1434,long-term memory (GO:0007616),0.9611484801808491,0.40632691595235904,1.0
1435,actomyosin structure organization (GO:0031032),0.9611484801808491,0.3474021416784061,1.0
1436,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.9611484801808491,0.2887937453462397,1.0
1437,protein sumoylation (GO:0016925),0.9611484801808491,0.2354256746682568,1.0
1438,RNA modification (GO:0009451),0.9611484801808491,0.28506989748369027,1.0
1439,regulation of carbohydrate catabolic process (GO:0043470),0.9611484801808491,0.271060769775327,1.0
1440,centromere complex assembly (GO:0034508),0.9611484801808491,0.4712011258346315,1.0
1441,spindle assembly checkpoint signaling (GO:0071173),0.9611484801808491,0.32050184282044597,1.0
1442,RNA interference (GO:0016246),0.9611484801808491,0.5287321956563688,1.0
1443,aerobic respiration (GO:0009060),0.9611484801808491,0.49184218560781595,1.0
1444,chromatin remodeling at centromere (GO:0031055),0.9611484801808491,0.4797535816738364,1.0
1445,neural tube closure (GO:0001843),0.9611484801808491,0.3310617991238459,1.0
1446,sister chromatid segregation (GO:0000819),0.9611484801808491,0.3206570321811679,1.0
1447,response to unfolded protein (GO:0006986),0.9611484801808491,0.2636306041068833,1.0
1448,chordate embryonic development (GO:0043009),0.9611484801808491,0.37588917272407696,1.0
1449,neuron migration (GO:0001764),0.9611484801808491,0.3750460452196588,1.0
1450,regulation of heart contraction (GO:0008016),0.9611484801808491,0.39650884825759114,1.0
1451,cardiac muscle contraction (GO:0060048),0.9611484801808491,0.7789846945561169,1.0
1452,mitotic sister chromatid segregation (GO:0000070),0.9611484801808491,0.19939509353646223,1.0
1453,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.9611484801808491,0.7787861687385106,1.0
1454,protein mannosylation (GO:0035268),0.9611484801808491,0.6408742952564042,1.0
1455,DNA replication-independent nucleosome assembly (GO:0006336),0.9611484801808491,0.3694699784154163,1.0
1456,mitotic spindle assembly checkpoint signaling (GO:0007094),0.9611484801808491,0.32050184282044597,1.0
1457,muscle filament sliding (GO:0030049),0.9611484801808491,0.559638109340279,1.0
1458,mitochondrial respiratory chain complex I assembly (GO:0032981),0.9611484801808491,0.7399546591647955,1.0
1459,cardiac muscle tissue morphogenesis (GO:0055008),0.9611484801808491,0.6683384098688869,1.0
1460,response to ATP (GO:0033198),0.9611484801808491,0.3857775320753685,1.0
1461,regulation of JUN kinase activity (GO:0043506),0.9611484801808491,0.41044236114680904,1.0
1462,regulation of calcium ion transmembrane transport (GO:1903169),0.9611484801808491,0.4849682919607818,1.0
1463,metallo-sulfur cluster assembly (GO:0031163),0.9611484801808491,0.3281257406196999,1.0
1464,regulation of striated muscle contraction (GO:0006942),0.9611484801808491,0.3836519248703285,1.0
1465,histone deubiquitination (GO:0016578),0.9611484801808491,0.3341026690987605,1.0
1466,positive regulation of dendritic spine development (GO:0060999),0.9611484801808491,0.5061378010749864,1.0
1467,positive regulation of protein binding (GO:0032092),0.9611484801808491,0.33367128991364003,1.0
1468,negative regulation of G0 to G1 transition (GO:0070317),0.9611484801808491,0.26720059601415524,1.0
1469,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.9611484801808491,0.7431264057298292,1.0
1470,tube closure (GO:0060606),0.9611484801808491,0.36021450546117506,1.0
1471,cardiac muscle cell differentiation (GO:0055007),0.9611484801808491,0.8173814416497657,1.0
1472,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.9611484801808491,0.19203043542411352,1.0
1473,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.9611484801808491,0.268845261763637,1.0
1474,regulation of voltage-gated calcium channel activity (GO:1901385),0.9611484801808491,0.7041466472980388,1.0
1475,mitotic spindle checkpoint signaling (GO:0071174),0.9611484801808491,0.32050184282044597,1.0
1476,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.9611484801808491,0.6581414338593848,1.0
1477,positive regulation of heart contraction (GO:0045823),0.9611484801808491,0.5803627270601318,1.0
1478,sulfur compound transport (GO:0072348),0.9616261245783163,-0.6386704413396137,-1.011201518196613
1479,regulation of programmed cell death (GO:0043067),0.9635510928285628,-0.6138758133653907,-1.0108837688551653
1480,muscle cell differentiation (GO:0042692),0.9662214366629072,-0.6447696894209837,-1.0102928217216947
1481,regulation of establishment of protein localization (GO:0070201),0.9664627701011622,-0.6354794597547356,-1.0104280432545465
1482,negative regulation of ERBB signaling pathway (GO:1901185),0.9664862148379463,-0.6344906619202028,-1.0103421211823498
1483,regulation of cell-cell adhesion (GO:0022407),0.9701948228818071,-0.626737842204717,-1.0094737433736574
1484,steroid biosynthetic process (GO:0006694),0.9704138620101751,-0.6195209757950368,-1.0097225702983745
1485,negative regulation of protein transport (GO:0051224),0.97064657927245,-0.6542081455099398,-1.0095151893967367
1486,positive regulation of cell communication (GO:0010647),0.9711058444198941,-0.6605054096150902,-1.0095400745618934
1487,fat-soluble vitamin metabolic process (GO:0006775),0.9717595491009056,-0.6604200696279405,-1.0090696236086627
1488,positive regulation of growth (GO:0045927),0.9722664792477179,-0.6235009612927523,-1.0090943170978763
1489,negative regulation of neurogenesis (GO:0050768),0.9728781395929069,-0.6469681202645973,-1.008834075621
1490,negative regulation of protein kinase activity (GO:0006469),0.9731082646268029,-0.6130627375147165,-1.008722288329388
1491,regulation of protein transport (GO:0051223),0.973985667079567,-0.6422918004733114,-1.008527386875537
1492,fatty acid oxidation (GO:0019395),0.9739898617478595,-0.6343019228342337,-1.0084408206828364
1493,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.9752942066505241,-0.6456526981031208,-1.008173512075859
1494,Rho protein signal transduction (GO:0007266),0.9766782942564671,-0.6425508639996063,-1.0079162553640888
1495,regulation of protein processing (GO:0070613),0.9771359547637126,-0.634299821117347,-1.007783899337119
1496,regulation of autophagosome assembly (GO:2000785),0.9772849596690776,-0.6459796900541602,-1.0067696774990766
1497,positive regulation of DNA biosynthetic process (GO:2000573),0.9773083863672598,-0.6327817938490959,-1.0069606345191215
1498,regulation of cellular component movement (GO:0051270),0.9773843962619487,-0.6448404452742064,-1.0068529567831168
1499,actin filament bundle organization (GO:0061572),0.9774163535230517,-0.6428924700029384,-1.0076652079927633
1500,positive regulation of establishment of protein localization (GO:1904951),0.9775566643603706,-0.6361130378693869,-1.007028244376837
1501,bicellular tight junction assembly (GO:0070830),0.9780517975566613,-0.6442833711835999,-1.0073129751651986
1502,negative regulation of mitochondrion organization (GO:0010823),0.9782516648173267,-0.6295675586236171,-1.0070290081671904
1503,regulation of vesicle-mediated transport (GO:0060627),0.9784158215557697,-0.6325536538924075,-1.0074382227890424
1504,regulation of protein ubiquitination (GO:0031396),0.9787243205062074,-0.6182844319664819,-1.0070587499653376
1505,negative regulation of apoptotic signaling pathway (GO:2001234),0.978755938519625,-0.6198635028865851,-1.0073129811931814
1506,negative regulation of phosphorylation (GO:0042326),0.9789741518912075,-0.6223269949014686,-1.0071094083503742
1507,epithelial cell differentiation (GO:0030855),0.9821825261165428,-0.6155585396214766,-1.005817289802426
1508,lipid catabolic process (GO:0016042),0.9822951327119457,-0.6379141023023649,-1.0057036902885157
1509,cellular response to dsRNA (GO:0071359),0.9823679045262207,-0.6353688116851128,-1.0059962787862275
1510,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.9828509159571536,-0.6508054510699003,-1.0058215023298698
1511,negative regulation of intracellular signal transduction (GO:1902532),0.9836949747188655,-0.6107924920779065,-1.0053490973489694
1512,ion transport (GO:0006811),0.9839396716396408,-0.6272211370019756,-1.005409218743696
1513,regulation of vascular endothelial cell proliferation (GO:1905562),0.986089929734483,-0.6590497395369944,-1.0048575550494845
1514,positive regulation of protein autophosphorylation (GO:0031954),0.9865879909365657,-0.6641744004464608,-1.0046940351569462
1515,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.986644650046224,-0.637890153259421,-1.0048837819340783
1516,positive regulation of cellular protein metabolic process (GO:0032270),0.9895687264691558,-0.6193027318615972,-1.0039561937984767
1517,lamellipodium organization (GO:0097581),0.9896358457619346,-0.64664385156902,-1.004048076277476
1518,phosphate-containing compound metabolic process (GO:0006796),0.9900716827609091,-0.6109115237028673,-1.004183077979626
1519,regulation of wound healing (GO:0061041),0.9902383460662352,-0.626850301900202,-1.0040654019876298
1520,regulation of secretion (GO:0051046),0.9947324332130617,-0.6537524892579787,-1.003076243154712
1521,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.9950301296951061,-0.6342969844412303,-1.003133549962048
1522,acylglycerol biosynthetic process (GO:0046463),0.9998290799013757,-0.6657934748471054,-1.0022910496799142
1523,endoplasmic reticulum calcium ion homeostasis (GO:0032469),1.0,-0.4174360164251464,-0.629759742452363
1524,ribosomal small subunit assembly (GO:0000028),1.0,-0.542344861961414,-0.8028189231895971
1525,endoplasmic reticulum mannose trimming (GO:1904380),1.0,-0.5573230147533585,-0.8368621040110358
1526,"DNA catabolic process, endonucleolytic (GO:0000737)",1.0,-0.6492449701485578,-0.9982006170829552
1527,mitotic metaphase plate congression (GO:0007080),1.0,-0.27334286572690797,-0.4449224449787148
1528,establishment of epithelial cell polarity (GO:0090162),1.0,-0.5125619085835244,-0.783254228981682
1529,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",1.0,-0.5023546130357699,-0.7602846780623372
1530,DNA strand elongation involved in DNA replication (GO:0006271),1.0,0.596076349147658,0.850039309171647
1531,ribosomal large subunit assembly (GO:0000027),1.0,-0.6119029736613437,-0.9385172756988198
1532,cell cycle G2/M phase transition (GO:0044839),1.0,-0.2998932145574291,-0.48319195329428194
1533,replication fork processing (GO:0031297),1.0,-0.5235476854274709,-0.82628545336542
1534,neuropeptide signaling pathway (GO:0007218),1.0,-0.5005581864175463,-0.8071462662830882
1535,cellular response to DNA damage stimulus (GO:0006974),1.0,-0.5024735596793984,-0.8201848405993002
1536,cardiac muscle cell action potential (GO:0086001),1.0,0.45223733922233145,0.9637043035590356
1537,response to calcium ion (GO:0051592),1.0,-0.5337487656532359,-0.8580633988978366
1538,neurotrophin TRK receptor signaling pathway (GO:0048011),1.0,-0.5268692483221744,-0.818073586491796
1539,DNA double-strand break processing (GO:0000729),1.0,-0.3571460655590233,-0.5415702105048911
1540,sphingolipid metabolic process (GO:0006665),1.0,-0.43816727052390747,-0.7022915676209288
1541,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1.0,-0.2642880528388811,-0.41939919527328373
1542,regulation of amyloid-beta clearance (GO:1900221),1.0,-0.4999488080815679,-0.7900642116757747
1543,L-amino acid transport (GO:0015807),1.0,-0.5771493266970886,-0.9112119407168809
1544,negative regulation of cell aging (GO:0090344),1.0,-0.6325197012434082,-0.9429146694809221
1545,"base-excision repair, gap-filling (GO:0006287)",1.0,-0.4110108617903886,-0.6466891406424917
1546,cation transport (GO:0006812),1.0,-0.5642345441396567,-0.9220006322361283
1547,nuclear envelope organization (GO:0006998),1.0,-0.5124979763643405,-0.7867291285101735
1548,regulation of proteasomal protein catabolic process (GO:0061136),1.0,-0.6029101081791277,-0.97040982449516
1549,snRNA transcription by RNA polymerase II (GO:0042795),1.0,-0.27388811918454614,-0.4457111581010989
1550,gene expression (GO:0010467),1.0,-0.4216958350486121,-0.6945825558431808
1551,monosaccharide transmembrane transport (GO:0015749),1.0,-0.538288139775039,-0.7974906437915913
1552,divalent inorganic cation homeostasis (GO:0072507),1.0,-0.3903221490211064,-0.6115601468509808
1553,RNA transport (GO:0050658),1.0,-0.5178904290664276,-0.8356355446198183
1554,cholesterol transport (GO:0030301),1.0,-0.6030090533378523,-0.9643789638939312
1555,cellular response to insulin stimulus (GO:0032869),1.0,-0.5234866991075012,-0.8441934267849475
1556,ventricular septum development (GO:0003281),1.0,-0.40440927342711996,-0.6377459643662577
1557,steroid hormone biosynthetic process (GO:0120178),1.0,-0.6062274442037952,-0.9538316857588217
1558,protein localization to nucleus (GO:0034504),1.0,-0.62054765900199,-0.9969522044029566
1559,regulation of BMP signaling pathway (GO:0030510),1.0,-0.5207365502884431,-0.8350727721192165
1560,mitotic DNA damage checkpoint signaling (GO:0044773),1.0,-0.45394625656113563,-0.728629100473184
1561,chemical synaptic transmission (GO:0007268),1.0,-0.5540538288970975,-0.9014575861284551
1562,lysosome localization (GO:0032418),1.0,-0.6184667435828828,-0.9730437106274525
1563,actin polymerization or depolymerization (GO:0008154),1.0,-0.5763969672839871,-0.917175319487421
1564,protein localization to chromatin (GO:0071168),1.0,-0.568595008283987,-0.8697476520274694
1565,"base-excision repair, AP site formation (GO:0006285)",1.0,-0.5493857060275394,-0.8739920715489902
1566,protein peptidyl-prolyl isomerization (GO:0000413),1.0,-0.6249469281392881,-0.9597727692087719
1567,nucleobase-containing compound catabolic process (GO:0034655),1.0,-0.6216743468575661,-0.9768025328650229
1568,error-prone translesion synthesis (GO:0042276),1.0,-0.5469913634944557,-0.8325838487546989
1569,regulation of organelle assembly (GO:1902115),1.0,-0.5758941983336213,-0.9369207085561839
1570,regulation of Notch signaling pathway (GO:0008593),1.0,-0.6021431166885176,-0.9799722017328385
1571,regulation of protein localization to cell surface (GO:2000008),1.0,-0.608144009492579,-0.956186343414946
1572,ribosomal large subunit biogenesis (GO:0042273),1.0,-0.4640980741076205,-0.7443933909875395
1573,chaperone-mediated protein complex assembly (GO:0051131),1.0,-0.5881333709684786,-0.9256687649859032
1574,organic cation transport (GO:0015695),1.0,-0.4916590165695226,-0.7619997182703878
1575,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1.0,-0.42469816824183865,-0.6765609076341775
1576,regulation of mitochondrial translation (GO:0070129),1.0,0.2837315752294706,0.7792234634420494
1577,protein-DNA complex assembly (GO:0065004),1.0,-0.47339403019013104,-0.7724657511898672
1578,fibroblast growth factor receptor signaling pathway (GO:0008543),1.0,-0.5385776164100329,-0.8665258296723964
1579,mRNA polyadenylation (GO:0006378),1.0,-0.3346765054401212,-0.5177148468593593
1580,global genome nucleotide-excision repair (GO:0070911),1.0,-0.4053076999493538,-0.6169385614187228
1581,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),1.0,-0.5673329686112683,-0.8640451315182022
1582,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),1.0,-0.5531206142226006,-0.8384730142447256
1583,protein autoprocessing (GO:0016540),1.0,-0.6509645028310338,-1.000259837084726
1584,circulatory system development (GO:0072359),1.0,-0.6039740335157857,-0.9776640520801047
1585,establishment of spindle orientation (GO:0051294),1.0,-0.5321086285558779,-0.8386941976881411
1586,negative regulation of protein modification process (GO:0031400),1.0,-0.5194481777726658,-0.8408457132936621
1587,intermediate filament organization (GO:0045109),1.0,-0.351426972956074,-0.5442394109652412
1588,non-motile cilium assembly (GO:1905515),1.0,-0.357591789239539,-0.5586408259362357
1589,regulation of neurotransmitter secretion (GO:0046928),1.0,-0.6135139603435273,-0.9592465463369311
1590,synaptic vesicle membrane organization (GO:0048499),1.0,-0.3668128432499427,-0.5496231323002321
1591,anterograde trans-synaptic signaling (GO:0098916),1.0,-0.5941851020369965,-0.964891617247458
1592,mRNA processing (GO:0006397),1.0,-0.3261645946107168,-0.5344071728933701
1593,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1.0,-0.6175031179820839,-0.9758805059912178
1594,negative regulation of cell motility (GO:2000146),1.0,-0.5873657155237448,-0.9533291446007618
1595,response to estrogen (GO:0043627),1.0,-0.5206106407957198,-0.8195591900867119
1596,peptidyl-threonine modification (GO:0018210),1.0,-0.5359111350907276,-0.8538004681866938
1597,negative regulation of Wnt signaling pathway (GO:0030178),1.0,-0.3780978397679374,-0.61760740171634
1598,maturation of LSU-rRNA (GO:0000470),1.0,-0.4067423299886405,-0.638913366184785
1599,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),1.0,0.3471031441190901,0.8670899233983598
1600,activin receptor signaling pathway (GO:0032924),1.0,-0.5503514686093242,-0.8716763659376133
1601,snRNA transcription (GO:0009301),1.0,-0.27736101380734346,-0.45073619706583756
1602,neural tube development (GO:0021915),1.0,-0.459679100988009,-0.7031477720329601
1603,positive regulation of small molecule metabolic process (GO:0062013),1.0,-0.6134990309834476,-0.9162191522599933
1604,regulation of exit from mitosis (GO:0007096),1.0,-0.6042035363175626,-0.9348808303674391
1605,positive regulation of mRNA processing (GO:0050685),1.0,-0.43734261874137875,-0.6801325163900593
1606,protein-containing complex subunit organization (GO:0043933),1.0,-0.6218348213690401,-0.9971747613167994
1607,regulation of transport (GO:0051049),1.0,-0.578230116262475,-0.9226080594884514
1608,negative regulation of cell migration (GO:0030336),1.0,-0.589248649947912,-0.954204002703628
1609,regulation of regulated secretory pathway (GO:1903305),1.0,-0.45944425479471174,-0.7121990192626405
1610,regulation of macroautophagy (GO:0016241),1.0,-0.5474012037244583,-0.8943324566588271
1611,transcription initiation from RNA polymerase II promoter (GO:0006367),1.0,-0.3358706652436335,-0.5478314317545889
1612,DNA synthesis involved in DNA repair (GO:0000731),1.0,-0.40655860110925823,-0.6446282646700046
1613,peptidyl-lysine modification (GO:0018205),1.0,-0.310311401405758,-0.5048260473463158
1614,plasma membrane bounded cell projection morphogenesis (GO:0120039),1.0,-0.6002102066329811,-0.9601686821904839
1615,striated muscle cell differentiation (GO:0051146),1.0,0.7606639876850788,1.021713069959421
1616,regulation of non-canonical Wnt signaling pathway (GO:2000050),1.0,-0.6085120013541261,-0.9255110323012764
1617,ephrin receptor signaling pathway (GO:0048013),1.0,-0.5258143058023603,-0.8368248772372127
1618,regulation of hematopoietic stem cell differentiation (GO:1902036),1.0,-0.5862565700296894,-0.9392959585832205
1619,regulation of neuron projection arborization (GO:0150011),1.0,-0.41945694130362,-0.6368105345184396
1620,regulation of dendrite morphogenesis (GO:0048814),1.0,-0.3565057013870654,-0.542996286223565
1621,synaptic vesicle transport along microtubule (GO:0099517),1.0,0.4067636530650275,0.7426343359379103
1622,regulation of signal transduction by p53 class mediator (GO:1901796),1.0,-0.42331704405813564,-0.6891442209417595
1623,ameboidal-type cell migration (GO:0001667),1.0,-0.4620541677197817,-0.7335206655626025
1624,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1.0,-0.6339081928339854,-0.9966500954524712
1625,histone H2A monoubiquitination (GO:0035518),1.0,-0.3399636910504066,-0.5291109541409555
1626,regulation of dendritic spine morphogenesis (GO:0061001),1.0,-0.5586038086539074,-0.8707375173420696
1627,histone mRNA catabolic process (GO:0071044),1.0,-0.4621802125447597,-0.695295753569892
1628,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1.0,-0.34381065644909525,-0.5411105137170197
1629,vesicle transport along actin filament (GO:0030050),1.0,-0.5982392355687102,-0.9203920789072273
1630,intracellular pH reduction (GO:0051452),1.0,-0.5106598884143198,-0.8066817576159562
1631,rRNA metabolic process (GO:0016072),1.0,-0.33030292835554254,-0.5340002510250713
1632,regulation of cell communication (GO:0010646),1.0,-0.4046148086195633,-0.6383519715100282
1633,aortic valve development (GO:0003176),1.0,-0.5079392460818599,-0.7957815121201051
1634,outflow tract septum morphogenesis (GO:0003148),1.0,-0.43233617395946256,-0.6866461311437322
1635,negative regulation of protein polymerization (GO:0032272),1.0,-0.5348704789756419,-0.8319081873045128
1636,"DNA-templated transcription, initiation (GO:0006352)",1.0,-0.3244656427654049,-0.5310929731987527
1637,cellular response to radiation (GO:0071478),1.0,-0.591821863714438,-0.9443876966159301
1638,cardiac ventricle morphogenesis (GO:0003208),1.0,-0.3645071166620748,-0.5761741364066607
1639,negative regulation of supramolecular fiber organization (GO:1902904),1.0,-0.4982296334773592,-0.8056853956395571
1640,transcription by RNA polymerase III (GO:0006383),1.0,0.2756014001638488,0.6385415935269846
1641,protein localization to Golgi apparatus (GO:0034067),1.0,-0.553392505047582,-0.8784459094448299
1642,regulation of isotype switching (GO:0045191),1.0,-0.6127031863443557,-0.9218280994068118
1643,actin filament-based transport (GO:0099515),1.0,-0.6041792058727774,-0.9303887518555051
1644,positive regulation of response to cytokine stimulus (GO:0060760),1.0,-0.6388031378961871,-0.9661098229339428
1645,neurotransmitter secretion (GO:0007269),1.0,-0.5532890824522113,-0.8545991157035053
1646,positive regulation of monooxygenase activity (GO:0032770),1.0,-0.6111940484162955,-0.9667625747223112
1647,amino acid import (GO:0043090),1.0,-0.5717031019998994,-0.8797635328007408
1648,cobalamin metabolic process (GO:0009235),1.0,-0.6025190673301734,-0.9181943297345846
1649,determination of left/right symmetry (GO:0007368),1.0,-0.5964275587394368,-0.9253588423814991
1650,cellular response to misfolded protein (GO:0071218),1.0,-0.4869727158389885,-0.7412982421297806
1651,protein localization to centrosome (GO:0071539),1.0,-0.3732842946175193,-0.5829826330595368
1652,transcription elongation from RNA polymerase II promoter (GO:0006368),1.0,-0.5852523848985922,-0.9511715445626038
1653,Golgi to plasma membrane transport (GO:0006893),1.0,-0.3862302088152077,-0.6103487275358738
1654,protein hydroxylation (GO:0018126),1.0,-0.5939808287951485,-0.9131057739542258
1655,heart development (GO:0007507),1.0,-0.48782082335428584,-0.7909050737106587
1656,negative regulation of neuron apoptotic process (GO:0043524),1.0,-0.4958468986820894,-0.8040682710309521
1657,mitotic spindle assembly (GO:0090307),1.0,-0.4326198857155624,-0.6793815632687411
1658,tight junction assembly (GO:0120192),1.0,-0.6394925930036696,-1.0003071607932605
1659,mitochondrial transport (GO:0006839),1.0,-0.47880608679181735,-0.7810194924215862
1660,cellular nitrogen compound biosynthetic process (GO:0044271),1.0,-0.6134619616605523,-0.9566241002040506
1661,DNA alkylation (GO:0006305),1.0,-0.38011483146296265,-0.5817903477375584
1662,protein glycosylation (GO:0006486),1.0,-0.5792899869661767,-0.933444207118001
1663,negative regulation of DNA recombination at telomere (GO:0048239),1.0,-0.5489193089744472,-0.8604829250927613
1664,histone H4-K5 acetylation (GO:0043981),1.0,-0.4732984983800708,-0.7286296247376319
1665,peptidyl-serine phosphorylation (GO:0018105),1.0,-0.5113263220075339,-0.8311410395328499
1666,endomembrane system organization (GO:0010256),1.0,-0.5474189133857215,-0.8998125020799022
1667,mRNA 3'-end processing (GO:0031124),1.0,-0.3203070913439985,-0.5154167963700071
1668,peptidyl-lysine methylation (GO:0018022),1.0,-0.37838868899761213,-0.5819683194688211
1669,muscle tissue morphogenesis (GO:0060415),1.0,-0.5370349324556388,-0.8230212365915351
1670,nucleotide-sugar biosynthetic process (GO:0009226),1.0,-0.538440967457267,-0.8200771765461233
1671,vasculogenesis (GO:0001570),1.0,-0.5937702621837575,-0.9331506466227526
1672,oligodendrocyte differentiation (GO:0048709),1.0,-0.6544892478301478,-0.9902044105644401
1673,regulation of nuclear division (GO:0051783),1.0,-0.4273067505529094,-0.6403295906648209
1674,very long-chain fatty acid metabolic process (GO:0000038),1.0,-0.3966988723970027,-0.626285809247229
1675,beta-catenin destruction complex disassembly (GO:1904886),1.0,-0.6057041273983771,-0.9300087633024768
1676,positive regulation of ion transport (GO:0043270),1.0,-0.5645077250347594,-0.8991942302716732
1677,cellular response to amino acid starvation (GO:0034198),1.0,-0.4538266342098056,-0.7257772380255146
1678,regulation of mitotic spindle organization (GO:0060236),1.0,-0.5078245943522913,-0.7988289694514964
1679,synapse assembly (GO:0007416),1.0,-0.44313796275421724,-0.7139570040263751
1680,cellular polysaccharide biosynthetic process (GO:0033692),1.0,-0.5968047625382543,-0.9323112675607296
1681,positive regulation of cellular protein catabolic process (GO:1903364),1.0,0.5905527277092292,1.0420210068334785
1682,heart looping (GO:0001947),1.0,-0.6046260361700561,-0.9247699436033467
1683,regulation of posttranscriptional gene silencing (GO:0060147),1.0,-0.42135449288825344,-0.6769540993378974
1684,diol metabolic process (GO:0034311),1.0,-0.5447938134524385,-0.8443229488788482
1685,cytosolic transport (GO:0016482),1.0,-0.4844449400239133,-0.7869271788288145
1686,cellular response to light stimulus (GO:0071482),1.0,-0.4824002347853318,-0.7824750369993192
1687,positive regulation of canonical Wnt signaling pathway (GO:0090263),1.0,-0.45875546901270037,-0.7460781448242915
1688,translational elongation (GO:0006414),1.0,-0.29392750682075475,-0.4746420714669154
1689,regulation of DNA repair (GO:0006282),1.0,-0.528101261805306,-0.8234404033964833
1690,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),1.0,-0.38534100331873977,-0.6223762670940947
1691,amyloid fibril formation (GO:1990000),1.0,-0.4924298544830507,-0.7854913713461642
1692,regulation of microtubule polymerization or depolymerization (GO:0031110),1.0,0.5173999603605843,0.8656953367352248
1693,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1.0,-0.6265093126767328,-0.9586554989695526
1694,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1.0,-0.5920470247058477,-0.9643613954703678
1695,mRNA modification (GO:0016556),1.0,-0.41664538033140547,-0.6329315282108462
1696,lysosome organization (GO:0007040),1.0,-0.5795654820403313,-0.924317752097219
1697,regulation of trans-synaptic signaling (GO:0099177),1.0,-0.4828864234270854,-0.7766739142978082
1698,positive regulation of amyloid precursor protein catabolic process (GO:1902993),1.0,-0.6143859652762217,-0.953064181674488
1699,nervous system development (GO:0007399),1.0,-0.46395211766648986,-0.762053773558446
1700,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1.0,-0.649323026667279,-0.9942695484290994
1701,DNA methylation or demethylation (GO:0044728),1.0,-0.38011483146296265,-0.5817903477375584
1702,oligosaccharide metabolic process (GO:0009311),1.0,-0.5679463885142567,-0.8851554414859931
1703,regulation of RNA metabolic process (GO:0051252),1.0,-0.5432341135074027,-0.8666239829324279
1704,negative regulation of canonical Wnt signaling pathway (GO:0090090),1.0,-0.39596088661870527,-0.6463364928101165
1705,nucleotide biosynthetic process (GO:0009165),1.0,-0.5355845301040517,-0.8404506275303818
1706,enzyme linked receptor protein signaling pathway (GO:0007167),1.0,-0.6052143279401608,-0.9978592088974221
1707,ceramide biosynthetic process (GO:0046513),1.0,-0.5236546681882034,-0.8239338984333047
1708,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),1.0,-0.6462851173179215,-0.9888904212776469
1709,establishment of skin barrier (GO:0061436),1.0,-0.6548622990912046,-0.9854817756895116
1710,cardiac muscle cell action potential involved in contraction (GO:0086002),1.0,-0.4939074417666737,-0.776367949751198
1711,mitochondrial translation (GO:0032543),1.0,0.25169536606222176,0.5715055844952197
1712,beta-catenin-TCF complex assembly (GO:1904837),1.0,-0.5798180217143483,-0.9039928005923523
1713,axon guidance (GO:0007411),1.0,-0.5372961029825333,-0.8738299212908195
1714,positive regulation of nitric-oxide synthase activity (GO:0051000),1.0,-0.5125606570924204,-0.7879413718632131
1715,chemical homeostasis (GO:0048878),1.0,-0.5730667835973324,-0.9185602928556202
1716,nucleosome disassembly (GO:0006337),1.0,-0.6424334677093716,-0.9905168004656177
1717,regulation of ceramide biosynthetic process (GO:2000303),1.0,-0.6473961459813303,-0.9887569235701154
1718,synaptic vesicle exocytosis (GO:0016079),1.0,-0.6177728978597685,-0.9657284830927986
1719,positive regulation of receptor internalization (GO:0002092),1.0,-0.6545847999879753,-0.9848654677082112
1720,posttranscriptional regulation of gene expression (GO:0010608),1.0,-0.47021385651757075,-0.7381212177930554
1721,piRNA metabolic process (GO:0034587),1.0,-0.6602500399644794,-0.9874276560624661
1722,positive regulation of dendrite morphogenesis (GO:0050775),1.0,0.46322183584897025,0.8771151561640002
1723,vacuolar acidification (GO:0007035),1.0,-0.42676620869589943,-0.6571820367236765
1724,RNA metabolic process (GO:0016070),1.0,-0.4961913912962074,-0.8066953065215112
1725,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1.0,-0.5861184175867609,-0.9217625852321032
1726,cytoplasmic microtubule organization (GO:0031122),1.0,-0.4266131942981633,-0.6844716127668503
1727,regulation of endocytosis (GO:0030100),1.0,-0.4575655423687311,-0.7232946002602331
1728,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),1.0,-0.6479189063314702,-0.9871772310520958
1729,transcription by RNA polymerase II (GO:0006366),1.0,-0.4048483421259597,-0.669084130347793
1730,DNA replication checkpoint signaling (GO:0000076),1.0,-0.4479975038792874,-0.709192961420024
1731,regulation of cell-substrate junction assembly (GO:0090109),1.0,-0.37771983745395465,-0.5704067083349394
1732,regulation of cell cycle process (GO:0010564),1.0,-0.5213255395665501,-0.8397426240795792
1733,regulation of neuron apoptotic process (GO:0043523),1.0,-0.5422832095080337,-0.8920367990368413
1734,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",1.0,-0.474315827490845,-0.7170774905292417
1735,rRNA transcription (GO:0009303),1.0,-0.46896064370719603,-0.7333395308412544
1736,microtubule polymerization (GO:0046785),1.0,-0.4119349294551794,-0.6485494243047146
1737,positive regulation of cholesterol efflux (GO:0010875),1.0,-0.5419061390057278,-0.8587384801777846
1738,regulation of amyloid-beta formation (GO:1902003),1.0,-0.5160746040935185,-0.8212627652590211
1739,ncRNA processing (GO:0034470),1.0,-0.3209182670789013,-0.5203567608257745
1740,Arp2/3 complex-mediated actin nucleation (GO:0034314),1.0,-0.35905262564155843,-0.5434236817645007
1741,"DNA-templated transcription, elongation (GO:0006354)",1.0,-0.5452058518546534,-0.8874142527506363
1742,Golgi to plasma membrane protein transport (GO:0043001),1.0,-0.481615242636048,-0.74474614810069
1743,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),1.0,-0.5960626534854591,-0.9330337031326558
1744,regulation of exosomal secretion (GO:1903541),1.0,-0.6180517694182076,-0.9406701301637888
1745,positive regulation of stress-activated MAPK cascade (GO:0032874),1.0,-0.5946929307510322,-0.9576974893138941
1746,regulation of primary metabolic process (GO:0080090),1.0,-0.39635307910213535,-0.6462629139992677
1747,positive regulation of neural precursor cell proliferation (GO:2000179),1.0,-0.5667119089017926,-0.8760030299924945
1748,negative regulation of striated muscle cell differentiation (GO:0051154),1.0,0.3394640427777791,0.6371331742012197
1749,cell morphogenesis involved in neuron differentiation (GO:0048667),1.0,-0.49382754323065875,-0.7771300912172507
1750,COPII-coated vesicle budding (GO:0090114),1.0,-0.5870742674660223,-0.9552568031772315
1751,protein insertion into ER membrane (GO:0045048),1.0,-0.5688040362392859,-0.8968787708125339
1752,determination of heart left/right asymmetry (GO:0061371),1.0,-0.6025364396562165,-0.9225971507147613
1753,"retrograde transport, endosome to Golgi (GO:0042147)",1.0,-0.42645133948117675,-0.6870488219925954
1754,organonitrogen compound biosynthetic process (GO:1901566),1.0,-0.500444166259455,-0.8142371188240499
1755,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),1.0,-0.5815839550060715,-0.8862345932396736
1756,cellular glucose homeostasis (GO:0001678),1.0,-0.4934506204080839,-0.7725648999266443
1757,transcription-coupled nucleotide-excision repair (GO:0006283),1.0,-0.20263523624955257,-0.3243822031192833
1758,negative regulation of endothelial cell proliferation (GO:0001937),1.0,-0.6154394745268725,-0.9820710590063105
1759,regulation of lipid metabolic process (GO:0019216),1.0,-0.5324306686623675,-0.8637436482770318
1760,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),1.0,0.5016263186674056,1.0246713981940008
1761,amino acid import across plasma membrane (GO:0089718),1.0,-0.5581169954303378,-0.8489596373287803
1762,development of primary male sexual characteristics (GO:0046546),1.0,-0.5784808744103219,-0.9085977315226827
1763,neuron projection development (GO:0031175),1.0,-0.4714129744003658,-0.7701879243351781
1764,cellular protein localization (GO:0034613),1.0,-0.5713710036714488,-0.9420758061625696
1765,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1.0,-0.36191458269290855,-0.5593348828261344
1766,histone methylation (GO:0016571),1.0,-0.5106444328528351,-0.7858048922299211
1767,regulation of RIG-I signaling pathway (GO:0039535),1.0,-0.6251284483640769,-0.9443261386134673
1768,long-term synaptic potentiation (GO:0060291),1.0,-0.4885034821681108,-0.7439566531697475
1769,phosphatidylinositol dephosphorylation (GO:0046856),1.0,-0.5181034807391227,-0.791143941467183
1770,metal ion homeostasis (GO:0055065),1.0,-0.6066803911483842,-0.9586426360820279
1771,negative regulation of neuron death (GO:1901215),1.0,-0.5942250150770865,-0.9710303717200685
1772,negative regulation of fat cell differentiation (GO:0045599),1.0,-0.6043840201762256,-0.962076349023053
1773,acidic amino acid transport (GO:0015800),1.0,-0.6204413985817123,-0.9551255655980038
1774,peptidyl-threonine dephosphorylation (GO:0035970),1.0,-0.33427482381455886,-0.5144269124157055
1775,mitochondrion disassembly (GO:0061726),1.0,-0.3848521684773891,-0.6244738637467284
1776,nucleus organization (GO:0006997),1.0,-0.5823925009303188,-0.9329632506147377
1777,synapse organization (GO:0050808),1.0,-0.5592760929106124,-0.9019250748418998
1778,tRNA aminoacylation for protein translation (GO:0006418),1.0,-0.3592164498166558,-0.5608020186300369
1779,dendrite morphogenesis (GO:0048813),1.0,-0.5631805797068583,-0.8905806364141565
1780,alpha-amino acid metabolic process (GO:1901605),1.0,-0.4924432405844281,-0.7784000289647633
1781,histone H4 acetylation (GO:0043967),1.0,-0.6145818034673041,-0.9790884804139509
1782,nucleocytoplasmic transport (GO:0006913),1.0,-0.3699244137263777,-0.5825078948913395
1783,dendritic spine morphogenesis (GO:0060997),1.0,-0.5880715990177744,-0.8877407093744623
1784,regulation of mitotic metaphase/anaphase transition (GO:0030071),1.0,-0.5680883830897048,-0.873654435518129
1785,histone H2A acetylation (GO:0043968),1.0,-0.4713145604035717,-0.7114134694169824
1786,fatty acid transmembrane transport (GO:1902001),1.0,-0.5587662414085915,-0.8501776100262309
1787,long-chain fatty-acyl-CoA metabolic process (GO:0035336),1.0,-0.4316433577910239,-0.6650997429313675
1788,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),1.0,-0.4255157395168193,-0.6487386761503562
1789,macroautophagy (GO:0016236),1.0,-0.49918214680539047,-0.8183223164496453
1790,negative regulation of ubiquitin-protein transferase activity (GO:0051444),1.0,0.35798341088772695,0.8807421554641229
1791,protein import into nucleus (GO:0006606),1.0,-0.48762774524223723,-0.7768130073583299
1792,canonical Wnt signaling pathway (GO:0060070),1.0,-0.5332331894183124,-0.8547622830233157
1793,protein K11-linked ubiquitination (GO:0070979),1.0,0.3458269180821144,0.6448320414804025
1794,ceramide metabolic process (GO:0006672),1.0,-0.5671360915140168,-0.9017886085286089
1795,spliceosomal complex assembly (GO:0000245),1.0,-0.4841316139404368,-0.7634614516474362
1796,regulation of nitric-oxide synthase activity (GO:0050999),1.0,-0.5319325240777287,-0.844759637159643
1797,nuclear-transcribed mRNA catabolic process (GO:0000956),1.0,-0.31571011652887887,-0.5138766380037046
1798,regulation of anatomical structure morphogenesis (GO:0022603),1.0,-0.6068072172228353,-0.9922125234759496
1799,regulation of cell cycle phase transition (GO:1901987),1.0,-0.5016264243598516,-0.8133086977002759
1800,negative regulation of nucleic acid-templated transcription (GO:1903507),1.0,-0.5207118742886746,-0.8556094253051275
1801,iron-sulfur cluster assembly (GO:0016226),1.0,-0.43509886472943615,-0.68109519731122
1802,peptide biosynthetic process (GO:0043043),1.0,-0.42100988318374916,-0.6909979176693894
1803,establishment of mitotic spindle orientation (GO:0000132),1.0,-0.5411634779404153,-0.8517999926493598
1804,protein-containing complex disassembly (GO:0032984),1.0,-0.5776897325655302,-0.9247279444059304
1805,transition metal ion transport (GO:0000041),1.0,-0.5922135266219642,-0.9404481939100304
1806,tRNA transport (GO:0051031),1.0,0.27558204507357065,0.8060288327329213
1807,"mRNA cis splicing, via spliceosome (GO:0045292)",1.0,-0.4316849341815913,-0.6554452634548953
1808,calcium ion transmembrane transport (GO:0070588),1.0,-0.5922716934717832,-0.9433279543455112
1809,histone H2A ubiquitination (GO:0033522),1.0,-0.32647719769444766,-0.4995415775375657
1810,positive regulation of CREB transcription factor activity (GO:0032793),1.0,-0.4704229507107216,-0.7272755855796279
1811,regulation of macromolecule metabolic process (GO:0060255),1.0,-0.5880946190543518,-0.9536032459207215
1812,electron transport chain (GO:0022900),1.0,-0.4007381325177458,-0.6111863056937663
1813,"protein alpha-1,2-demannosylation (GO:0036508)",1.0,-0.48185312105600947,-0.7340293796985371
1814,mRNA catabolic process (GO:0006402),1.0,-0.44675496600535874,-0.7124131456072574
1815,DNA-dependent DNA replication (GO:0006261),1.0,-0.3985743489135691,-0.6459427403827033
1816,sodium ion import across plasma membrane (GO:0098719),1.0,-0.41488493058270004,-0.6176555874858539
1817,endocytic recycling (GO:0032456),1.0,-0.4959161061034878,-0.7902103172103563
1818,cell junction organization (GO:0034330),1.0,-0.4125029200738874,-0.6633936399709867
1819,positive regulation of smoothened signaling pathway (GO:0045880),1.0,-0.5641267135399073,-0.8697132193608026
1820,negative regulation of telomere maintenance (GO:0032205),1.0,-0.5866211872285985,-0.887135219154643
1821,positive regulation of telomere capping (GO:1904355),1.0,-0.4446616393811512,-0.6747721882513152
1822,protein insertion into mitochondrial membrane (GO:0051204),1.0,-0.442573277711573,-0.6868315382237454
1823,organelle disassembly (GO:1903008),1.0,0.23849076281287257,0.585968907968071
1824,fatty acid catabolic process (GO:0009062),1.0,-0.5608355708786283,-0.8956795648048277
1825,cholesterol metabolic process (GO:0008203),1.0,-0.5795984354546811,-0.9238143767653784
1826,regulation of response to DNA damage stimulus (GO:2001020),1.0,-0.47289359726816327,-0.7441442598445389
1827,Wnt signaling pathway (GO:0016055),1.0,-0.5124495906559611,-0.8179174861607931
1828,GPI anchor biosynthetic process (GO:0006506),1.0,-0.3908066538216892,-0.6186969538942262
1829,nuclear membrane reassembly (GO:0031468),1.0,-0.2613328233183543,-0.4149273997095376
1830,telomere maintenance via telomerase (GO:0007004),1.0,-0.5898988155877086,-0.9366435672026712
1831,negative regulation of ATPase activity (GO:0032780),1.0,-0.42050176786419885,-0.6403338592230415
1832,regulation of centriole replication (GO:0046599),1.0,-0.4952518874225736,-0.7684172490521881
1833,preassembly of GPI anchor in ER membrane (GO:0016254),1.0,-0.49486003357742214,-0.7556753051254018
1834,long-chain fatty acid transport (GO:0015909),1.0,-0.4536638405196587,-0.7144787393076076
1835,error-free translesion synthesis (GO:0070987),1.0,-0.6092325243568706,-0.9403747483109494
1836,mitochondrial RNA metabolic process (GO:0000959),1.0,-0.311179554350263,-0.466199554042438
1837,muscle organ development (GO:0007517),1.0,-0.40665131047753217,-0.6472623672838983
1838,cellular response to metal ion (GO:0071248),1.0,-0.6128462466749679,-0.9949751709276272
1839,organelle assembly (GO:0070925),1.0,-0.4646608904272835,-0.7626688713351392
1840,regulation of organelle organization (GO:0033043),1.0,-0.6161173193985815,-0.9940371532399053
1841,rRNA modification (GO:0000154),1.0,-0.41919470507071055,-0.6457117786823708
1842,stress fiber assembly (GO:0043149),1.0,-0.5723799755876251,-0.8694661358953485
1843,regulation of apoptotic signaling pathway (GO:2001233),1.0,-0.6284620393700747,-0.9802519509201026
1844,protein localization to cilium (GO:0061512),1.0,-0.39532673851590777,-0.6224162494545008
1845,histone deacetylation (GO:0016575),1.0,-0.38788579785379895,-0.6277402737438733
1846,positive regulation of TOR signaling (GO:0032008),1.0,-0.5354853548963208,-0.8388448940706795
1847,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1.0,-0.5357462236134962,-0.8074602097871016
1848,skeletal muscle tissue development (GO:0007519),1.0,-0.6215833157642493,-0.9921167515022793
1849,protein complex oligomerization (GO:0051259),1.0,-0.5704930965941868,-0.9100332480410218
1850,inorganic cation transmembrane transport (GO:0098662),1.0,-0.5927336043633868,-0.9744776816413067
1851,connective tissue development (GO:0061448),1.0,-0.5653208357508211,-0.8938423300519527
1852,cellular response to acid chemical (GO:0071229),1.0,-0.4418151754443218,-0.689541179584308
1853,telomere maintenance (GO:0000723),1.0,-0.5802280289016706,-0.9132582530573167
1854,central nervous system development (GO:0007417),1.0,-0.5761620786240199,-0.9441486260366125
1855,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),1.0,-0.476904098899003,-0.7479834917034456
1856,regulation of mitotic sister chromatid separation (GO:0010965),1.0,-0.3902901290104408,-0.6118065278699865
1857,positive regulation of cellular component organization (GO:0051130),1.0,-0.5978237645488809,-0.9606290476131728
1858,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),1.0,-0.5811589180176104,-0.9345300529849448
1859,protein modification by small protein removal (GO:0070646),1.0,-0.4631370041432469,-0.7619856348595601
1860,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),1.0,-0.5158917496107264,-0.7962583824188971
1861,mRNA methylation (GO:0080009),1.0,-0.42248692247517416,-0.6344099042240209
1862,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),1.0,-0.4131113176704035,-0.632426727732067
1863,post-Golgi vesicle-mediated transport (GO:0006892),1.0,-0.44784884558451066,-0.7226452864049471
1864,lipid homeostasis (GO:0055088),1.0,-0.526709004844049,-0.8412271246852991
1865,regulation of telomere capping (GO:1904353),1.0,-0.39111892510765756,-0.6086102682928427
1866,actin filament capping (GO:0051693),1.0,-0.6184590527317207,-0.964068793256404
1867,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),1.0,-0.4978880788742963,-0.8085789528997323
1868,regulation of mitotic cell cycle phase transition (GO:1901990),1.0,-0.4600655989155006,-0.7475303187137861
1869,negative regulation of protein kinase B signaling (GO:0051898),1.0,-0.5897711109676098,-0.9399501123330715
1870,cotranslational protein targeting to membrane (GO:0006613),1.0,0.41736573843628066,0.9749799864356624
1871,regulation of hematopoietic progenitor cell differentiation (GO:1901532),1.0,-0.5828816630625191,-0.9367725080358884
1872,protein export from nucleus (GO:0006611),1.0,-0.4528267706655949,-0.7098589082138903
1873,positive regulation of peptide hormone secretion (GO:0090277),1.0,-0.5746113405518226,-0.9126999508849593
1874,response to amino acid starvation (GO:1990928),1.0,-0.4533159499534993,-0.724762923230297
1875,purine-containing compound biosynthetic process (GO:0072522),1.0,-0.5317384479741042,-0.8328686539805057
1876,regulation of ion transmembrane transport (GO:0034765),1.0,-0.5008366626274925,-0.7830980443414637
1877,regulation of neurotransmitter receptor activity (GO:0099601),1.0,-0.4795496008476682,-0.7530623039044945
1878,regulation of autophagy (GO:0010506),1.0,-0.603692802632936,-0.9934320987440746
1879,regulation of canonical Wnt signaling pathway (GO:0060828),1.0,-0.4173082026033138,-0.6837788480034868
1880,positive regulation of protein localization to plasma membrane (GO:1903078),1.0,-0.6136647328414373,-0.9818539588983359
1881,nucleotide metabolic process (GO:0009117),1.0,-0.37554098762101085,-0.5702691315805907
1882,glial cell differentiation (GO:0010001),1.0,0.349676285714958,0.956592773740365
1883,7-methylguanosine mRNA capping (GO:0006370),1.0,0.3821459163532087,0.8890866279467062
1884,melanosome organization (GO:0032438),1.0,-0.3980703383204647,-0.6223046296922319
1885,positive regulation of lipid biosynthetic process (GO:0046889),1.0,-0.47355216808977285,-0.7350094191269179
1886,regulation of blood circulation (GO:1903522),1.0,-0.4169440541991878,-0.6629065294960395
1887,positive regulation of double-strand break repair (GO:2000781),1.0,-0.45066095440816,-0.7095874492032711
1888,ERAD pathway (GO:0036503),1.0,-0.38305955374518236,-0.6171909532995362
1889,acetylcholine receptor signaling pathway (GO:0095500),1.0,-0.5405473061408611,-0.8245832780418872
1890,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",1.0,-0.3494706787936721,-0.5410099013767007
1891,blood vessel morphogenesis (GO:0048514),1.0,-0.5853666453058295,-0.9453730694687605
1892,negative regulation of apoptotic process (GO:0043066),1.0,-0.6029568544914591,-0.9996700165950801
1893,regulation of cellular protein localization (GO:1903827),1.0,-0.5818486787557382,-0.9269749505282862
1894,regulation of heart rate by cardiac conduction (GO:0086091),1.0,-0.4030063569110824,-0.6313525751041995
1895,neural crest cell differentiation (GO:0014033),1.0,-0.3001721382074315,-0.4524070038383704
1896,limb development (GO:0060173),1.0,-0.4962740787538243,-0.7673625630341013
1897,tetrapyrrole metabolic process (GO:0033013),1.0,-0.6142463108237708,-0.9400304723225624
1898,ganglioside metabolic process (GO:0001573),1.0,-0.5706350314225173,-0.8494182682569688
1899,positive regulation of catalytic activity (GO:0043085),1.0,-0.5167252008872022,-0.8274255015198124
1900,positive regulation of cholesterol transport (GO:0032376),1.0,-0.4924484846201326,-0.7884777918292191
1901,positive regulation of stem cell proliferation (GO:2000648),1.0,-0.6231799164372243,-0.9614445609941535
1902,regulation of cell cycle G2/M phase transition (GO:1902749),1.0,-0.23191807261652955,-0.37112461657425877
1903,negative regulation of axonogenesis (GO:0050771),1.0,-0.5378631985592351,-0.8268523723038209
1904,IRE1-mediated unfolded protein response (GO:0036498),1.0,-0.31514223194505603,-0.5123093863905264
1905,regulation of dendrite development (GO:0050773),1.0,-0.37982802410052946,-0.5951522790407605
1906,cellular macromolecule catabolic process (GO:0044265),1.0,-0.6040812248293147,-0.9508469958846182
1907,regulation of glycogen biosynthetic process (GO:0005979),1.0,-0.5882487282999849,-0.9175278452013405
1908,negative regulation of epithelial cell proliferation (GO:0050680),1.0,-0.533374435524316,-0.8603214293171942
1909,positive regulation of endocytosis (GO:0045807),1.0,-0.5684846344723542,-0.8994540976919647
1910,mesenchymal cell differentiation (GO:0048762),1.0,-0.5757071824256088,-0.9075205128364798
1911,glycolipid metabolic process (GO:0006664),1.0,-0.5539501671466345,-0.8603861181315622
1912,positive regulation of epithelial to mesenchymal transition (GO:0010718),1.0,-0.4635306251198026,-0.7189072843234954
1913,cellular response to calcium ion (GO:0071277),1.0,-0.5235908262524132,-0.8307303712013646
1914,mRNA stabilization (GO:0048255),1.0,-0.6173922858995231,-0.9723497709351564
1915,positive regulation of neuron differentiation (GO:0045666),1.0,-0.38827889532516696,-0.6040533795882977
1916,negative regulation of response to endoplasmic reticulum stress (GO:1903573),1.0,-0.5643537170990264,-0.8774805979423657
1917,protein autoubiquitination (GO:0051865),1.0,-0.5016257333531525,-0.8071859673902387
1918,negative regulation of amyloid-beta formation (GO:1902430),1.0,-0.4336503591056189,-0.6723196438764352
1919,cellular response to catecholamine stimulus (GO:0071870),1.0,-0.3291728683082914,-0.49920832510697377
1920,positive regulation of response to DNA damage stimulus (GO:2001022),1.0,-0.5566063038629152,-0.8738859336168738
1921,autonomic nervous system development (GO:0048483),1.0,-0.5499803916498283,-0.8523640710708613
1922,DNA damage checkpoint signaling (GO:0000077),1.0,-0.4306068659955099,-0.6777198285415322
1923,positive regulation of exosomal secretion (GO:1903543),1.0,-0.613620491566688,-0.9289728723619032
1924,regulation of calcineurin-NFAT signaling cascade (GO:0070884),1.0,-0.5946231759938639,-0.9206365083659113
1925,regulation of ubiquitin protein ligase activity (GO:1904666),1.0,0.3885440591384604,0.615662267015382
1926,lung development (GO:0030324),1.0,-0.6119793727838887,-0.9677665132652729
1927,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),1.0,-0.3519467858202957,-0.571548979420853
1928,regulation of epithelial to mesenchymal transition (GO:0010717),1.0,-0.3727201724990118,-0.5892543480575819
1929,regulation of protein-containing complex disassembly (GO:0043244),1.0,-0.5591589179433398,-0.8554455993506952
1930,regulation of neuroblast proliferation (GO:1902692),1.0,-0.5730009578131302,-0.8621821544272286
1931,response to insulin (GO:0032868),1.0,-0.4961772639435902,-0.7945330893242947
1932,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",1.0,-0.27191031134562366,-0.41368067331939407
1933,cellular response to ionizing radiation (GO:0071479),1.0,-0.5833184284675972,-0.9272099862968324
1934,regulation of translational initiation (GO:0006446),1.0,-0.5592754362899857,-0.8963978334585939
1935,7-methylguanosine RNA capping (GO:0009452),1.0,0.3821459163532087,0.8890866279467062
1936,regulation of RNA splicing (GO:0043484),1.0,-0.4015122417951163,-0.6437962608244805
1937,regulation of protein catabolic process (GO:0042176),1.0,-0.5729864102095579,-0.9313621636248298
1938,negative regulation of RNA metabolic process (GO:0051253),1.0,-0.4701953121929927,-0.721393546291873
1939,nuclear transport (GO:0051169),1.0,-0.48626649966700297,-0.7293985903826824
1940,vesicle coating (GO:0006901),1.0,-0.5920470247058477,-0.9643613954703678
1941,mitotic chromosome condensation (GO:0007076),1.0,0.2509029975795942,0.3800244204263795
1942,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),1.0,-0.5049985604037851,-0.7882838532399662
1943,regulation of histone H3-K4 methylation (GO:0051569),1.0,0.32307020177863954,0.5938340058836447
1944,membrane protein proteolysis (GO:0033619),1.0,-0.5281247821329526,-0.8335246395486098
1945,positive regulation of supramolecular fiber organization (GO:1902905),1.0,-0.5530807495899774,-0.8956407405453766
1946,"DNA-templated transcription, termination (GO:0006353)",1.0,-0.3232982827288365,-0.5201703277926074
1947,regulation of cilium assembly (GO:1902017),1.0,-0.49702189687062637,-0.7984655676194166
1948,negative regulation of protein serine/threonine kinase activity (GO:0071901),1.0,-0.5869215971430289,-0.9538728763011015
1949,regulation of axonogenesis (GO:0050770),1.0,-0.4733898294190395,-0.7540001854776699
1950,pre-replicative complex assembly (GO:0036388),1.0,-0.41664928956912184,-0.6649012950440586
1951,negative regulation of cell differentiation (GO:0045596),1.0,-0.5427238916649741,-0.8939388310680202
1952,cellular response to alkaloid (GO:0071312),1.0,-0.5860647763529798,-0.9135099758092797
1953,DNA strand elongation (GO:0022616),1.0,0.3717034768854368,0.49974261956396304
1954,protein localization to organelle (GO:0033365),1.0,-0.5651348311280591,-0.9241970593251858
1955,mesenchymal cell development (GO:0014031),1.0,-0.3812604982749016,-0.5668661361236293
1956,lipid modification (GO:0030258),1.0,-0.5752284405502911,-0.9213882046770173
1957,secondary alcohol metabolic process (GO:1902652),1.0,-0.5814466500178583,-0.9265316011379378
1958,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),1.0,-0.6200884663103317,-0.9880012347751725
1959,glucan catabolic process (GO:0009251),1.0,-0.6196248767849641,-0.9284163850404944
1960,potassium ion transmembrane transport (GO:0071805),1.0,-0.5739380917854312,-0.930106743491681
1961,spindle assembly (GO:0051225),1.0,-0.5301065077121752,-0.8381565559920521
1962,protein import into mitochondrial matrix (GO:0030150),1.0,-0.4460371832353956,-0.6965815233832855
1963,transcription initiation from RNA polymerase I promoter (GO:0006361),1.0,-0.361738691090087,-0.5698838639392593
1964,mitotic nuclear membrane organization (GO:0101024),1.0,-0.2790572141079604,-0.4418658577420918
1965,triglyceride biosynthetic process (GO:0019432),1.0,-0.641102638705849,-0.9693907921133081
1966,platelet-derived growth factor receptor signaling pathway (GO:0048008),1.0,-0.6407001370337098,-0.9816551390672554
1967,plasma membrane bounded cell projection assembly (GO:0120031),1.0,-0.5824198976245224,-0.9511080666439723
1968,interleukin-1-mediated signaling pathway (GO:0070498),1.0,-0.5945623291781221,-0.9618119201068358
1969,regulation of cell division (GO:0051302),1.0,-0.5815208012221097,-0.9303562971482633
1970,neuron cell-cell adhesion (GO:0007158),1.0,-0.4568490463316395,-0.6943128261311523
1971,long-chain fatty acid biosynthetic process (GO:0042759),1.0,-0.5909538455386912,-0.9314104068434514
1972,negative regulation of transcription regulatory region DNA binding (GO:2000678),1.0,-0.613795033010496,-0.940717343394431
1973,apoptotic mitochondrial changes (GO:0008637),1.0,-0.34413057224393795,-0.542318778046763
1974,sensory perception of sound (GO:0007605),1.0,-0.5108899112799736,-0.8117680661624364
1975,positive regulation of protein targeting to mitochondrion (GO:1903955),1.0,-0.6171702163427336,-0.9813170885541771
1976,detection of mechanical stimulus (GO:0050982),1.0,-0.5352744205241196,-0.8379507960734074
1977,positive regulation of histone methylation (GO:0031062),1.0,-0.5873350282576866,-0.9137987488598085
1978,potassium ion homeostasis (GO:0055075),1.0,-0.6235154060757393,-0.9631126705823354
1979,cellular response to pH (GO:0071467),1.0,-0.5115525703426655,-0.7742029086908699
1980,cellular protein-containing complex assembly (GO:0034622),1.0,-0.5110025613523685,-0.841805522340838
1981,protein palmitoylation (GO:0018345),1.0,-0.4217309417115348,-0.6622140892092169
1982,protein catabolic process (GO:0030163),1.0,-0.49061311208003905,-0.7780927897338721
1983,mitotic nuclear membrane reassembly (GO:0007084),1.0,-0.2790572141079604,-0.4418658577420918
1984,anaphase-promoting complex-dependent catabolic process (GO:0031145),1.0,-0.4545773409406608,-0.7343351737109461
1985,excitatory postsynaptic potential (GO:0060079),1.0,-0.5152240168397775,-0.7780996637973976
1986,sterol homeostasis (GO:0055092),1.0,-0.5587802050869505,-0.9098073510303814
1987,regulation of establishment of planar polarity (GO:0090175),1.0,-0.3736745196211358,-0.6073218530004292
1988,response to retinoic acid (GO:0032526),1.0,-0.5419658443918218,-0.8630485742594666
1989,membrane repolarization (GO:0086009),1.0,-0.5989460993065419,-0.8914433477697822
1990,cytoplasmic translational initiation (GO:0002183),1.0,0.463601734906797,1.1441051314206914
1991,ribonucleoprotein complex assembly (GO:0022618),1.0,-0.34634413650717705,-0.5567802216681041
1992,response to metal ion (GO:0010038),1.0,-0.6030128916005439,-0.967181147995643
1993,regulation of plasma membrane bounded cell projection organization (GO:0120035),1.0,-0.6567082745028087,-0.9931095087723983
1994,regulation of telomerase RNA localization to Cajal body (GO:1904872),1.0,-0.4794345333021848,-0.7520295057421539
1995,negative regulation of synaptic transmission (GO:0050805),1.0,-0.6394799924322453,-0.9738640902515227
1996,negative regulation of amyloid precursor protein catabolic process (GO:1902992),1.0,-0.4252635559697727,-0.6587641299165627
1997,intra-Golgi vesicle-mediated transport (GO:0006891),1.0,-0.46714027564089705,-0.7289839772626608
1998,regulation of cholesterol efflux (GO:0010874),1.0,-0.4839960795961772,-0.7864819469434042
1999,regulation of postsynaptic membrane potential (GO:0060078),1.0,-0.564133186223131,-0.886399825001216
2000,regulation of axon extension (GO:0030516),1.0,0.3365786568571341,0.6373997853311816
2001,DNA replication (GO:0006260),1.0,-0.39256130986179066,-0.6413892702800723
2002,protein localization to plasma membrane (GO:0072659),1.0,-0.5344376487450453,-0.8621839112751897
2003,positive regulation of developmental growth (GO:0048639),1.0,-0.39743223717339915,-0.636840516100682
2004,actin nucleation (GO:0045010),1.0,-0.5206779725808438,-0.8170006256223101
2005,establishment of melanosome localization (GO:0032401),1.0,-0.35547576420935095,-0.5387930375410291
2006,histone ubiquitination (GO:0016574),1.0,-0.45818075299206457,-0.7149654662973604
2007,microtubule nucleation (GO:0007020),1.0,-0.39118598652675135,-0.5970690684191273
2008,regulation of peptidyl-threonine phosphorylation (GO:0010799),1.0,-0.3578487383649403,-0.5656091894648119
2009,negative regulation of ion transmembrane transporter activity (GO:0032413),1.0,-0.5767864680466827,-0.8882057331848803
2010,regulation of cellular protein catabolic process (GO:1903362),1.0,-0.6518014397800048,-0.984007904509979
2011,regulation of transposition (GO:0010528),1.0,-0.6102519080641231,-0.9333954299933596
2012,RNA phosphodiester bond hydrolysis (GO:0090501),1.0,-0.6335066738078127,-1.00188298154595
2013,peptidyl-serine modification (GO:0018209),1.0,-0.5312819187523525,-0.8656962195421598
2014,import into nucleus (GO:0051170),1.0,-0.4798704988095509,-0.7624758080413108
2015,regulation of response to cytokine stimulus (GO:0060759),1.0,-0.5696217213660675,-0.8788582346743917
2016,positive regulation of cation transmembrane transport (GO:1904064),1.0,-0.607758491278271,-0.9365206349393286
2017,cellular protein metabolic process (GO:0044267),1.0,-0.5577704383557831,-0.9193990327855521
2018,dopaminergic neuron differentiation (GO:0071542),1.0,-0.6240936390372154,-0.9494371924071213
2019,G2/M transition of mitotic cell cycle (GO:0000086),1.0,-0.30041556677831976,-0.4838486055204689
2020,regulation of cell differentiation (GO:0045595),1.0,-0.5247437002866493,-0.852113262062623
2021,neurotrophin signaling pathway (GO:0038179),1.0,-0.4646457322904449,-0.7258611848611929
2022,regulation of cytokinesis (GO:0032465),1.0,-0.5155069721492036,-0.841220935595662
2023,regulation of generation of precursor metabolites and energy (GO:0043467),1.0,-0.38505131373174367,-0.6048781861721904
2024,NLS-bearing protein import into nucleus (GO:0006607),1.0,-0.40162025008317026,-0.6053647422974887
2025,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1.0,-0.6297260452899164,-0.9795365115799827
2026,mitochondrion organization (GO:0007005),1.0,-0.39534998253145237,-0.6569962415439475
2027,negative regulation of protein phosphorylation (GO:0001933),1.0,-0.5525332641196502,-0.9101097487033873
2028,negative regulation of epithelial cell differentiation (GO:0030857),1.0,-0.6598698030336722,-0.9954493535740118
2029,regulation of protein binding (GO:0043393),1.0,-0.4378778218909446,-0.7221110564927624
2030,endocrine system development (GO:0035270),1.0,-0.48375268691815276,-0.7565565731524757
2031,regulation of protein serine/threonine kinase activity (GO:0071900),1.0,-0.5155011052114106,-0.8322361438180211
2032,regulation of cyclin-dependent protein kinase activity (GO:1904029),1.0,-0.5604639539914048,-0.9024845202014773
2033,axonal transport (GO:0098930),1.0,-0.36261613264056264,-0.5613913604066998
2034,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1.0,-0.3775232969063904,-0.6041650767992809
2035,regulation of osteoblast differentiation (GO:0045667),1.0,-0.5573738571896039,-0.8921823519108141
2036,regulation of cellular localization (GO:0060341),1.0,-0.5962170490854241,-0.9453849988536787
2037,negative regulation of reactive oxygen species metabolic process (GO:2000378),1.0,-0.4414901183477159,-0.681871660992438
2038,potassium ion transport (GO:0006813),1.0,-0.5770086215178463,-0.9311796729021367
2039,nucleic acid metabolic process (GO:0090304),1.0,-0.5545072313337477,-0.8898367500816114
2040,negative regulation of lipid catabolic process (GO:0050995),1.0,-0.6329204624194756,-0.9791336999814472
2041,regulation of cellular amino acid metabolic process (GO:0006521),1.0,-0.4767152279489906,-0.7636628692505006
2042,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1.0,-0.2727402169388905,-0.42452136894054915
2043,carbohydrate biosynthetic process (GO:0016051),1.0,-0.6289127357126499,-0.9517526478595888
2044,regulation of sodium ion transport (GO:0002028),1.0,-0.3716568167919618,-0.582740715177098
2045,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",1.0,-0.3496095289157439,-0.5700915172632228
2046,central nervous system neuron differentiation (GO:0021953),1.0,-0.47328277852183764,-0.7318064806909429
2047,purine ribonucleoside monophosphate metabolic process (GO:0009167),1.0,-0.5865015441501575,-0.910577225597803
2048,"protein localization to chromosome, centromeric region (GO:0071459)",1.0,0.3617345989205285,0.8435237690847346
2049,protein K63-linked ubiquitination (GO:0070534),1.0,-0.46483052159183696,-0.7412986136750312
2050,peptidyl-L-cysteine S-palmitoylation (GO:0018230),1.0,-0.527541555853914,-0.8297014718749139
2051,response to endoplasmic reticulum stress (GO:0034976),1.0,-0.5854519190708993,-0.9530546334386611
2052,cellular response to unfolded protein (GO:0034620),1.0,-0.32850219324481017,-0.5170823825496328
2053,heme biosynthetic process (GO:0006783),1.0,-0.5471460224584815,-0.865845686829776
2054,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),1.0,0.46167035969478204,0.9585132229624621
2055,muscle contraction (GO:0006936),1.0,-0.42435092282081227,-0.6838326831257143
2056,negative regulation of microtubule polymerization or depolymerization (GO:0031111),1.0,-0.5581496300831998,-0.8822139147150828
2057,peptidyl-lysine trimethylation (GO:0018023),1.0,-0.5563175578132319,-0.8658535757045183
2058,regulation of smoothened signaling pathway (GO:0008589),1.0,-0.5173538276540045,-0.8219888261219398
2059,ribosome biogenesis (GO:0042254),1.0,-0.3193379569536,-0.5197600043911776
2060,pigment granule transport (GO:0051904),1.0,-0.36356548504541397,-0.5551484898593144
2061,negative regulation of cellular response to growth factor stimulus (GO:0090288),1.0,-0.41549961526591384,-0.6668439929535921
2062,establishment of vesicle localization (GO:0051650),1.0,-0.6204103356639067,-0.9956338017869509
2063,RNA splicing (GO:0008380),1.0,-0.3097305220313714,-0.4966272261768971
2064,glycosaminoglycan metabolic process (GO:0030203),1.0,-0.6032496225713074,-0.9585886116277661
2065,nucleotide-excision repair (GO:0006289),1.0,-0.26703068860161805,-0.4313438926318975
2066,sensory perception of mechanical stimulus (GO:0050954),1.0,-0.4901784890184517,-0.7786158616098632
2067,positive regulation of macroautophagy (GO:0016239),1.0,-0.5983731221712693,-0.9665944433883494
2068,positive regulation of ion transmembrane transporter activity (GO:0032414),1.0,-0.41523920795487645,-0.6374852216479143
2069,plasma membrane bounded cell projection organization (GO:0120036),1.0,-0.47205494862539554,-0.7742514110173311
2070,protein-containing complex assembly (GO:0065003),1.0,-0.6006996696946034,-0.9859946161602545
2071,mitotic G1 DNA damage checkpoint signaling (GO:0031571),1.0,-0.40572408066896526,-0.641045209737699
2072,lytic vacuole organization (GO:0080171),1.0,-0.508838297012637,-0.8121086370535174
2073,histone modification (GO:0016570),1.0,-0.4840103285902396,-0.7912886535729388
2074,modulation of chemical synaptic transmission (GO:0050804),1.0,-0.5375000284907699,-0.870213381555355
2075,regulation of lipid catabolic process (GO:0050994),1.0,-0.6238325407197444,-0.966259018703986
2076,maturation of SSU-rRNA (GO:0030490),1.0,-0.4878129534466347,-0.7572026511152823
2077,regulation of protein sumoylation (GO:0033233),1.0,0.29085088960023814,1.1392955787395769
2078,regulation of ATP metabolic process (GO:1903578),1.0,0.19643685545076597,0.6210448627491618
2079,regulation of adenylate cyclase activity (GO:0045761),1.0,-0.5419286962825542,-0.8285001459481417
2080,negative regulation of axon extension involved in axon guidance (GO:0048843),1.0,-0.3664578558332844,-0.5556096524724659
2081,protein K48-linked ubiquitination (GO:0070936),1.0,-0.39291731799357216,-0.6319713652123874
2082,entrainment of circadian clock by photoperiod (GO:0043153),1.0,-0.4468973700112585,-0.7239558340479558
2083,positive regulation of apoptotic process (GO:0043065),1.0,-0.5966786945145155,-0.9825090996719279
2084,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),1.0,-0.569440106427906,-0.9215291793451968
2085,ubiquinone biosynthetic process (GO:0006744),1.0,-0.49648464623021277,-0.7681933724828907
2086,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1.0,-0.29473208026568914,-0.46949515879524745
2087,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),1.0,-0.5124372112863514,-0.8042685194249015
2088,negative chemotaxis (GO:0050919),1.0,-0.4942970869168914,-0.7818819671879924
2089,histone H3 deacetylation (GO:0070932),1.0,-0.45484758955345145,-0.7060888195609825
2090,synaptic vesicle endocytosis (GO:0048488),1.0,-0.46889540818847086,-0.7539005226197985
2091,multivesicular body assembly (GO:0036258),1.0,-0.32322676308141246,-0.5046864657092901
2092,protein N-linked glycosylation via asparagine (GO:0018279),1.0,-0.5975241996037721,-0.907052657331765
2093,regulation of transcription regulatory region DNA binding (GO:2000677),1.0,-0.48895081034441246,-0.7553396101617241
2094,peptidyl-asparagine modification (GO:0018196),1.0,-0.5974327902474217,-0.9089601256533283
2095,intrinsic apoptotic signaling pathway (GO:0097193),1.0,-0.6223483020749011,-0.9965849500141651
2096,neuron differentiation (GO:0030182),1.0,-0.5511314530732213,-0.8840141812389221
2097,tRNA aminoacylation (GO:0043039),1.0,-0.3839496272712726,-0.5945070757213983
2098,regulation of cellular ketone metabolic process (GO:0010565),1.0,-0.6216602163489368,-0.9954286932883043
2099,histone mRNA metabolic process (GO:0008334),1.0,-0.32852675657110164,-0.5158579771755138
2100,histone H4-K8 acetylation (GO:0043982),1.0,-0.4732984983800708,-0.7286296247376319
2101,regulation of mRNA polyadenylation (GO:1900363),1.0,-0.4361935883525435,-0.6729457287870104
2102,growth hormone receptor signaling pathway (GO:0060396),1.0,-0.6457163316304273,-0.9712396980117246
2103,inositol phosphate-mediated signaling (GO:0048016),1.0,-0.5500587996024724,-0.8333015165530222
2104,cytoskeleton organization (GO:0007010),1.0,-0.613363223590598,-0.9865243347894098
2105,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",1.0,-0.27191031134562366,-0.41368067331939407
2106,sterol metabolic process (GO:0016125),1.0,-0.5112288218003463,-0.8247130320645094
2107,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1.0,-0.6270843108958386,-1.001379103334729
2108,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1.0,-0.5041408649847919,-0.8098703862503244
2109,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",1.0,-0.3646596212533517,-0.5913047795682951
2110,regulation of cellular pH (GO:0030641),1.0,-0.49529498082258705,-0.7810713501611563
2111,protein targeting to peroxisome (GO:0006625),1.0,-0.3621434356580585,-0.5648174256173522
2112,phospholipid biosynthetic process (GO:0008654),1.0,-0.5543907241118832,-0.8747452731242547
2113,metal ion export (GO:0070839),1.0,-0.5998127053605409,-0.9326793113291977
2114,chromatin disassembly (GO:0031498),1.0,-0.6424334677093716,-0.9905168004656177
2115,regulation of G2/M transition of mitotic cell cycle (GO:0010389),1.0,-0.36131799247076685,-0.5837668101591762
2116,negative regulation of GTPase activity (GO:0034260),1.0,-0.5119016416381172,-0.8028429908936504
2117,glycosphingolipid metabolic process (GO:0006687),1.0,-0.5568801005222471,-0.8597016645712509
2118,regulation of secretion by cell (GO:1903530),1.0,-0.5805923567894432,-0.9102201895806064
2119,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),1.0,-0.611671603025706,-0.905157978718305
2120,vesicle cytoskeletal trafficking (GO:0099518),1.0,-0.500331143099464,-0.7832329478081956
2121,chromatin remodeling (GO:0006338),1.0,-0.41161934802488465,-0.6578441700837382
2122,autophagosome organization (GO:1905037),1.0,-0.6169420157735017,-0.9952305979774705
2123,endoplasmic reticulum organization (GO:0007029),1.0,-0.5709502779412139,-0.920366911381162
2124,regulation of cellular amine metabolic process (GO:0033238),1.0,-0.4341253668089226,-0.6955476833463373
2125,generation of neurons (GO:0048699),1.0,-0.4912512339652742,-0.800665886504231
2126,regulation of muscle cell differentiation (GO:0051147),1.0,-0.5904486084868678,-0.9395900326617317
2127,negative regulation of axon extension (GO:0030517),1.0,-0.38661239108328055,-0.602513876699661
2128,regulation of nucleic acid-templated transcription (GO:1903506),1.0,-0.60817066750752,-1.0005176127436304
2129,endosome organization (GO:0007032),1.0,0.3376207762108613,0.9096440602198358
2130,embryonic heart tube development (GO:0035050),1.0,-0.6698390020696924,-1.000048971427981
2131,positive regulation of neuron projection development (GO:0010976),1.0,-0.3636995360713195,-0.5884827058159032
2132,RNA catabolic process (GO:0006401),1.0,-0.569276553774752,-0.9173672445781642
2133,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1.0,-0.4334309934817731,-0.6766390864938149
2134,RNA biosynthetic process (GO:0032774),1.0,-0.49735914171622875,-0.7839142560576599
2135,chromatin organization (GO:0006325),1.0,-0.47944133404235834,-0.7731918211846411
2136,regulation of viral release from host cell (GO:1902186),1.0,-0.5175838985951657,-0.8006387505300057
2137,artery morphogenesis (GO:0048844),1.0,-0.6099014334168842,-0.967819356958734
2138,ribosomal small subunit biogenesis (GO:0042274),1.0,-0.38505018863403423,-0.6052406500317273
2139,RNA stabilization (GO:0043489),1.0,-0.5236629370926194,-0.8064047054101473
2140,histone H4-K16 acetylation (GO:0043984),1.0,-0.4245046086261757,-0.6583720815911588
2141,maturation of 5.8S rRNA (GO:0000460),1.0,0.31252559091755067,0.8927311186973634
2142,heart morphogenesis (GO:0003007),1.0,-0.5465761655423124,-0.862129508935414
2143,regulation of transcription by RNA polymerase III (GO:0006359),1.0,-0.6304183464973182,-0.9759251656586596
2144,cyclic-nucleotide-mediated signaling (GO:0019935),1.0,0.422679256140367,0.635371251563321
2145,regulation of mitotic cell cycle (GO:0007346),1.0,-0.5110270304843717,-0.8285920847024248
2146,mitochondrial fission (GO:0000266),1.0,-0.645184780552148,-0.985719288642084
2147,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),1.0,0.4560872118719183,1.0436003101874436
2148,cytoskeleton-dependent intracellular transport (GO:0030705),1.0,-0.45075323048329774,-0.6943074850833292
2149,cellular response to osmotic stress (GO:0071470),1.0,-0.5473057339815677,-0.8315776206567475
2150,mismatch repair (GO:0006298),1.0,-0.49270914477275757,-0.7676455865502122
2151,mitochondrial translational termination (GO:0070126),1.0,0.2826971967675036,0.5552776790323865
2152,adenine nucleotide transport (GO:0051503),1.0,-0.5669070182532626,-0.8758095486431823
2153,spliceosomal snRNP assembly (GO:0000387),1.0,-0.2950378146149911,-0.4647280369342519
2154,glucose 6-phosphate metabolic process (GO:0051156),1.0,-0.4900474650863372,-0.7635060104309007
2155,establishment of mitotic spindle localization (GO:0040001),1.0,-0.5315439634597683,-0.8314058410028673
2156,regulation of exocytosis (GO:0017157),1.0,-0.5786434345614135,-0.8968420465220326
2157,regulation of centrosome cycle (GO:0046605),1.0,-0.4098507490654242,-0.6235191631992512
2158,negative regulation of viral genome replication (GO:0045071),1.0,-0.6150917964716517,-0.9785944058669617
2159,proteasomal protein catabolic process (GO:0010498),1.0,-0.49263830787602236,-0.8041793402994861
2160,DNA metabolic process (GO:0006259),1.0,-0.4302888921028245,-0.7050272483865275
2161,mitotic cell cycle phase transition (GO:0044772),1.0,-0.3711976965598782,-0.6038133412734151
2162,insulin receptor signaling pathway (GO:0008286),1.0,-0.5429298608218981,-0.8676369869929337
2163,calcium ion import (GO:0070509),1.0,-0.5304916759182943,-0.8128490013153483
2164,smoothened signaling pathway (GO:0007224),1.0,-0.4820655633801263,-0.7425942534654841
2165,purine nucleotide metabolic process (GO:0006163),1.0,-0.5995959555873469,-0.9432619194260238
2166,intracellular protein transmembrane transport (GO:0065002),1.0,-0.357638963923388,-0.5765628438620329
2167,limb morphogenesis (GO:0035108),1.0,-0.6340152521841866,-0.9762102012725608
2168,glutamate receptor signaling pathway (GO:0007215),1.0,-0.5645023995753518,-0.8834323717638032
2169,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),1.0,-0.5053835719105877,-0.7943920052443378
2170,positive regulation of transcription of Notch receptor target (GO:0007221),1.0,-0.5882183888024822,-0.9032663398542234
2171,endoplasmic reticulum to cytosol transport (GO:1903513),1.0,-0.5503955431593652,-0.8176452374794356
2172,neuron projection organization (GO:0106027),1.0,-0.5758474996241131,-0.8814072401903541
2173,Golgi organization (GO:0007030),1.0,-0.581618212904095,-0.9478851398228014
2174,establishment of protein localization to mitochondrion (GO:0072655),1.0,-0.30908883112801566,-0.5023777929482058
2175,positive regulation of cation channel activity (GO:2001259),1.0,-0.6358407187301218,-0.9952062337888499
2176,GPI anchor metabolic process (GO:0006505),1.0,-0.40108843522690485,-0.6368071930449162
2177,regulation of nervous system process (GO:0031644),1.0,-0.6116215273474855,-0.935960813479391
2178,regulation of insulin receptor signaling pathway (GO:0046626),1.0,-0.59496086891925,-0.9426695603139017
2179,pore complex assembly (GO:0046931),1.0,-0.6239061960650902,-0.9618747581206092
2180,regulation of cholesterol transport (GO:0032374),1.0,-0.5861345988987329,-0.9117792638159222
2181,negative regulation of neuron projection development (GO:0010977),1.0,-0.38560181432892854,-0.6002449414370578
2182,positive regulation of mRNA catabolic process (GO:0061014),1.0,-0.4791582535962333,-0.7583439498317747
2183,"positive regulation of gene expression, epigenetic (GO:0045815)",1.0,-0.48994220204456607,-0.772643162754654
2184,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",1.0,-0.44093576439276927,-0.6634834598852878
2185,serine family amino acid metabolic process (GO:0009069),1.0,-0.6232695807358528,-0.9402873929370164
2186,midbody abscission (GO:0061952),1.0,-0.5108751417581914,-0.7870988428261299
2187,negative regulation of oxidative stress-induced cell death (GO:1903202),1.0,-0.5886698795559531,-0.9266689263457507
2188,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",1.0,-0.31938520597156994,-0.49843375490108194
2189,positive regulation of binding (GO:0051099),1.0,-0.4570477077166939,-0.7460757936666129
2190,histone H3 acetylation (GO:0043966),1.0,-0.5771789304823007,-0.9098994523475954
2191,negative regulation of phosphatase activity (GO:0010923),1.0,0.2527182007745011,0.723246415717856
2192,receptor catabolic process (GO:0032801),1.0,-0.5936593389226581,-0.9019146798646014
2193,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),1.0,-0.38059851830215924,-0.5766069050065016
2194,protein localization to microtubule organizing center (GO:1905508),1.0,-0.36917466843576485,-0.567854694713104
2195,phospholipid transport (GO:0015914),1.0,-0.514943331725281,-0.8226875623836045
2196,post-transcriptional gene silencing by RNA (GO:0035194),1.0,0.24923684014593106,0.5582115505285404
2197,intraciliary transport involved in cilium assembly (GO:0035735),1.0,-0.3273960622442706,-0.5244202948989007
2198,chromosome organization (GO:0051276),1.0,-0.5211624509543056,-0.837915400902045
2199,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),1.0,-0.4405927083879405,-0.6629024753598869
2200,cellular response to decreased oxygen levels (GO:0036294),1.0,-0.5833499407817014,-0.9325364677676988
2201,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1.0,-0.5476966451448116,-0.8705648264226219
2202,"nucleotide-excision repair, DNA gap filling (GO:0006297)",1.0,-0.41095770930603326,-0.6344651628717617
2203,axonemal dynein complex assembly (GO:0070286),1.0,-0.6398227573854928,-1.0009936816406713
2204,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),1.0,0.29715540993372536,0.3289877152779211
2205,DNA modification (GO:0006304),1.0,-0.508215752687247,-0.8143321606421209
2206,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",1.0,-0.4463887469601572,-0.7086963695634696
2207,translation (GO:0006412),1.0,-0.31804625007781245,-0.5241742892412112
2208,chromatin assembly (GO:0031497),1.0,-0.6178760328289957,-0.9998300225776137
2209,macromolecule catabolic process (GO:0009057),1.0,-0.5945458552246412,-0.9205327887936942
2210,snRNA 3'-end processing (GO:0034472),1.0,-0.5111647155665933,-0.7851120907953477
2211,regulation of cellular catabolic process (GO:0031329),1.0,-0.5360586761392367,-0.868796356497235
2212,negative regulation of endocytosis (GO:0045806),1.0,-0.5947765683786188,-0.9202565714453349
2213,RNA-dependent DNA biosynthetic process (GO:0006278),1.0,-0.5790258537269285,-0.9240069185306423
2214,membrane protein intracellular domain proteolysis (GO:0031293),1.0,-0.4608293658644451,-0.7131998180317332
2215,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),1.0,-0.555300814547984,-0.836769585611167
2216,epithelial to mesenchymal transition (GO:0001837),1.0,-0.5844489483248015,-0.9239171968951311
2217,regulation of protein modification by small protein conjugation or removal (GO:1903320),1.0,-0.5343217409046542,-0.8221359523158283
2218,mRNA transport (GO:0051028),1.0,-0.5497552069046041,-0.8881176306927524
2219,protein polymerization (GO:0051258),1.0,-0.5601637758571425,-0.9026253612829527
2220,telomere capping (GO:0016233),1.0,-0.5571614411171505,-0.8707436175342101
2221,"retrograde protein transport, ER to cytosol (GO:0030970)",1.0,-0.4794226337167873,-0.7205543626586548
2222,protein heterooligomerization (GO:0051291),1.0,-0.47762714096493925,-0.732248722889077
2223,nucleobase-containing small molecule interconversion (GO:0015949),1.0,-0.2760489025309641,-0.43601546409455405
2224,protein targeting to ER (GO:0045047),1.0,0.42706107906418705,1.0548264476014517
2225,positive regulation of microtubule polymerization (GO:0031116),1.0,-0.5871686571863541,-0.920188507314424
2226,protein targeting to mitochondrion (GO:0006626),1.0,-0.2450625205685679,-0.3993243523081977
2227,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",1.0,-0.48274486206001094,-0.7510736582408485
2228,mRNA metabolic process (GO:0016071),1.0,-0.47889853629942913,-0.7779536967222079
2229,regulation of neuron differentiation (GO:0045664),1.0,-0.38052663477464665,-0.6115269899272041
2230,rRNA methylation (GO:0031167),1.0,0.24445271779597905,0.6082406477417364
2231,glycolipid biosynthetic process (GO:0009247),1.0,-0.5583973159075544,-0.8703396863075812
2232,regulation of NMDA receptor activity (GO:2000310),1.0,-0.5118929451434775,-0.8001158829750431
2233,translesion synthesis (GO:0019985),1.0,-0.4119269798787738,-0.6487363781066415
2234,ion homeostasis (GO:0050801),1.0,-0.4151758509091887,-0.65068669308514
2235,regulation of rRNA processing (GO:2000232),1.0,-0.4775665108184901,-0.7250183970156405
2236,aminoglycan biosynthetic process (GO:0006023),1.0,-0.53684205992599,-0.8555790724308625
2237,organelle organization (GO:0006996),1.0,-0.5439620131343045,-0.9001005399697201
2238,actin filament polymerization (GO:0030041),1.0,-0.6066553558826149,-0.9485408563482012
2239,negative regulation of fatty acid metabolic process (GO:0045922),1.0,-0.5846878423598817,-0.8685996424025846
2240,positive regulation of cell projection organization (GO:0031346),1.0,-0.3953775125033897,-0.6398451884209191
2241,inositol phosphate metabolic process (GO:0043647),1.0,-0.5965827121342218,-0.9426556590172964
2242,retrograde axonal transport (GO:0008090),1.0,-0.4749550694563125,-0.7238507154868565
2243,fatty acid biosynthetic process (GO:0006633),1.0,-0.5444939079531305,-0.8750051993485509
2244,organic cyclic compound biosynthetic process (GO:1901362),1.0,-0.638785235819571,-0.9953791306030539
2245,transport across blood-brain barrier (GO:0150104),1.0,-0.5739378531787307,-0.9264755249921286
2246,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",1.0,-0.5386579979484656,-0.842659038698984
2247,Notch signaling pathway (GO:0007219),1.0,-0.5651191255177379,-0.9027403628076386
2248,positive regulation of transcription by RNA polymerase I (GO:0045943),1.0,-0.5427248789666557,-0.8336917236209971
2249,regulation of cellular protein metabolic process (GO:0032268),1.0,-0.4786123593927729,-0.751419971720953
2250,"chemical synaptic transmission, postsynaptic (GO:0099565)",1.0,-0.5252484367710092,-0.8158671866548607
2251,glycoprotein metabolic process (GO:0009100),1.0,-0.5995134649480554,-0.9475663422374314
2252,cell-cell junction organization (GO:0045216),1.0,-0.56504578727667,-0.9049575118211747
2253,tRNA processing (GO:0008033),1.0,0.3124161073825503,0.7519699246876625
2254,mitotic sister chromatid cohesion (GO:0007064),1.0,0.41172018323923143,1.023883723216547
2255,"regulation of synaptic transmission, glutamatergic (GO:0051966)",1.0,-0.5989858933600047,-0.9480388791542408
2256,determination of bilateral symmetry (GO:0009855),1.0,-0.6330058028467924,-0.978399377934271
2257,cellular response to topologically incorrect protein (GO:0035967),1.0,-0.4047423348750704,-0.6409504774842766
2258,positive regulation of neurogenesis (GO:0050769),1.0,-0.532376160115754,-0.859893013121454
2259,ubiquinone metabolic process (GO:0006743),1.0,-0.5396925031658757,-0.8246337222507344
2260,regulation of epidermal cell differentiation (GO:0045604),1.0,-0.6264107030648561,-0.956989218381295
2261,glycogen catabolic process (GO:0005980),1.0,-0.46904246888882034,-0.6928614028767616
2262,transcription by RNA polymerase I (GO:0006360),1.0,-0.36934634062169147,-0.5837768941775919
2263,triglyceride homeostasis (GO:0070328),1.0,-0.5533916726176766,-0.8753329942147411
2264,mitotic nuclear division (GO:0140014),1.0,0.23107911522250002,0.5919233143165986
2265,regulation of cell junction assembly (GO:1901888),1.0,-0.6163237010010298,-0.933714280353311
2266,protein transport (GO:0015031),1.0,-0.5539598933236042,-0.9080496066664527
2267,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1.0,-0.5002991341574132,-0.8116044599824619
2268,fatty acid beta-oxidation (GO:0006635),1.0,-0.4955056261474319,-0.7859989935512901
2269,positive regulation of DNA recombination (GO:0045911),1.0,-0.6064496177214119,-0.930456265901455
2270,photoperiodism (GO:0009648),1.0,-0.44610505695147584,-0.7203976303876928
2271,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),1.0,-0.36443875396349723,-0.5544963929825394
2272,positive regulation of immunoglobulin mediated immune response (GO:0002891),1.0,-0.4896066992369869,-0.7367412598460074
2273,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),1.0,-0.5686472107849555,-0.920806856945222
2274,aminoglycan catabolic process (GO:0006026),1.0,-0.6090624495963206,-0.9485060109640282
2275,positive regulation of histone H3-K4 methylation (GO:0051571),1.0,-0.4955345770703887,-0.7376838372332762
2276,negative regulation of platelet activation (GO:0010544),1.0,-0.5487875532896124,-0.834117635517377
2277,organelle transport along microtubule (GO:0072384),1.0,-0.5333273101918292,-0.8371908729982852
2278,negative regulation of mRNA catabolic process (GO:1902373),1.0,-0.5520652834020361,-0.8592655158484274
2279,establishment or maintenance of apical/basal cell polarity (GO:0035088),1.0,-0.4332334710455936,-0.6572754187061678
2280,regulation of mRNA processing (GO:0050684),1.0,-0.3136735687585057,-0.4910692829968927
2281,cellular response to peptide hormone stimulus (GO:0071375),1.0,-0.6153189257537385,-0.9821128094519418
2282,regulation of neuron projection development (GO:0010975),1.0,-0.4357468054912056,-0.701608038391339
2283,phospholipid translocation (GO:0045332),1.0,-0.6389894573801045,-0.9854310133363299
2284,cellular response to glucose starvation (GO:0042149),1.0,-0.5002402619885465,-0.8010148624584417
2285,protein depolymerization (GO:0051261),1.0,0.46413712316863814,1.1218048194490464
2286,negative regulation of biosynthetic process (GO:0009890),1.0,-0.6269622668114536,-0.967714312613643
2287,histone lysine demethylation (GO:0070076),1.0,0.2988131094927816,0.5623128692715651
2288,diol biosynthetic process (GO:0034312),1.0,-0.5748478396267416,-0.8908672709011377
2289,melanosome transport (GO:0032402),1.0,-0.36356548504541397,-0.5551484898593144
2290,negative regulation of chemotaxis (GO:0050922),1.0,-0.5826500743910712,-0.9109413028879179
2291,regulation of cardiac muscle cell proliferation (GO:0060043),1.0,-0.5875615857907918,-0.9091193032961931
2292,positive regulation of proteolysis (GO:0045862),1.0,-0.6162004359874527,-0.9861373294332613
2293,regulation of actin filament-based process (GO:0032970),1.0,-0.6140475002183072,-0.994141376460641
2294,RNA destabilization (GO:0050779),1.0,0.29697736748064313,0.6521445532924731
2295,negative regulation of transferase activity (GO:0051348),1.0,-0.27537770816440876,-0.4316150169563525
2296,mitochondrial translational elongation (GO:0070125),1.0,0.2779945036441273,0.5826285054675377
2297,double-strand break repair via homologous recombination (GO:0000724),1.0,-0.3232486225439552,-0.5220397916252262
2298,response to UV (GO:0009411),1.0,-0.5603575138404453,-0.91754499322179
2299,positive regulation of cell differentiation (GO:0045597),1.0,-0.6130489955206356,-0.9980490595824391
2300,regulation of cardiac muscle hypertrophy (GO:0010611),1.0,-0.6532096239496453,-0.9959301689964514
2301,"RNA splicing, via transesterification reactions (GO:0000375)",1.0,-0.45527417138487913,-0.7149122718162202
2302,regulation of intracellular pH (GO:0051453),1.0,-0.5627321879668518,-0.8886392640991183
2303,response to organophosphorus (GO:0046683),1.0,-0.5141183666456638,-0.7865109546469385
2304,positive regulation of axon extension (GO:0045773),1.0,-0.5010519322039129,-0.769879624733183
2305,dendritic spine organization (GO:0097061),1.0,-0.573385357191235,-0.8865451643157274
2306,regulation of ion transport (GO:0043269),1.0,-0.5067001581708103,-0.7997438590919583
2307,tRNA export from nucleus (GO:0006409),1.0,0.32523837902264596,0.95052526333041
2308,homologous chromosome segregation (GO:0045143),1.0,-0.564691046170255,-0.856337676949514
2309,negative regulation of mitotic cell cycle (GO:0045930),1.0,-0.6253979553149458,-0.9833044957615666
2310,cellular response to retinoic acid (GO:0071300),1.0,-0.5612599650482866,-0.8735810504295385
2311,calcium-ion regulated exocytosis (GO:0017156),1.0,-0.5868637128941157,-0.9116371572476858
2312,actin filament organization (GO:0007015),1.0,-0.5625106777933748,-0.9179045918436991
2313,regulation of protein-containing complex assembly (GO:0043254),1.0,-0.5989955366927177,-0.9664868240734457
2314,cilium assembly (GO:0060271),1.0,-0.4137622661103318,-0.6765757379981209
2315,neuromuscular process (GO:0050905),1.0,-0.5231483580648137,-0.8092567031609645
2316,translational termination (GO:0006415),1.0,0.2678496659407147,0.5305349127665353
2317,regulation of cardiac conduction (GO:1903779),1.0,-0.41528174825907144,-0.6592934849538186
2318,regulation of mitotic spindle assembly (GO:1901673),1.0,-0.45837333087088994,-0.6929200718884317
2319,signal release from synapse (GO:0099643),1.0,-0.5625949383942584,-0.8704767377867555
2320,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1.0,-0.4584019128964847,-0.7168590604563405
2321,negative regulation of cellular amide metabolic process (GO:0034249),1.0,-0.4818389787194475,-0.7907530000391699
2322,positive regulation of Wnt signaling pathway (GO:0030177),1.0,-0.5104662197827332,-0.8315213017566093
2323,protein modification by small protein conjugation (GO:0032446),1.0,-0.5153682525479231,-0.8475220734381345
2324,regulation of muscle contraction (GO:0006937),1.0,-0.5257331091138989,-0.8374031875746503
2325,regulation of synapse organization (GO:0050807),1.0,-0.5497279604880908,-0.832686427912769
2326,DNA duplex unwinding (GO:0032508),1.0,-0.5359110476068742,-0.8432431003541264
2327,cation transmembrane transport (GO:0098655),1.0,-0.5494583314042365,-0.8622886799139657
2328,cellular macromolecule biosynthetic process (GO:0034645),1.0,-0.37709035650386935,-0.6262394254967805
2329,negative regulation of response to wounding (GO:1903035),1.0,-0.5310620849049418,-0.8140535637382135
2330,mitochondrion localization (GO:0051646),1.0,-0.4219346425401366,-0.6432832496984187
2331,"nucleotide-excision repair, DNA incision (GO:0033683)",1.0,-0.3361755348087132,-0.522242347492109
2332,mitotic cytokinesis (GO:0000281),1.0,-0.38779342716050524,-0.6157059727797491
2333,inorganic anion transmembrane transport (GO:0098661),1.0,-0.5982452037237049,-0.9628690416512155
2334,barbed-end actin filament capping (GO:0051016),1.0,-0.6184590527317207,-0.964068793256404
2335,ribosome assembly (GO:0042255),1.0,-0.45360697434413816,-0.7111348754616437
2336,presynaptic endocytosis (GO:0140238),1.0,-0.4225068068599409,-0.6732078539862374
2337,negative regulation of RNA splicing (GO:0033119),1.0,-0.5321654296555147,-0.8340106164035392
2338,male gonad development (GO:0008584),1.0,-0.5781027004575705,-0.9081048629476465
2339,regulation of water loss via skin (GO:0033561),1.0,-0.6548622990912046,-0.9854817756895116
2340,protein secretion (GO:0009306),1.0,-0.6189152962102767,-0.9584669829088595
2341,ncRNA catabolic process (GO:0034661),1.0,-0.3073921263874601,-0.47275402051974424
2342,regulation of phosphoprotein phosphatase activity (GO:0043666),1.0,-0.5566897520966256,-0.8741480402972455
2343,protein ubiquitination (GO:0016567),1.0,-0.4858116897857595,-0.8013717669265384
2344,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),1.0,-0.40321007338130604,-0.6108268583108274
2345,axon development (GO:0061564),1.0,-0.39381973481016386,-0.6216865677466014
2346,postreplication repair (GO:0006301),1.0,-0.41522917500221146,-0.6554672322132624
2347,regulation of developmental growth (GO:0048638),1.0,-0.5314045940361002,-0.8282212415887062
2348,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),1.0,-0.5328060843180051,-0.839209448560534
2349,regulation of smooth muscle contraction (GO:0006940),1.0,-0.5822173030462838,-0.9163434702317392
2350,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1.0,-0.4277422835277792,-0.6785975172518334
2351,ATP-dependent chromatin remodeling (GO:0043044),1.0,-0.3524815684604679,-0.556390413716303
2352,vascular transport (GO:0010232),1.0,-0.5643994382979849,-0.9124049903182261
2353,regulation of TORC1 signaling (GO:1903432),1.0,-0.4497091654357884,-0.7021649924681967
2354,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",1.0,-0.2951096442314509,-0.4781823409768773
2355,intracellular protein transport (GO:0006886),1.0,-0.5147571392053197,-0.8442602923041942
2356,protein polyubiquitination (GO:0000209),1.0,-0.4769024197107688,-0.7877750777488373
2357,negative regulation of transposition (GO:0010529),1.0,-0.5870846331743869,-0.9055804457970663
2358,negative regulation of macroautophagy (GO:0016242),1.0,-0.5878083304744999,-0.9121164579892376
2359,protein localization to chromosome (GO:0034502),1.0,-0.42372020646920094,-0.6669965586379739
2360,G1/S transition of mitotic cell cycle (GO:0000082),1.0,-0.5030110824046592,-0.8032927821927968
2361,snRNA metabolic process (GO:0016073),1.0,-0.6156212692710425,-0.942189362995763
2362,regulation of type I interferon-mediated signaling pathway (GO:0060338),1.0,-0.5509136228925549,-0.8638650848901578
2363,membrane assembly (GO:0071709),1.0,0.5788434095177374,0.7929240822913324
2364,regulation of steroid metabolic process (GO:0019218),1.0,-0.453299584037914,-0.6773791758393121
2365,mitotic G2/M transition checkpoint (GO:0044818),1.0,-0.501565500671366,-0.802610059273693
2366,DNA biosynthetic process (GO:0071897),1.0,-0.3972435557930621,-0.6058609639495739
2367,regulation of autophagy of mitochondrion (GO:1903146),1.0,-0.6024093926947318,-0.9429730005078371
2368,positive regulation of exocytosis (GO:0045921),1.0,-0.6178847808399384,-0.9581158261377265
2369,regulation of p38MAPK cascade (GO:1900744),1.0,-0.5710657853876345,-0.8999097718367028
2370,response to ketone (GO:1901654),1.0,-0.5959313009267552,-0.9359552082747365
2371,glial cell development (GO:0021782),1.0,-0.5874217213195052,-0.9094635497921189
2372,negative regulation of cellular metabolic process (GO:0031324),1.0,-0.6228913185349414,-0.9965191958809931
2373,digestive tract morphogenesis (GO:0048546),1.0,-0.5571034221196697,-0.8537042424416091
2374,transition metal ion homeostasis (GO:0055076),1.0,-0.6299949618096817,-1.0014270031063734
2375,ubiquitin-dependent protein catabolic process (GO:0006511),1.0,-0.4587736190488052,-0.7536758661578593
2376,inner ear morphogenesis (GO:0042472),1.0,-0.569673036041881,-0.8775570976040971
2377,dephosphorylation (GO:0016311),1.0,-0.5435642722263649,-0.8924905469194592
2378,activation of GTPase activity (GO:0090630),1.0,-0.602338791900689,-0.9711848992443025
2379,regulation of stem cell population maintenance (GO:2000036),1.0,-0.4995869185086693,-0.7575638702749024
2380,multivesicular body organization (GO:0036257),1.0,-0.3161869834130219,-0.49355665704565155
2381,cellular response to hormone stimulus (GO:0032870),1.0,-0.5716559792789918,-0.9181718561239698
2382,nitric oxide biosynthetic process (GO:0006809),1.0,-0.6507890867465183,-0.9910043443455211
2383,anterograde synaptic vesicle transport (GO:0048490),1.0,0.4067636530650275,0.7426343359379103
2384,negative regulation of transport (GO:0051051),1.0,-0.6188064912484342,-0.9814021429288553
2385,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",1.0,-0.5023546130357699,-0.7602846780623372
2386,"synaptic transmission, glutamatergic (GO:0035249)",1.0,-0.6558923779180794,-1.0015825138787773
2387,positive regulation of protein metabolic process (GO:0051247),1.0,-0.58865070730892,-0.9590934615301371
2388,regulation of epithelial cell migration (GO:0010632),1.0,-0.6009495941054883,-0.9420303978948719
2389,protein lipidation (GO:0006497),1.0,-0.2957280431384659,-0.4792093782780117
2390,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),1.0,-0.6123033704611501,-0.9502937978808972
2391,dicarboxylic acid metabolic process (GO:0043648),1.0,-0.5945255054350616,-0.9492802440859903
2392,positive regulation of RNA splicing (GO:0033120),1.0,0.2624562448797199,0.40756735819203405
2393,COPII vesicle coating (GO:0048208),1.0,-0.5920470247058477,-0.9643613954703678
2394,axonogenesis (GO:0007409),1.0,-0.48323189022142427,-0.783100638585753
2395,atrioventricular valve morphogenesis (GO:0003181),1.0,-0.3876531299679547,-0.582438089409195
2396,peptidyl-lysine dimethylation (GO:0018027),1.0,-0.5561901556467331,-0.8527983013520419
2397,regulation of TOR signaling (GO:0032006),1.0,-0.4924160680771404,-0.7903777952688984
2398,cellular respiration (GO:0045333),1.0,-0.3199511584396626,-0.5074742463485932
2399,regulation of cellular response to stress (GO:0080135),1.0,-0.5200428185088388,-0.8432188103282233
2400,organelle fission (GO:0048285),1.0,-0.5665464494772023,-0.8875720769231484
2401,positive regulation of cellular amide metabolic process (GO:0034250),1.0,-0.5876867280329386,-0.9636583507348649
2402,regulation of cation channel activity (GO:2001257),1.0,-0.5208866086144138,-0.8231411341588132
2403,small GTPase mediated signal transduction (GO:0007264),1.0,-0.5798286013313405,-0.9385635699027944
2404,ubiquitin-dependent ERAD pathway (GO:0030433),1.0,-0.3560867021665431,-0.5701606597043527
2405,calcium ion import into cytosol (GO:1902656),1.0,-0.6529606568666662,-0.9859467058617938
2406,selective autophagy (GO:0061912),1.0,-0.5253461574698796,-0.8424880734789016
2407,regulation of synaptic vesicle exocytosis (GO:2000300),1.0,-0.304300830648558,-0.45897631397051214
2408,oligosaccharide biosynthetic process (GO:0009312),1.0,-0.5737427076195964,-0.867006097384951
2409,regulation of neuron migration (GO:2001222),1.0,-0.47611148697407674,-0.7297095764739712
2410,clathrin coat assembly (GO:0048268),1.0,-0.43697167511058055,-0.6611425465599077
2411,Golgi to endosome transport (GO:0006895),1.0,-0.4027686606750204,-0.6340174048684338
2412,embryonic organ development (GO:0048568),1.0,-0.630428002819389,-0.9944913866470059
2413,mesoderm formation (GO:0001707),1.0,-0.622577987467521,-0.9578912751410217
2414,chromosome condensation (GO:0030261),1.0,-0.561723747533381,-0.8907982898082678
2415,base-excision repair (GO:0006284),1.0,-0.47384165732643924,-0.7496462260578899
2416,modulation of excitatory postsynaptic potential (GO:0098815),1.0,-0.5596921071757252,-0.8569481426429937
2417,DNA methylation (GO:0006306),1.0,-0.38128030727663975,-0.5941696276430153
2418,regulation of telomere maintenance via telomerase (GO:0032210),1.0,-0.38249651844567434,-0.6158664445821532
2419,lamellipodium assembly (GO:0030032),1.0,-0.6372392031509757,-0.9772328050549084
2420,cellular response to nerve growth factor stimulus (GO:1990090),1.0,-0.3766372785773864,-0.5791204162448674
2421,regulation of epithelial cell differentiation (GO:0030856),1.0,-0.6118050367963782,-0.9537981179599824
2422,nucleobase-containing small molecule catabolic process (GO:0034656),1.0,-0.6336041980685988,-0.9703307897366036
2423,porphyrin-containing compound biosynthetic process (GO:0006779),1.0,-0.5358818274606008,-0.8439555195883147
2424,negative regulation of TOR signaling (GO:0032007),1.0,-0.42284385235839683,-0.6687236186467402
2425,triglyceride metabolic process (GO:0006641),1.0,-0.6037397962672033,-0.9548874385600709
2426,double-strand break repair (GO:0006302),1.0,-0.3395031241794704,-0.5485082109569955
2427,negative regulation of mRNA processing (GO:0050686),1.0,-0.5714719618931021,-0.8781041768046903
2428,mitotic spindle organization (GO:0007052),1.0,-0.31662234064830025,-0.5151628641903677
2429,DNA replication initiation (GO:0006270),1.0,-0.32774835125632806,-0.517931905175571
2430,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1.0,-0.5470094563347386,-0.876750876352017
2431,protein import (GO:0017038),1.0,-0.4319471331241135,-0.6934719075696848
2432,negative regulation of kinase activity (GO:0033673),1.0,-0.5403564993559844,-0.880860380098994
2433,regulation of dopamine secretion (GO:0014059),1.0,-0.5691625987459565,-0.858596996651607
2434,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),1.0,-0.6071035510950753,-0.9735497485461925
2435,regulation of calcium ion-dependent exocytosis (GO:0017158),1.0,-0.5832323658993591,-0.9163463824640571
2436,resolution of meiotic recombination intermediates (GO:0000712),1.0,-0.3228741144740652,-0.49744962414351895
2437,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),1.0,-0.5884588428607707,-0.9254988096157127
2438,nuclear membrane organization (GO:0071763),1.0,-0.4435161259295489,-0.6962170233492888
2439,protein monoubiquitination (GO:0006513),1.0,-0.39826257656976083,-0.638149222285434
2440,regulation of transmembrane transport (GO:0034762),1.0,-0.49510196082586516,-0.7539307147407583
2441,negative regulation of neuron differentiation (GO:0045665),1.0,-0.6195651741481274,-0.9771512900663768
2442,mRNA destabilization (GO:0061157),1.0,-0.5186208163995799,-0.8227361180673148
2443,cellular response to UV (GO:0034644),1.0,-0.588492660897873,-0.9528718192039727
2444,response to amino acid (GO:0043200),1.0,-0.5870174350923922,-0.9238432374240207
2445,"synaptic transmission, cholinergic (GO:0007271)",1.0,-0.5042902643666356,-0.7630543724254596
2446,peptidyl-threonine phosphorylation (GO:0018107),1.0,-0.49602033217503116,-0.7889746740092959
2447,synaptic vesicle cycle (GO:0099504),1.0,-0.589243943645549,-0.90725942206011
2448,gene silencing by miRNA (GO:0035195),1.0,-0.5722681834815295,-0.9087834495694086
2449,transferrin transport (GO:0033572),1.0,-0.5231860180393522,-0.8189440662247298
2450,cell junction assembly (GO:0034329),1.0,-0.52544663430731,-0.8538645428819163
2451,regulation of ion transmembrane transporter activity (GO:0032412),1.0,-0.5381180161044452,-0.8376376707063694
2452,positive regulation of developmental process (GO:0051094),1.0,-0.4908139171557366,-0.8010545071681172
2453,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),1.0,-0.6071530512630133,-0.9657263743466539
2454,presynapse assembly (GO:0099054),1.0,0.27629574266013557,0.41109696931418727
2455,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),1.0,-0.2342567693052345,-0.3527513794982216
2456,phospholipid dephosphorylation (GO:0046839),1.0,-0.5211041095763401,-0.8306194455094351
2457,regulation of neuronal synaptic plasticity (GO:0048168),1.0,-0.32180659632935915,-0.4945720522988669
2458,regulation of double-strand break repair via homologous recombination (GO:0010569),1.0,-0.6273887084548624,-0.9943465614299232
2459,protein ADP-ribosylation (GO:0006471),1.0,-0.525467799022131,-0.829681215386388
2460,regulation of catecholamine secretion (GO:0050433),1.0,-0.5933232162655361,-0.9057573714953401
2461,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),1.0,-0.6193990266586265,-0.9627843588953288
2462,mitotic G2 DNA damage checkpoint signaling (GO:0007095),1.0,-0.4964836088378523,-0.7891214990115346
2463,cardiac myofibril assembly (GO:0055003),1.0,-0.5607706896080917,-0.8525745884232656
2464,3'-UTR-mediated mRNA destabilization (GO:0061158),1.0,-0.5900716918743826,-0.8817256398123716
2465,positive regulation of nucleic acid-templated transcription (GO:1903508),1.0,-0.5565503768941843,-0.9166062501043812
2466,protein K63-linked deubiquitination (GO:0070536),1.0,-0.5913106039418081,-0.9188521677657362
2467,post-translational protein modification (GO:0043687),1.0,-0.5621858456558843,-0.9234388911681607
2468,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),1.0,-0.527541555853914,-0.8297014718749139
2469,lipid translocation (GO:0034204),1.0,-0.5972207257208781,-0.9234390542780819
2470,cell cycle G1/S phase transition (GO:0044843),1.0,-0.4783584245570283,-0.7557442386804525
2471,cellular response to arsenic-containing substance (GO:0071243),1.0,-0.521292556585214,-0.8013170252966679
2472,regulation of glucose import (GO:0046324),1.0,-0.5951093410820433,-0.9389561906478238
2473,positive regulation of microtubule polymerization or depolymerization (GO:0031112),1.0,-0.3612398519412607,-0.5658810442173589
2474,transforming growth factor beta receptor signaling pathway (GO:0007179),1.0,-0.5102121895575273,-0.8208682012486496
2475,regulation of rhodopsin mediated signaling pathway (GO:0022400),1.0,-0.6141774787926123,-0.9433413845531177
2476,regulation of centrosome duplication (GO:0010824),1.0,-0.4497181572980079,-0.6941706807271134
2477,neurotransmitter transport (GO:0006836),1.0,-0.46181555524104523,-0.7353556307508713
2478,wound healing (GO:0042060),1.0,-0.5727073035694978,-0.9026048048357471
2479,rRNA processing (GO:0006364),1.0,-0.33417887335380814,-0.5406663748240217
2480,peroxisome organization (GO:0007031),1.0,-0.5204333459030798,-0.8281589734359092
2481,DNA repair (GO:0006281),1.0,-0.339793928087269,-0.5521569930408964
2482,potassium ion import across plasma membrane (GO:1990573),1.0,-0.44536382720469514,-0.7070683622206851
2483,regulation of translation (GO:0006417),1.0,-0.4886590181434195,-0.7982545970912237
2484,cellular response to transforming growth factor beta stimulus (GO:0071560),1.0,-0.5730007981588163,-0.9253002609066227
2485,regulation of G0 to G1 transition (GO:0070316),1.0,-0.35335727888684604,-0.5642567168369345
2486,polyol metabolic process (GO:0019751),1.0,-0.577807815009915,-0.9117126423079567
2487,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),1.0,-0.2478701913354852,-0.3937064841445686
2488,glycogen metabolic process (GO:0005977),1.0,-0.3976951800063724,-0.6151975147821321
2489,phosphorylation (GO:0016310),1.0,-0.606940062370719,-1.0012215379390528
2490,mitotic cell cycle checkpoint signaling (GO:0007093),1.0,-0.5688514844915438,-0.9048864698795539
2491,regulation of mRNA catabolic process (GO:0061013),1.0,-0.40864602930153987,-0.6704066044571549
2492,mitotic cytokinetic process (GO:1902410),1.0,-0.3491029052548521,-0.5435640446247476
2493,melanosome localization (GO:0032400),1.0,-0.33336671213211394,-0.5105752987786699
2494,negative regulation of telomere maintenance via telomerase (GO:0032211),1.0,-0.298592718562668,-0.46657052775363683
2495,regulation of protein targeting to mitochondrion (GO:1903214),1.0,-0.6113419254751536,-0.9630263601580165
2496,negative regulation of smoothened signaling pathway (GO:0045879),1.0,-0.5112633871715278,-0.787148951782789
2497,supramolecular fiber organization (GO:0097435),1.0,-0.5339679726027081,-0.8816552223141462
2498,negative regulation of signal transduction in absence of ligand (GO:1901099),1.0,-0.649323026667279,-0.9942695484290994
2499,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",1.0,-0.47470847899385515,-0.7577296522580189
2500,positive regulation of protein tyrosine kinase activity (GO:0061098),1.0,-0.6279546256759971,-0.9950789736990182
2501,'de novo' posttranslational protein folding (GO:0051084),1.0,0.2988343078470075,0.5360438031104046
2502,double-strand break repair via nonhomologous end joining (GO:0006303),1.0,-0.3491662893935403,-0.5499763621383984
2503,maintenance of protein localization in organelle (GO:0072595),1.0,-0.6058676445360272,-0.9150953632063946
2504,negative regulation of reproductive process (GO:2000242),1.0,-0.6583459159143463,-0.9990694712920428
2505,regulation of clathrin-dependent endocytosis (GO:2000369),1.0,-0.5626421758276127,-0.8409045638347081
2506,regulation of cell cycle (GO:0051726),1.0,-0.6084480752783687,-0.9974751487336738
2507,positive regulation of TORC1 signaling (GO:1904263),1.0,-0.29773185819607756,-0.4487395801004709
2508,termination of RNA polymerase I transcription (GO:0006363),1.0,-0.33131262704846454,-0.5209609076686028
2509,positive regulation of ubiquitin-protein transferase activity (GO:0051443),1.0,-0.2938325482136851,-0.46260102096421146
2510,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),1.0,-0.4711911155367235,-0.7121442458993723
2511,autophagy of mitochondrion (GO:0000422),1.0,-0.38585235353190833,-0.6259702347930446
2512,regulation of hippo signaling (GO:0035330),1.0,0.3069580007519919,0.6805899985141669
2513,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",1.0,-0.612216271436346,-0.9907597576822945
2514,regulation of cardiac muscle cell contraction (GO:0086004),1.0,0.4577084069677192,0.8939827516077519
2515,phosphatidylcholine biosynthetic process (GO:0006656),1.0,-0.4874042820658603,-0.7538885990309857
2516,regulation of cellular amide metabolic process (GO:0034248),1.0,-0.5393437325879578,-0.8322957815675174
2517,protein acetylation (GO:0006473),1.0,-0.5120256885106446,-0.8134607498999897
2518,protein deacylation (GO:0035601),1.0,-0.29999990284813877,-0.45645523035525704
2519,cell-cell junction assembly (GO:0007043),1.0,-0.5700492923734147,-0.9087034675952355
2520,nitric oxide mediated signal transduction (GO:0007263),1.0,-0.6323145847099805,-0.9817634582197119
2521,RNA 3'-end processing (GO:0031123),1.0,-0.32114432521206726,-0.5161909236975245
2522,regulation of spindle organization (GO:0090224),1.0,-0.5858203693078677,-0.9086949829677156
2523,negative regulation of proteasomal protein catabolic process (GO:1901799),1.0,-0.4043674509791012,-0.6415235270219778
2524,N-terminal protein amino acid acetylation (GO:0006474),1.0,-0.3383381153256097,-0.5095860775427289
2525,embryonic cranial skeleton morphogenesis (GO:0048701),1.0,-0.5271566643310598,-0.8045003386726834
2526,non-canonical Wnt signaling pathway (GO:0035567),1.0,-0.3678828284228447,-0.5959862737088654
2527,energy reserve metabolic process (GO:0006112),1.0,-0.6315165269594702,-0.9837130574478363
2528,amide biosynthetic process (GO:0043604),1.0,-0.5812934812858341,-0.9194933107910634
2529,mitochondrial calcium ion homeostasis (GO:0051560),1.0,-0.6347457476287962,-0.9753461496572887
2530,embryonic heart tube morphogenesis (GO:0003143),1.0,-0.5997076398175794,-0.9191403993607222
2531,regulation of vacuole organization (GO:0044088),1.0,0.42980831699907296,0.9178195071246854
2532,regulation of AMPA receptor activity (GO:2000311),1.0,-0.5970385122107377,-0.9195769194547685
2533,protein acylation (GO:0043543),1.0,-0.4109249259489868,-0.6545276870366779
2534,positive regulation of cilium assembly (GO:0045724),1.0,-0.3888575792898127,-0.594843510097783
2535,regulation of signal transduction (GO:0009966),1.0,-0.5665561375030118,-0.9307664026897546
2536,glycoprotein biosynthetic process (GO:0009101),1.0,-0.5942872727284847,-0.9505843198038499
2537,regulation of cellular component organization (GO:0051128),1.0,-0.5122819252285696,-0.8273271353589371
2538,regulation of double-strand break repair (GO:2000779),1.0,-0.5275266968809705,-0.8242091198079293
2539,mRNA export from nucleus (GO:0006406),1.0,-0.5463402193690823,-0.8853215670942983
2540,axon extension (GO:0048675),1.0,0.38791298171452526,0.6716270276055595
2541,neuron projection morphogenesis (GO:0048812),1.0,-0.515199740665878,-0.8318499970872195
2542,negative regulation of translation (GO:0017148),1.0,-0.5067997331938239,-0.8330822565644843
2543,protein stabilization (GO:0050821),1.0,-0.5857694798556279,-0.9618266439122163
2544,regulation of gene silencing by miRNA (GO:0060964),1.0,-0.4204567887953152,-0.6778109829518911
2545,response to reactive oxygen species (GO:0000302),1.0,-0.5704257804169601,-0.9154633342694319
2546,reverse cholesterol transport (GO:0043691),1.0,0.3846033883242243,0.8877850961834884
2547,regulation of potassium ion transmembrane transport (GO:1901379),1.0,-0.5551353912336753,-0.8765339106852009
2548,mitochondrial gene expression (GO:0140053),1.0,-0.418800343244519,-0.6456318573102917
2549,regulation of cellular component biogenesis (GO:0044087),1.0,-0.5590135533678614,-0.8674635901905492
2550,RNA methylation (GO:0001510),1.0,-0.3581722641118788,-0.5621837864322212
2551,RNA export from nucleus (GO:0006405),1.0,-0.5132948913682696,-0.830525817898372
2552,microtubule bundle formation (GO:0001578),1.0,-0.41423247611237257,-0.6587000736435218
2553,positive regulation of telomere maintenance (GO:0032206),1.0,-0.3717886830877137,-0.592570166038085
2554,protein localization to endoplasmic reticulum (GO:0070972),1.0,-0.6408155702463891,-0.9697586001311226
2555,membrane lipid biosynthetic process (GO:0046467),1.0,-0.459523897579787,-0.735439467978406
2556,protein localization to cell junction (GO:1902414),1.0,0.3895251338598907,1.0419237880403232
2557,nucleic acid phosphodiester bond hydrolysis (GO:0090305),1.0,-0.6037572749920441,-0.9574559856169844
2558,response to light stimulus (GO:0009416),1.0,-0.5487784416337771,-0.8740239265004495
2559,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),1.0,-0.5739432819495818,-0.8943896388389433
2560,positive regulation of p38MAPK cascade (GO:1900745),1.0,-0.44560397921467737,-0.6914666480629555
2561,cholesterol homeostasis (GO:0042632),1.0,-0.5608127450386979,-0.9115031002604351
2562,regulation of gene silencing by RNA (GO:0060966),1.0,-0.42135449288825344,-0.6769540993378974
2563,neural crest cell development (GO:0014032),1.0,-0.3133459142113381,-0.4920668961585101
2564,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1.0,-0.4427546652311518,-0.7080724189774213
2565,protein deubiquitination (GO:0016579),1.0,-0.4637304731179723,-0.7629668873876081
2566,peptidyl-glutamic acid modification (GO:0018200),1.0,-0.5603700116583457,-0.8747920081822795
2567,regulation of aerobic respiration (GO:1903715),1.0,0.3743630513867001,0.8176149225596574
2568,stress granule assembly (GO:0034063),1.0,0.30574789665698754,0.6193911309986534
2569,positive regulation of DNA repair (GO:0045739),1.0,-0.4911819670107233,-0.7738800936587744
2570,fatty acid transport (GO:0015908),1.0,-0.5322307443389215,-0.8113394079509749
2571,regulation of DNA recombination at telomere (GO:0072695),1.0,-0.5489193089744472,-0.8604829250927613
2572,rRNA catabolic process (GO:0016075),1.0,-0.31404502041957405,-0.4812122836099574
2573,response to cAMP (GO:0051591),1.0,-0.6336684252189148,-0.9933569613078734
2574,sodium ion transmembrane transport (GO:0035725),1.0,-0.5646197699556785,-0.9011749779011886
2575,neuron projection extension (GO:1990138),1.0,-0.5718480763853566,-0.8854526296179422
2576,positive regulation of potassium ion transport (GO:0043268),1.0,-0.5594319530447011,-0.8629520834815598
2577,protein deacetylation (GO:0006476),1.0,-0.2811118086992701,-0.4468853664981746
2578,protein dephosphorylation (GO:0006470),1.0,-0.5518973099096235,-0.905009813578042
2579,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1.0,-0.6020563554123828,-0.946645676856631
2580,cytoplasmic translation (GO:0002181),1.0,0.4169316019640103,0.9702962569739068
2581,phosphate ion transport (GO:0006817),1.0,-0.5953057683882441,-0.8872191137063064
2582,negative regulation of organelle assembly (GO:1902116),1.0,-0.5838915466167158,-0.9241472864198316
2583,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1.0,-0.43896910728697586,-0.722897395223624
2584,cilium-dependent cell motility (GO:0060285),1.0,-0.48852042843739707,-0.7471106528440413
2585,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),1.0,-0.6526940799350377,-0.9992846527977485
2586,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),1.0,-0.6121181906809092,-0.9389879862161278
2587,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),1.0,0.32523837902264596,0.95052526333041
2588,diacylglycerol metabolic process (GO:0046339),1.0,-0.5727737600818061,-0.8946388597140765
2589,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),1.0,-0.3684349083269231,-0.5909093565145916
2590,positive regulation of triglyceride metabolic process (GO:0090208),1.0,-0.5926778258679671,-0.9085803069939857
2591,positive regulation of axonogenesis (GO:0050772),1.0,-0.5329155757987951,-0.8612855661725032
2592,release of cytochrome c from mitochondria (GO:0001836),1.0,-0.5801987020263293,-0.8918381973186312
2593,regulation of cellular macromolecule biosynthetic process (GO:2000112),1.0,-0.5976522861201443,-0.984703731121796
2594,response to glucose (GO:0009749),1.0,-0.576614797784219,-0.9068827746378028
2595,transepithelial transport (GO:0070633),1.0,-0.4782980633704708,-0.721507581754603
2596,anion transmembrane transport (GO:0098656),1.0,-0.44700127188539945,-0.7216923131307397
2597,signal transduction by p53 class mediator (GO:0072331),1.0,-0.5802349185411341,-0.9039603480108604
2598,recombinational repair (GO:0000725),1.0,-0.36397345015308924,-0.5846180944037246
2599,negative regulation of cell cycle G2/M phase transition (GO:1902750),1.0,-0.4471435868342932,-0.7208989941381488
2600,negative regulation of BMP signaling pathway (GO:0030514),1.0,-0.44097324997199094,-0.6905901657255374
2601,cellular component assembly (GO:0022607),1.0,-0.5848632136400456,-0.9580980646813306
2602,negative regulation of cellular protein metabolic process (GO:0032269),1.0,-0.5490914608499113,-0.9012491887034172
2603,axoneme assembly (GO:0035082),1.0,-0.4633650394433462,-0.7247882361646425
2604,organophosphate ester transport (GO:0015748),1.0,-0.6040023312671348,-0.9372879595378462
2605,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",1.0,-0.5820512504039111,-0.8948916575949547
2606,peptidyl-tyrosine dephosphorylation (GO:0035335),1.0,-0.5883339958028461,-0.9175438513965749
2607,amyloid precursor protein metabolic process (GO:0042982),1.0,0.46459199878057206,1.023125766784811
2608,chaperone cofactor-dependent protein refolding (GO:0051085),1.0,0.298778671432827,0.6653373305264918
2609,cytoskeleton-dependent cytokinesis (GO:0061640),1.0,-0.5218307184484915,-0.8369673850648021
2610,tRNA modification (GO:0006400),1.0,-0.35639420107033254,-0.5707677596597958
2611,histone lysine methylation (GO:0034968),1.0,-0.3807382230739808,-0.5925837244768646
2612,neuromuscular junction development (GO:0007528),1.0,-0.62540197200957,-0.966322130667136
2613,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",1.0,-0.5011956836236258,-0.7665349072363242
2614,regulation of long-term synaptic potentiation (GO:1900271),1.0,-0.5909253287450453,-0.9194035962326657
2615,regulation of mitochondrial membrane permeability (GO:0046902),1.0,-0.6362289170947495,-0.959516604640666
2616,negative regulation of MAP kinase activity (GO:0043407),1.0,-0.406230523337359,-0.6567510036330069
2617,gonad development (GO:0008406),1.0,-0.5633325300221902,-0.893712944783683
2618,positive regulation of telomerase activity (GO:0051973),1.0,-0.4116155786069545,-0.6425887636089282
2619,positive regulation of synaptic transmission (GO:0050806),1.0,-0.5351910835489437,-0.8424880236447764
2620,autophagosome maturation (GO:0097352),1.0,-0.6140634109717541,-0.9576996659732036
2621,peptidyl-proline modification (GO:0018208),1.0,-0.5542395766338288,-0.8691539975697736
2622,cardiac muscle cell contraction (GO:0086003),1.0,-0.37734325804547647,-0.5755393281447202
2623,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),1.0,-0.33426621969089,-0.5180709068006139
2624,sympathetic nervous system development (GO:0048485),1.0,0.3744688294739212,0.696342601134877
2625,intracellular estrogen receptor signaling pathway (GO:0030520),1.0,-0.5523982729850114,-0.848766858790594
2626,establishment of protein localization to extracellular region (GO:0035592),1.0,-0.6134008998985565,-0.936074464125732
2627,purine ribonucleotide transport (GO:0015868),1.0,-0.6383498932442033,-0.9692885806669161
2628,epithelium development (GO:0060429),1.0,-0.6114698239542118,-0.9914698737544181
2629,phagosome acidification (GO:0090383),1.0,-0.5665711726389067,-0.8847899032924555
2630,heterocycle biosynthetic process (GO:0018130),1.0,-0.5926421343104278,-0.8782029789434846
2631,negative regulation of epithelial to mesenchymal transition (GO:0010719),1.0,-0.4662927722859598,-0.7283546431020749
2632,regulation of ubiquitin-protein transferase activity (GO:0051438),1.0,-0.3176001868139452,-0.49642457276600355
2633,regulation of sodium ion transmembrane transporter activity (GO:2000649),1.0,-0.5517434648191609,-0.853989265040585
2634,nucleoside diphosphate metabolic process (GO:0009132),1.0,-0.5518547865919325,-0.8188191900621228
2635,cAMP-mediated signaling (GO:0019933),1.0,-0.6691189372281652,-0.9963706882729213
2636,negative regulation of double-strand break repair (GO:2000780),1.0,-0.6026912643212485,-0.9471403723141624
2637,telomere maintenance via telomere lengthening (GO:0010833),1.0,-0.5621065501708558,-0.8987570021098239
2638,establishment of protein localization to organelle (GO:0072594),1.0,-0.597922041034563,-0.956799779581774
2639,positive regulation of lipid catabolic process (GO:0050996),1.0,-0.6431878381163194,-0.9917684006163602
2640,response to ionizing radiation (GO:0010212),1.0,-0.5358132260807055,-0.8502198733688219
2641,contractile actin filament bundle assembly (GO:0030038),1.0,-0.5723799755876251,-0.8694661358953485
2642,tRNA 5'-end processing (GO:0099116),1.0,-0.37794935311302347,-0.5991757403875034
2643,regulation of telomerase activity (GO:0051972),1.0,-0.36096990570790993,-0.5707643237662355
2644,positive regulation of stem cell differentiation (GO:2000738),1.0,-0.4805383444529741,-0.7244645693069865
2645,purine ribonucleotide biosynthetic process (GO:0009152),1.0,-0.5384914380040147,-0.8513290428985725
2646,regulation of Golgi organization (GO:1903358),1.0,0.31379117811278623,0.6382645423337243
2647,nitric oxide metabolic process (GO:0046209),1.0,-0.6408830881267938,-0.972286819845336
2648,termination of RNA polymerase II transcription (GO:0006369),1.0,-0.29427351514690164,-0.46024016354322456
2649,regulation of bicellular tight junction assembly (GO:2000810),1.0,-0.613291984182154,-0.9210172912531333
2650,peroxisomal membrane transport (GO:0015919),1.0,-0.4021483735004847,-0.6288641809437941
2651,intracellular lipid transport (GO:0032365),1.0,-0.34403188404707985,-0.5331584474837814
2652,protein targeting to membrane (GO:0006612),1.0,-0.4877522193460072,-0.7957088114933146
2653,neural crest cell migration (GO:0001755),1.0,-0.4019087373565881,-0.6343073615441976
2654,acylglycerol metabolic process (GO:0006639),1.0,-0.503169934027256,-0.800378441127117
2655,membrane organization (GO:0061024),1.0,-0.5840964945718775,-0.9622077975278496
2656,membrane depolarization (GO:0051899),1.0,-0.5129240970460173,-0.7843479196743667
2657,positive regulation of cell growth (GO:0030307),1.0,-0.5947543522327202,-0.9681390408473473
2658,positive regulation of cell cycle G2/M phase transition (GO:1902751),1.0,-0.4143067019484111,-0.6261456236763702
2659,neuronal action potential (GO:0019228),1.0,-0.4711921983488772,-0.7300138946146928
2660,regulation of embryonic development (GO:0045995),1.0,-0.629750163431146,-0.987804639900317
2661,sphingolipid catabolic process (GO:0030149),1.0,-0.5118858223384002,-0.7851084414942916
2662,cellular response to hypoxia (GO:0071456),1.0,-0.5399891267566451,-0.8726034029864624
2663,high-density lipoprotein particle remodeling (GO:0034375),1.0,-0.3279508213075736,-0.5098941143948809
2664,histone exchange (GO:0043486),1.0,0.35307703769929966,0.7093623975702636
2665,"mRNA splicing, via spliceosome (GO:0000398)",1.0,-0.3449797253490381,-0.5610745548663139
2666,RNA polyadenylation (GO:0043631),1.0,-0.3346765054401212,-0.5177148468593593
2667,phosphatidylinositol biosynthetic process (GO:0006661),1.0,-0.5997606576129486,-0.9812893554266865
2668,cellular response to starvation (GO:0009267),1.0,-0.5716148352449002,-0.9329525425043567
2669,C21-steroid hormone metabolic process (GO:0008207),1.0,-0.5952087615470336,-0.9275496017425663
2670,superoxide metabolic process (GO:0006801),1.0,-0.625904709238826,-0.9797539120090253
2671,regulation of transcription by RNA polymerase I (GO:0006356),1.0,-0.5276558210485534,-0.8070822420042599
2672,nuclear export (GO:0051168),1.0,-0.40755511473312617,-0.6578673184188442
2673,regulation of mRNA stability (GO:0043488),1.0,-0.44377931522101977,-0.7271152296443756
2674,DNA unwinding involved in DNA replication (GO:0006268),1.0,-0.5508954333750202,-0.8374300412519355
2675,membrane protein ectodomain proteolysis (GO:0006509),1.0,-0.5835542720955668,-0.8990162601131307
2676,regulation of protein localization to membrane (GO:1905475),1.0,-0.6402469820153871,-0.9997781239565018
2677,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),1.0,-0.5119260184612283,-0.8412692189713357
2678,hippo signaling (GO:0035329),1.0,-0.39303190540974664,-0.6073847102109092
2679,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),1.0,-0.36832582431424815,-0.570396842663726
2680,response to steroid hormone (GO:0048545),1.0,-0.5717948348753734,-0.8900562662713515
2681,regulation of systemic arterial blood pressure (GO:0003073),1.0,0.5575962389771525,1.1020720750822754
2682,positive regulation of excitatory postsynaptic potential (GO:2000463),1.0,-0.3821601712243047,-0.5732490975173733
2683,signal transduction in response to DNA damage (GO:0042770),1.0,-0.5160739119898811,-0.8241633505655847
2684,ribonucleoprotein complex biogenesis (GO:0022613),1.0,-0.3832505439991945,-0.6179992968474096
2685,positive regulation of epithelial cell migration (GO:0010634),1.0,-0.6187607571877826,-0.9907334147120671
2686,gastrulation (GO:0007369),1.0,-0.6105974206310154,-0.9376552910604493
2687,response to purine-containing compound (GO:0014074),1.0,-0.5896849996913188,-0.9026809715695631
2688,N-acetylglucosamine metabolic process (GO:0006044),1.0,-0.5149143850031586,-0.7745689593206022
2689,regulation of myotube differentiation (GO:0010830),1.0,-0.37730288486490626,-0.5928272994684384
2690,regulation of cellular response to growth factor stimulus (GO:0090287),1.0,-0.6105041257521194,-0.944041612855046
2691,DNA recombination (GO:0006310),1.0,-0.5274400537719899,-0.8394279635665427
2692,DNA integrity checkpoint signaling (GO:0031570),1.0,-0.42023428030389054,-0.6677954107024687
2693,synaptic vesicle recycling (GO:0036465),1.0,-0.41911901358815923,-0.6697389558342013
2694,cellular response to epidermal growth factor stimulus (GO:0071364),1.0,-0.6077505086844206,-0.9417242670134005
2695,intracellular steroid hormone receptor signaling pathway (GO:0030518),1.0,-0.5165628441390631,-0.8098611971673568
2696,cilium movement (GO:0003341),1.0,-0.5396447128901285,-0.8596928760593237
2697,internal peptidyl-lysine acetylation (GO:0018393),1.0,-0.47010835976741794,-0.7393279269095488
2698,interstrand cross-link repair (GO:0036297),1.0,-0.2538750777688033,-0.40549680962138246
2699,organelle fusion (GO:0048284),1.0,0.36733554223595555,0.49682277212121745
2700,glutamate metabolic process (GO:0006536),1.0,-0.5283151771658885,-0.802685103603223
2701,mitochondrial fusion (GO:0008053),1.0,0.4398079213817749,0.6266514712927879
2702,protein targeting (GO:0006605),1.0,-0.4714616644258406,-0.7685235973632488
2703,regulation of protein metabolic process (GO:0051246),1.0,-0.5321954770988447,-0.8360311937724694
2704,anterograde axonal transport (GO:0008089),1.0,0.47631081225151223,1.021569399672687
2705,protein import into peroxisome membrane (GO:0045046),1.0,-0.3759865842122624,-0.5822248485089708
2706,positive regulation of filopodium assembly (GO:0051491),1.0,-0.5085769989948761,-0.8123082492327842
2707,positive regulation of Notch signaling pathway (GO:0045747),1.0,-0.5568170664175355,-0.8806217718371133
2708,cilium organization (GO:0044782),1.0,-0.5095997875626055,-0.8333455716950724
2709,regulation of lipoprotein lipase activity (GO:0051004),1.0,-0.6280569651900572,-0.9635729026166673
2710,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1.0,-0.5485615915118792,-0.8633384614757232
2711,regulation of supramolecular fiber organization (GO:1902903),1.0,0.5977793466537847,0.8774479074313795
2712,sphingolipid biosynthetic process (GO:0030148),1.0,-0.4389411562293456,-0.6993364576427532
2713,regulation of phospholipase C activity (GO:1900274),1.0,-0.6459175631635949,-0.9616224241624339
2714,regulation of protein autophosphorylation (GO:0031952),1.0,-0.5896973598209315,-0.9225686348723334
2715,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),1.0,-0.4960989602121424,-0.7681873822982975
2716,tail-anchored membrane protein insertion into ER membrane (GO:0071816),1.0,-0.6342158295688628,-0.9706129583785262
2717,semaphorin-plexin signaling pathway (GO:0071526),1.0,-0.521048140522646,-0.819971965433966
2718,miRNA metabolic process (GO:0010586),1.0,0.2584223653352197,1.0184859154929589
2719,protein alkylation (GO:0008213),1.0,-0.6493842945609686,-0.9677854798924052
2720,regulation of Wnt signaling pathway (GO:0030111),1.0,-0.5775404893138754,-0.9365255558366404
2721,positive regulation of cellular protein localization (GO:1903829),1.0,-0.6083453277085564,-0.990353496647426
2722,cellular response to organic cyclic compound (GO:0071407),1.0,-0.6031617157828122,-0.9797241395380899
2723,regulation of microtubule polymerization (GO:0031113),1.0,-0.50947597146128,-0.8145981702111634
2724,cyclic purine nucleotide metabolic process (GO:0052652),1.0,-0.5431842830621239,-0.8291055008278627
2725,regulation of axon extension involved in axon guidance (GO:0048841),1.0,-0.33490478045745675,-0.510485585665456
2726,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",1.0,-0.5265573883229756,-0.8090418995801569
2727,apical junction assembly (GO:0043297),1.0,-0.6403676049594936,-1.001392916530646
2728,protein transmembrane import into intracellular organelle (GO:0044743),1.0,-0.4267272926349147,-0.6702565748758719
2729,gland development (GO:0048732),1.0,-0.6002748148926923,-0.9780016890416248
2730,meiosis I (GO:0007127),1.0,-0.5345560351367404,-0.8313999683855904
2731,regulation of keratinocyte proliferation (GO:0010837),1.0,-0.5971994560546384,-0.9111343856354476
2732,regulation of spindle assembly (GO:0090169),1.0,-0.4850055863636597,-0.7550847206766964
2733,modification-dependent protein catabolic process (GO:0019941),1.0,-0.4304037985239999,-0.6988941219267406
2734,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),1.0,-0.32517271900780614,-0.504341430068833
2735,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",1.0,-0.2800494387097293,-0.4522654631498471
2736,regulation of membrane depolarization (GO:0003254),1.0,-0.4036987070013328,-0.6300180064625346
2737,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",1.0,-0.47869605135829596,-0.749544790752838
2738,sodium ion transport (GO:0006814),1.0,-0.5800407488853901,-0.936312700444076
2739,negative regulation of cell projection organization (GO:0031345),1.0,-0.33401426390804406,-0.5179500180641526
2740,negative regulation of protein ubiquitination (GO:0031397),1.0,-0.42207142407990395,-0.6770340585900396
2741,cellular response to organonitrogen compound (GO:0071417),1.0,-0.5777831400615048,-0.9348153861793719
2742,inorganic cation import across plasma membrane (GO:0098659),1.0,-0.5021875642756634,-0.8005574642333558
2743,regulation of cell morphogenesis (GO:0022604),1.0,-0.5854870337743703,-0.9189910047389092
2744,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",1.0,-0.39405515371009747,-0.6068434261553396
2745,negative regulation of developmental process (GO:0051093),1.0,-0.5600330785466541,-0.9050922595561202
2746,mitochondrial membrane organization (GO:0007006),1.0,-0.49437735532595817,-0.7839685848300103
2747,regulation of small GTPase mediated signal transduction (GO:0051056),1.0,-0.615999898535598,-0.998630818203656
2748,protein N-linked glycosylation (GO:0006487),1.0,-0.5014282399649995,-0.7862080122767475
2749,negative regulation of DNA binding (GO:0043392),1.0,-0.5733567206199095,-0.8814896073432444
2750,positive regulation of lipid metabolic process (GO:0045834),1.0,-0.5763626920250112,-0.901751766041205
2751,histone acetylation (GO:0016573),1.0,-0.5648581349814824,-0.9025191560653509
2752,nucleosome organization (GO:0034728),1.0,-0.609596947377382,-0.9855092507012413
2753,microtubule cytoskeleton organization involved in mitosis (GO:1902850),1.0,-0.30234550416828393,-0.4894131025940144
2754,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),1.0,-0.5596477823193664,-0.8562387209955359
2755,positive regulation of translation (GO:0045727),1.0,-0.5722144434113823,-0.9373960513749598
2756,regulation of stem cell differentiation (GO:2000736),1.0,-0.5934600803490528,-0.9565274269508175
2757,negative regulation of cell cycle process (GO:0010948),1.0,-0.5740333377988737,-0.9229919917530996
2758,regulation of cholesterol metabolic process (GO:0090181),1.0,-0.31017580597691813,-0.469333942171523
2759,neuron development (GO:0048666),1.0,-0.4478498099438966,-0.726981373962898
2760,autophagy of nucleus (GO:0044804),1.0,-0.4380412382202175,-0.6881314410776779
2761,N-glycan processing (GO:0006491),1.0,-0.563328737661456,-0.8807552407470612
2762,negative regulation of actin filament polymerization (GO:0030837),1.0,-0.5607456613772488,-0.8782692389447536
2763,protein localization to membrane (GO:0072657),1.0,-0.5612532172328364,-0.9201535774226149
2764,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),1.0,-0.6081113935196591,-0.9173066123073044
2765,positive regulation by host of viral transcription (GO:0043923),1.0,0.4041539492295093,0.7951223282917359
2766,establishment of protein localization to plasma membrane (GO:0061951),1.0,-0.5568657005306411,-0.8667478999351155
2767,negative regulation of lipid biosynthetic process (GO:0051055),1.0,-0.3835397629173731,-0.5831337011592835
2768,cellular monovalent inorganic cation homeostasis (GO:0030004),1.0,-0.5027218085377573,-0.7602805838546278
2769,RNA processing (GO:0006396),1.0,-0.3614453367207703,-0.5858025472555445
2770,brain development (GO:0007420),1.0,-0.5938901362062882,-0.9653983870805655
2771,adrenergic receptor signaling pathway (GO:0071875),1.0,-0.6324367334658864,-0.9436601375240451
2772,embryonic digestive tract development (GO:0048566),1.0,-0.6136639511889935,-0.9351177659419188
2773,positive regulation of cellular component movement (GO:0051272),1.0,-0.5530206372198547,-0.8427052826315872
2774,positive regulation of sprouting angiogenesis (GO:1903672),1.0,-0.6436303701673631,-0.9805844555422788
2775,female gamete generation (GO:0007292),1.0,-0.5974184983586505,-0.9324992368370754
2776,negative regulation of cation transmembrane transport (GO:1904063),1.0,-0.37192326305706114,-0.5538249317609755
2777,protein localization to cell periphery (GO:1990778),1.0,-0.5282384718390943,-0.8550069799998548
2778,ciliary basal body-plasma membrane docking (GO:0097711),1.0,-0.2358288129964667,-0.3755719939813757
2779,positive regulation of telomere maintenance via telomerase (GO:0032212),1.0,0.45439970843181476,0.7785579268606243
2780,regulation of neurogenesis (GO:0050767),1.0,-0.611680098554107,-0.9883765901432002
2781,regulation of microtubule-based process (GO:0032886),1.0,-0.37629101726931474,-0.5906671733941068
2782,heparan sulfate proteoglycan biosynthetic process (GO:0015012),1.0,-0.6049225500700534,-0.9255118329345152
2783,"regulation of DNA-templated transcription, elongation (GO:0032784)",1.0,-0.4824121134162709,-0.755902365473069
2784,positive regulation of regulated secretory pathway (GO:1903307),1.0,-0.5699308306074327,-0.8739439795303561
2785,muscle cell development (GO:0055001),1.0,0.4918181921059585,0.7298514460934122
2786,phagosome maturation (GO:0090382),1.0,-0.5800406966607754,-0.9135994545726731
2787,lipid droplet organization (GO:0034389),1.0,-0.5182125084061022,-0.7980012002783938
2788,regulation of cation transmembrane transport (GO:1904062),1.0,-0.480606861593175,-0.7348870489481686
2789,pharyngeal system development (GO:0060037),1.0,-0.4452402298026541,-0.6812894739830292
2790,postsynaptic membrane organization (GO:0001941),1.0,0.33526860854772467,0.5910832769819268
2791,"transcription, DNA-templated (GO:0006351)",1.0,-0.5009883637761386,-0.8269287236699722
2792,"regulation of gene expression, epigenetic (GO:0040029)",1.0,-0.4181143032682782,-0.6771808148322296
2793,cholesterol efflux (GO:0033344),1.0,-0.37225921248925764,-0.5731893787301359
2794,acylglycerol homeostasis (GO:0055090),1.0,-0.536105819019513,-0.8480900363759919
2795,cellular response to amino acid stimulus (GO:0071230),1.0,-0.4067149179891829,-0.6438549972685524
2796,regulation of cytoskeleton organization (GO:0051493),1.0,-0.5787946553547958,-0.936093035401273
2797,early endosome to late endosome transport (GO:0045022),1.0,-0.5550715195764419,-0.858687044741416
2798,histone monoubiquitination (GO:0010390),1.0,-0.43375705796764774,-0.678862593363126
2799,glycosphingolipid biosynthetic process (GO:0006688),1.0,-0.5136379288418842,-0.7659181297867083
2800,sphingosine metabolic process (GO:0006670),1.0,-0.5665650148662816,-0.883329532027114
2801,histone H3-K4 methylation (GO:0051568),1.0,-0.5371598953832512,-0.8367289472378289
2802,tRNA methylation (GO:0030488),1.0,-0.42569020783406986,-0.6514251979962253
2803,ventricular septum morphogenesis (GO:0060412),1.0,-0.49865102820905816,-0.7831564342218742
2804,nucleic acid-templated transcription (GO:0097659),1.0,-0.535911324670827,-0.8430012166412412
2805,positive regulation of embryonic development (GO:0040019),1.0,-0.4960289142910861,-0.7678588960227574
2806,protein modification process (GO:0036211),1.0,-0.610121108934033,-0.9761883403824425
2807,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1.0,-0.47978679053446355,-0.7793878779593348
